WO2000008169A1 - Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants - Google Patents

Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants Download PDF

Info

Publication number
WO2000008169A1
WO2000008169A1 PCT/EP1999/005467 EP9905467W WO0008169A1 WO 2000008169 A1 WO2000008169 A1 WO 2000008169A1 EP 9905467 W EP9905467 W EP 9905467W WO 0008169 A1 WO0008169 A1 WO 0008169A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
plants
doxs
plant
dna sequence
Prior art date
Application number
PCT/EP1999/005467
Other languages
German (de)
French (fr)
Other versions
WO2000008169A8 (en
Inventor
Andreas Reindl
Patricia Leon Mejia
Juan Manuel Esteves Palmas
Maria Araceli Cantero Gracia
Marcus Ebneth
Karin Herbers
Original Assignee
Sungene Gmbh & Co.Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998135219 external-priority patent/DE19835219A1/en
Priority claimed from DE1998145224 external-priority patent/DE19845224A1/en
Priority claimed from DE1998145216 external-priority patent/DE19845216A1/en
Priority claimed from DE1998145231 external-priority patent/DE19845231A1/en
Application filed by Sungene Gmbh & Co.Kgaa filed Critical Sungene Gmbh & Co.Kgaa
Priority to AU54157/99A priority Critical patent/AU757440B2/en
Priority to JP2000563793A priority patent/JP2002525034A/en
Priority to CA002339519A priority patent/CA2339519A1/en
Priority to EP99940083A priority patent/EP1102852A1/en
Publication of WO2000008169A1 publication Critical patent/WO2000008169A1/en
Publication of WO2000008169A8 publication Critical patent/WO2000008169A8/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1022Transferases (2.) transferring aldehyde or ketonic groups (2.2)

Definitions

  • the present invention relates to the use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content, specifically the use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this, the use of a DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No.
  • DOXS 1-deoxy-D-xylulose-5-phosphate synthase
  • DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 a DNA sequence SEQ-ID No. 5 and a DNA sequence SEQ-ID No.
  • ⁇ -Tocopherol is of great economic importance.
  • Isoprenoids or terpenoids consist of different classes of lipid-soluble molecules and are partially or completely formed from Cs-isoprene units.
  • Pure prenyl lipids e.g. carotenoids
  • C skeletons which are exclusively based on isoprene units
  • mixed prenyl lipids e.g. chlorophyll
  • the starting point for the biosynthesis of prenyl lipids are 3 x acetyl-CoA units, which are converted via ß-hydroxymethylglutaryl-CoA (HMG-CoA) and mevalonate into the starting isoprene unit (C 5 ), the isopentenyl pyrophosphate (IPP). It has recently been shown by in vivo feeding experiments with C 13 that in various eubacteria, green algae and plant chloroplasts a Mevalonate-independent path to the formation of IPP is followed:
  • Hydroxyethylthiamine which is formed by decarboxylation of pyruvate, and glyceraldehyde-3-phosphate (3-GAP) are mediated in a l-deoxy-D-xylulose-5-phosphate synthase
  • IPP is in equilibrium with its isomer, dimethylallyl pyrophosphate (DMAPP).
  • DMAPP dimethylallyl pyrophosphate
  • GPP monoterpene
  • FPP Farnesy pyrophosphate
  • GGPP geranyl-geranyl pyrophosphate
  • the ring structures of the mixed prenyl lipids that lead to the formation of vitamins E and K are quinones, the starting metabolites of which come from the Shikimate pathway.
  • the aromatic amino acids phenylalanine and tyrosine are converted into hydroxyphenyl pyruvate, which is converted into homogenisic acid by dioxygenation. This is bound to PPP to form the precursor of ⁇ -tocopherol and ⁇ -tocoquinone, 2-methyl-6-phytylquinol.
  • the object of the present invention was to develop a transgenic plant with an increased content of tocopherols, vitamin K, chlorophylls and carotenoids.
  • the task was surprisingly achieved by overexpressing a 1-deoxy-D-xylulose-5-phosphate synthesis (DOXS) gene in the plants.
  • DOXS 1-deoxy-D-xylulose-5-phosphate synthesis
  • IPP in order to increase the metabolite flow from the primary metabolism into the isopronide metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
  • the activity of DOXS in plants was increased by overexpression of the homologous gene (gene from organism of the same type). This can also be achieved by expressing a heterologous gene (gene from distant organisms). Nucleotide sequences are described from Arabidopsis thaliana DOXS (Acc. No. U 27099), rice (Acc. No. AF024512) and peppermint (Acc. No. AF019383).
  • the DOXS gene from Arabidopsis thaliana (SEQ ID No.:1; Mandel et al, Plant J. 9, 649-658 (1996); Acc. No. U27099) is expressed to a greater extent in transgenic plants. Plastid localization is ensured by the transit signal sequence contained in the gene sequence.
  • a DNA sequence which codes for a DOXS gene which is identified by SEQ-ID No. 1 hybridizes and that comes from other organisms such as E. coli (SEQ-ID No. 3) or preferably from other plants.
  • the GGPP which is now increasingly available, is being further converted towards tocopherols and carotenoids.
  • carotenoids perform important protective functions against oxygen radicals, such as singlet oxygen, which they can return to the ground state (Asada, 1994; Demming-Adams and Adams, Trends in Plant Sciences 1; 21-26 (1996) 1-Deoxy-D-xyllos-5-phosphate synthase defective Arabidopsis thaliana mutant isolated, which shows an "albino phenotype" (Mandel et al, 1996). From this it can be deduced that a reduced amount of carotenoids in the plastids has negative effects on the plant.
  • DOXS l-deoxy-D-xylulose-5-phosphate synthase
  • HPPD p-hydroxyphenylpyruvate dioxygenase
  • the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
  • the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
  • D-1-deoxy-xylulose-5-phosphate is further converted towards tocopherols and carotenoids.
  • homogentisic acid further increases the metabolite flow in the direction of phytylquinones and thus tocopherol, see Figure 1.
  • Homogentisic acid is formed from p-hydroxyphenyl pyruvate by the enzyme p-hydroxyphenyl pyruvate dioxygenase (HPPD).
  • HPPD p-hydroxyphenyl pyruvate dioxygenase
  • the HPPD gene from Streptomyces avermitilis (Denoya et al., J. Bacteriol. 176 (1994),
  • the transgenic plants are produced by transforming the plants with a construct containing the DOXS and HPPD genes.
  • As model plants for the production of Tocopherols vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
  • the invention also relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5, which code for a DOXS or HPPD or their functional equivalents, for producing a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
  • the nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or HPPD and which give the host the ability to overproduce tocopherol.
  • an expression cassette also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
  • an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS or HPPD gene.
  • An expression cassette is produced by fusing a suitable promoter with a suitable DOXS or HPPD DNA sequence and preferably a DNA inserted between the promoter and DOXS or HPPD DNA sequence which codes for a chloroplast-specific transit peptide, and a polyadenyly - Signaling according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
  • Transit peptides which controls the translocation of the polypeptide.
  • Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or HPPD part after translocation of the DOXS or HPPD gene into the chloroplasts.
  • the transit peptide which is derived from plastid transketolase (TK) is particularly preferred. or a functional equivalent of this transit peptide (e.g. the transit peptide of the Rubisco small subunit or the
  • Ferredoxin NADP oxidoreductase is derived.
  • the fused expression cassette which codes for a DOXS gene and an HPPD gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
  • Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
  • the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
  • the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
  • Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
  • the invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or hybridizing with these DNA sequences, as well as transgenic cells, tissues, parts and propagation material of such plants.
  • Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
  • DOXS l-deoxy-D-xylulose-5-phosphate synthase
  • GGPPOR geranylgeranyl pyrophosphate oxidoreductase
  • the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
  • the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
  • the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased in a further step of the invention by overexpression of a corresponding gene.
  • an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
  • the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants.
  • the Arabidopsis GGPPOR is preceded by a transit signal sequence.
  • a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants.
  • Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
  • the transgenic plants are produced by transforming the plants with a construct containing the DOXS and GGPPOR genes.
  • As model plants for the production of Tocopherols vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
  • the invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 which code for a DOXS or GGPPOR or their functional equivalents, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
  • the nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or GGPPOR and which give the host the ability to overproduce tocopherol.
  • the expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
  • an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and, if appropriate, further regulatory elements which are operatively linked to the intervening coding sequence for the DOXS or GGPPOR gene.
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
  • sequences preferred but not limited to the operative linkage are targeting sequences to ensure the sub-cellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or other compartments and Translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
  • the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
  • Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
  • any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
  • a plant promoter or a promoter which originates from a plant virus is preferably used.
  • the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294). As is known, this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
  • the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS or GGPPOR gene in the plant can be controlled at a specific point in time.
  • a chemically inducible promoter as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186), one inducible by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one inducible by abscisic acid (EP-A 335528) or inducible by ethanol or cyclohexanone ( WO 93/21334) promoters can include be used.
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular.
  • the promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
  • An expression cassette is produced by fusing a suitable promoter with a suitable DOXS or GGPPOR DNA sequence and preferably a DNA which is inserted between the promoter and DOXS or GGPPOR DNA sequence and which codes for a chloroplast-specific transit peptide and one Polyadenylation signal according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J.
  • Expression cassettes can also be used, the DNA sequence of which codes for a DOXS or GGPPOR fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
  • Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or GGPPOR part after translocation of the DOXS or GGPPOR gene into the chloroplasts.
  • Particularly preferred is the transit peptide derived from plastid transketolase (TK) or a functional equivalent of this transit peptide (eg the transit peptide of the small subunit of the
  • Rubisco or the ferredoxin NADP oxidoreductase is derived.
  • the fused expression cassette which codes for a DOXS gene or a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
  • Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ ID No. 1 or SEQ ID No. 3, SEQ ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
  • the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
  • the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
  • Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
  • the invention also relates to transgenic plants transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants.
  • Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
  • Process for transforming a plant is characterized in that expression cassettes containing a DNA sequence SEQ-ID No. 1 or a DNA sequence SEQ-ID No. 3 and a SEQ ID No. 7 or DNA sequences hybridizing with these zen into a plant cell, into callus tissue, an entire plant or protoplasts of plants.
  • DOXS l-deoxy-D-xylulose-5-phosphate synthase
  • HPPD p-hydroxyphenylpyruvate dioxygenase
  • GGPPOR geranylgeranylpyrophosphate oxidoreductase
  • the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
  • the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can also be done by expressing homologous or other heterologous DOXS genes - such as a DNA sequence SEQ-ID No. 1 - can be achieved.
  • the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased by overexpression of a corresponding homologous or heterologous gene in a further step which is essential to the invention.
  • an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
  • the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants.
  • the Arabidopsis GGPPOR is preceded by a transit signal sequence.
  • a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants.
  • Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
  • HPPD p-hydroxyphenylpyruvate dioxygenase
  • cDNAs coding for this enzyme have been described from various organisms such as, for example, from microorganisms, from plants and from humans.
  • the cloning of the HPPD gene from Streptomyces avermitilis is described (Denoya et al., J. Bacteriol. 176 (1994), 5312-5319; SEQ ID No. 5).
  • the HPPD from Streptomyces is preceded by a transit signal sequence.
  • a DNA sequence which codes for an HPPD gene which is identified by SEQ-ID No. 5 hybridizes and that comes from other organisms or plants.
  • the transgenic plants according to the invention are produced by transforming the plants with a construct containing the DOXS, the HPPD gene and the GGPPOR gene (Example 17). Tobacco and rapeseed were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
  • the invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7, which code for a DOXS, an HPPD and a GGPPOR or their functional equivalents, for the production of a plant with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
  • the nucleic acid sequences can be, for example, DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which encode for a DOXS, an HPPD and a GGPPOR and which give the host the ability to overproduce tocopherol.
  • an expression cassette also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
  • an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS, the HPPD or the GGPPOR gene.
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements such that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
  • sequences preferred but not limited to the operative linkage are targeting sequences to ensure the subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or others Compartments and translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
  • the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
  • Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
  • HPT hygromycin phosphotransferase
  • OCS octopine synthase terminator
  • PNOS nopalin synthase promoter - in addition, restriction sites are shown that only cut the vector once.
  • any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
  • a plant promoter or a plant virus-derived promoter is preferably used.
  • the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294).
  • this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
  • the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS, HPPD or GGPPOR gene in the plant can be controlled at a specific point in time.
  • a chemically inducible promoter by means of which the expression of the exogenous DOXS, HPPD or GGPPOR gene in the plant can be controlled at a specific point in time.
  • promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a salicylic acid-inducible promoter (WO 95/19443), a benzene-sulfonamide-inducible promoter
  • EP-A 388186 one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or that by ethanol or cyclohexanone-inducible (WO 93/21334) promoter can include be used.
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular.
  • the promoter of the cytosolic FBPase from potato or the ST-LSI promoter from potato are to be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
  • An expression cassette is produced by fusing a suitable promoter with a suitable DOXS, HPPD or GGPPOR DNA sequence and preferably a DNA inserted between promoter and DOXS, HPPD or GGPPOR DNA sequence, which is suitable for a chloroplast-specific transit peptide encoded, and a polyadenylation signal according to common recombination and cloning techniques, such as those described in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
  • Expression cassettes whose DNA sequence codes for a DOXS, HPPD or GGPPOR fusion protein can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
  • Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS, HPPD or GGPPOR part after translocation of the DOXS, HPPD or GGPPOR gene into the chloroplast.
  • the transit peptide which is derived from plastid transketolase (TK) or a functional equivalent is particularly preferred.
  • This transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is derived.
  • the fused expression cassette which codes for a DOXS gene, an HPPD gene and a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
  • Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
  • the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
  • the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
  • Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
  • the invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants.
  • Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various tree, nut and wine species.
  • DOXS gene from Arabidopsis or E. coli or DNA sequences hybridizing therewith and subsequent testing of chemicals for inhibition of DOXS enzyme activity.
  • the transgenic plants are produced by transforming the plants with a construct containing the DOXS gene.
  • Arabidopsis and oilseed rape were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
  • DOXS gene from Arabidopsis is cloned by isolating the cDNA specific for the DOXS gene (SEQ-ID No. 1).
  • the invention relates to the use of the DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 which codes for a DOXS or its functional equivalent, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
  • the nucleic acid sequence can e.g. be a DNA or a cDNA sequence. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS and which give the host the ability to overproduce tocopherol.
  • the expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
  • an expression cassette comprises upstream, ie at the 5 'end of the coding sequence, a promoter and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which match the coding sequence for the DOXS gene in between are operationally linked.
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
  • sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil bodies or other compartments and translation enhancers like the 5 'guiding sequence from tobacco Mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987) 8693-8711).
  • the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
  • Fig. Shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
  • HPT hygromycin phosphotransferase - OCS: octopine synthase terminator PNOS: nopalin synthase promoter also such restriction sites are shown that only cut the vector once.
  • any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
  • a plant promoter or a promoter derived from a plant virus is preferably used.
  • the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294).
  • this promoter contains different recognition sequences for transcriptional effectors which, in their entirety, lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
  • the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS gene in the plant can be controlled at a specific point in time.
  • a chemically inducible promoter by means of which the expression of the exogenous DOXS gene in the plant can be controlled at a specific point in time.
  • promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186 ), one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or one that can be induced by ethanol or cyclohexanone (WO 93 / 21334)
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that are leaf-specific are particularly noteworthy Ensure expression.
  • the promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989) 2445-245).
  • the expression cassette can therefore, for example, be a seed-specific promoter (preferably the phaseolin
  • An expression cassette is produced by fusing a suitable promoter with a suitable DOXS-DNA sequence and preferably a DNA inserted between promoter and DOXS-DNA sequence, which codes for a chloroplast-specific transit peptide, and a polyadenylation signal according to common recombination and cloning techniques, such as those for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
  • Sequences are particularly preferred which ensure targeting in the apoplasts, in plastids, in the vacuole, in the mitochondrion, in the endoplasmic reticulum (ER) or in the absence of corresponding operative sequences to ensure that they remain in the compartment of formation, the cytosol (Kermode, Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792).
  • Expression cassettes can also be used, the DNA sequence of which codes for a DOXS fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
  • Particularly preferred for the chloroplasts are specific transit peptides which, after translocation of the DOXS gene into the chloroplasts, are enzymatically removed from the DOXS part. will split.
  • the transit peptide which is derived from the plastidic transketolase (TK) or a functional equivalent of this transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is particularly preferred.
  • the inserted nucleotide sequence coding for a DOXS can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components, as well as consist of different heterologous DOXS gene sections of different organisms.
  • synthetic nucleotide sequences with codons are generated which are preferred by plants. These codons preferred by plants can be determined from codons with the highest protein frequency, which are expressed in most interesting plant species.
  • various DNA fragments can be manipulated in order to obtain a nucleotide sequence which expediently reads in the correct direction and which is equipped with a correct reading frame.
  • adapters or linkers can be attached to the fragments.
  • the promoter and terminator regions can expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence.
  • the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites.
  • the linker has a size of less than 100 bp within the regulatory areas, often less than 60 bp, but at least 5 bp.
  • the promoter can be native or homologous as well as foreign or heterologous to the host plant.
  • the expression cassette contains in the 5 '-3' transcription direction the promoter, a DNA sequence which codes for a DOXS gene and a region for the transcriptional termination. Different termination areas are interchangeable.
  • Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984) 835 ff) or functional equivalents.
  • An expression cassette can contain, for example, a constitutive promoter (preferably the CaMV 35 S promoter), the LeB4 signal peptide, the gene to be expressed and the ER retention signal.
  • a constitutive promoter preferably the CaMV 35 S promoter
  • the amino acid sequence KDEL lysine, aspartic acid, glutamic acid, leucine
  • KDEL lysine, aspartic acid, glutamic acid, leucine
  • the fused expression cassette which codes for a DOXS gene is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
  • Agrobacteria transformed with such a vector can then be used in a known manner to transform plants, in particular crop plants, such as e.g. of tobacco plants can be used, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • the transformation of plants by agrobacteria is known, among other things, from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. From the transformed cells of the wounded leaves or leaf pieces, transgenic plants can be regenerated in a known manner which contain a gene integrated into the expression cassette for the expression of a DOXS gene contain.
  • an expression cassette is inserted as an insert into a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example Contains sequences for replication or integration.
  • additional functional regulatory signals for example Contains sequences for replication or integration.
  • Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
  • the expression cassettes can be cloned into suitable vectors that allow their proliferation, for example in E. coli.
  • suitable cloning vectors include pBR332, pUC series, Ml3mp series and pACYC184.
  • Binary vectors which can replicate both in E. coli and in agrobacteria are particularly suitable.
  • Another object of the invention relates to the use of an expression cassette containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 and SEQ-ID No. 7, or with these hybridizing DNA sequences for the transformation of plants, cells, tissues or parts of plants.
  • the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
  • the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
  • Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
  • the expression cassette can also be used to transform bacteria, cyanobacteria, yeast, filamentous fungi and algae with the aim of increasing tocopherol, vitamin K, chlorophyll and / or carotenoid production.
  • transformation The transfer of foreign genes into the genome of a plant is called transformation.
  • the methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene cannon - the so-called particle bombardment method, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and the gene transfer mediated by Agrobacterium.
  • the methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol.
  • the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agro acteriu / n tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
  • Agrobacteria transformed with an expression cassette can also be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, oats, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes, rape, Alfalfa, lettuce and the various tree, nut and wine species can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • crop plants such as cereals, maize, oats, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes, rape, Alfalfa, lettuce and the various tree, nut and wine species can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • Functionally equivalent sequences which code for a DOXS gene are those sequences which, despite a different nucleotide sequence, still have the desired functions. Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon use of a plant.
  • a functional equivalent is also understood to mean, in particular, natural or artificial mutations in an originally isolated sequence coding for a DOXS, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
  • the present invention also encompasses those nucleotide sequences which are obtained by modifying the DOXS nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also be the insertion of further restriction enzyme interfaces.
  • Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
  • artificial DNA sequences are suitable as long as they have the desired property, for example, of increasing the tocopherol content in the plant, as described above
  • Such artificial DNA sequences can be Setting of proteins constructed using molecular modeling, which have DOXS activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence according to the codon usage specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
  • Suitable equivalent nucleic acid sequences are sequences which code for fusion proteins, part of the fusion protein being a plant DOXS polypeptide or a functionally equivalent part thereof.
  • the second part of the fusion protein can e.g. be another polypeptide with enzymatic activity or an antigenic polypeptide sequence that can be used to detect DOXS expression (e.g. myc-tag or his-tag).
  • this is preferably a regulatory protein sequence, such as e.g. a signal or transit peptide that directs the DOXS protein to the desired site of action.
  • the invention also relates to the expression products and fusion proteins produced according to the invention from a transit peptide and a polypeptide with DOXS activity.
  • increasing the tocopherol, vitamin K, chlorophyll and / or carotenoid content means the artificially acquired ability to increase the biosynthetic capacity of these compounds by functional overexpression of the DOXS gene in the plant compared to the non-genetically modified plant for the duration of at least one generation of plants.
  • the tocopherol biosynthesis site is generally the leaf tissue, so that leaf-specific expression of the DOXS gene is useful.
  • the tocopherol biosynthesis need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant - for example in fatty seeds.
  • constitutive expression of the exogenous DOXS gene is advantageous.
  • inducible expression may also appear desirable.
  • the effectiveness of the expression of the transgenically expressed DOXS gene can be determined, for example, in vitro by proliferation of the shoot meristem.
  • a change in the type and level of expression of the DOXS gene and its effect on the tocopherol Biosynthetic performance can be tested on test plants in greenhouse experiments.
  • the invention also relates to transgenic plants transformed with an expression cassette containing the
  • Plants in the sense of the invention are mono- and dicotyledonous plants or algae.
  • the complete cDNA sequence of the Arabidopsis DOXS is cloned into an expression vector (pQE, Qiagen) and overexpressed in E. coli.
  • the DOXS protein expressed with the aid of the expression cassette is particularly suitable for the detection of inhibitors specific for the DOXS.
  • the DOXS can be used, for example, in an enzyme test in which the activity of the DOXS is determined in the presence and absence of the active substance to be tested. By comparing the two activity determinations, a qualitative and quantitative statement can be made about the inhibitory behavior of the active substance to be tested. Methods for determining the activity of DOXS are described (Putra et. Al., Tetrahedron Letters 39 (1998), 23-26; Sprenger et al., PNAS 94 (1997), 12857-12862).
  • DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or introduces a hybridizing DNA sequence into a plant cell, into callus tissue, an entire plant or plant protoplasts.
  • cloning steps carried out in the context of the present invention such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking of DNA fragments, transformation of E. coli cells, cultivation of bacteria Multiplication of phages and sequence analysis of recombinant DNA were carried out as in Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6).
  • the bacterial strains used below (E. coli, XL-I Blue) were obtained from Stratagene.
  • the agrobacterial strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850 can) was developed by Deblaere et al. in (Nucl. Acids Res. 13 (1985) 4777).
  • the LBA4404 agrobacterial strain (Clontech) or other suitable strains can be used.
  • the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBluescript SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl. Acids Res. 12 (1984), 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990), 221-230).
  • the sequencing of recombinant DNA molecules was carried out using a laser fluorescence DNA sequencer from Licor (sold by MWG Biotech, Ebersbach) according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1977), 5463 - 5467).
  • the Arabisopsis thaliana DOXS gene was described in Mandel et al. (1996) described as a complete cDNA cloned into the vector pBluescript KS- (Stratagene).
  • a 2.3 kb fragment (labeled F-23-C) was isolated via the pBluescript KS-Hincll (blunt-end) and Sacl interfaces. This sequence contains the complete DOXS cDNA including chloroplast transit peptide from the ATG start codon to an EcoRI interface that is 80 bp downstream of the stop codon.
  • a culture of Escherichia coli XL1 Blue was grown in 300 ml Luria Broth medium for 12 hours at 37 ° C.
  • the genomic DNA of the bacterium was isolated from this culture by first pelleting at 5000 revolutions in a Sorvall RC50 fugue
  • the pellet was then resuspended in 1/30 volume of the original culture lysis buffer (25 mM EDTA, 0.5% SDS; 50 mM Tris HC1, pH 8.0). An equal volume of phenol / chloroform / isoamyl alcohol (25: 24: 1) was added and incubated at 70 degrees for 10 minutes. Subsequently, in a Heraeus under-table
  • oligonucleotides were derived from the DNA sequence of the DOXS (Acc. Number AF035440), to which a BamHI at the 5 'end and an Xbal or another BamHI restriction site were added at the 3' end.
  • DOXS Acc. Number AF035440
  • the oligonucleotide at the 5 'end comprises the sequence 5' -A1GGATCCATGAGTTTT-GATATTGCCAAATAC-3 '
  • the oligonucleotide at the 3 'end comprises the sequence 5' - ATTCT AG ATTATGCCAGCCAGGCCTTG- 3 'or 5'-ATG-GATCCTTATGCCAGCCAGGCCTTG -3 '(nucleotides 1845-1863 of the reverse complementary DNA sequence; written in italics) starting with the
  • the PCR reaction with the two BamHI-containing oligonucleotides was carried out with the Pfu polymerase (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template.
  • the PCR program was:
  • the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was determined by sequencing.
  • the BamHI fragment was isolated from the PCR script vector and ligated into a correspondingly cut Bin19 vector which additionally contains the transit peptide of the potato transketolase behind the CaMV 35S promoter. The transit peptide ensures plastid localization.
  • the constructs are shown in Figures 5 and 6 and the fragments have the following meaning:
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
  • Fragment B (259 bp) contains the transit peptide of the transketolase.
  • Fragment E contains the gene of the DOXS.
  • Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • the PCR reaction with the oligonucleotides containing 5 '-BamHI and 3' -Xbal was carried out using Taq polymerase (Takara, Sosei Co., Ltd.) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template.
  • the PCR program was:
  • the fragment was purified using the gene clean kit and ligated into the vector pGemT (Promega GmbH, Mannheim). It was cloned as a BamHI / Xbal fragment into a correspondingly cut pBinl9AR vector behind the CaMV 35S promoter. The sequence was checked by sequencing (SEQ-ID No. 3) and two non-conservative base changes were found, which lead to a change in amino acid 152 (asparagine) in valine and amino acid 330 (cysteine) in tryptophan compared to the published sequence.
  • RNA from 15 day old seedlings of different transgenic lines, which have the DOXS overexpression construct was determined according to the method of Logeman et al., Anal. Biochem. 163, 16-20 (1987) extracted, separated in a 1.2% agarose gel, transferred to filters and hybridized with a 2.1 kb long DOXS fragment as a probe ( Figure 7).
  • transgenic rape plants The production of the transgenic rape plants is based on a protocol by Bade, JB and Damm, B (in Gene, Transfer to Plants, Potrykus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30-38 ), which also gives the composition of the media used.
  • the transformations were carried out with the Agrobacterium strain LBA4404 (Clontech).
  • the pBIN19 constructs already described above with the entire DOXS cDNA were used as binary vectors. In these pBIN vectors, the NOS terminator sequence was replaced by the OCR terminator sequence.
  • Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min in 55 ° CH 2 0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Twenn 20 ) incubated for 20 min and washed six times with sterile H0 for 20 min each.
  • the seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium.
  • the roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx.
  • 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm.
  • An overnight culture of the Agrobacterium strain was set up at 29 ° C. in LB with kanamycin (20 mg / l), of which 2 ml in 50 ml LB without kanamycin for 4 h at 29 ° C. up to an OD 60 o of 0.4- 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an OD600 of 0.3 by adding further basal medium.
  • the callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min.
  • the Agrobacteria suspension was removed, the oilseed rape explants were washed for 1 min with 50 ml callus induction medium and then 100 ml callus induction medium was added.
  • the co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h. The co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm.
  • the washing medium with the explants was transferred to 15 cm petri dishes and the medium was removed using sterile pipettes. distant.
  • 20-30 explants were transferred to 90 mm petri dishes containing 25 ml shoot induction medium with kanamycin.
  • the petri dishes were closed with two layers of leucopore and incubated at 25 ° C and 2000 lux for 16/8 H photoperiods. Every 12 days, the developing calli was transferred to fresh petri dishes with sprout induction medium. All further steps for the regeneration of whole plants were carried out as by Bade, JB and Damm, B. (in Gene Transfer to Plants, Potrycus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30- 38).
  • the cDNA of DOXS (SEQ-ID No. 1) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
  • the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
  • Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
  • Leaf disks with a diameter of 0.9 cm were taken from completely unfolded leaves from plants which contained the construct pBinAR HPPD-DOXS and were frozen in liquid nitrogen.
  • the leaf material was homogenized in a HEPES-KOH buffer which contained proteinase inhibitors and the protein concentration was determined from the extract using the Bio-Rad protein assay according to the manufacturer's instructions.
  • 45 ⁇ g protein of each extract were mixed with a volume of application buffer (Laemmli, 1970) and incubated for 5 min at 95 ° C. The proteins were then separated on a 12.5 percent SDS-PAGE gel. The proteins were then transferred to Porablot membrane (Machery and Nagel) using semi-dry electroblots.
  • the DOXS protein was detected by means of an antibody against the E. coli DOXS from rabbits.
  • the color reaction is based on the binding of a secondary antibody and an alkaline phosphatase, which converts NBT / BCIP into a dye.
  • Secondary antibody and alkaline Phosphatase are from Pierce and were carried out according to the manufacturer's instructions.
  • Figure 10 shows the detection of the DOXS protein in leaves of 5 transgenic plants.
  • 1 marker; 2: plant 10; 3:62; 4: 63; 5: 69; 7:71; 8: 112; 9: 113; 10: 116; 11: WT1; 12: WT2; 13: 100 recombinant protein; 14:50ng recombinant protein; 15:10 ng recombinant protein.
  • a culture of Streptomyces avermitilis U11864 was made in 300 ml of YEME medium (5 g malt extract, 2 g yeast extract, 2 g glucose)
  • the genomic DNA of the bacterium was isolated from this culture by first pelleting it at 5000 U in a Sorvall RC5C fugue. The pellet was then resuspended in 1/30 volume of lysis buffer (25 mM EDTA, 0.5% SDS, 50 mM Tris-HCl, pH 8.0). An equal volume of phenol /
  • the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCAGCGGA - CAAGCCAAC-3 '(37 to 55 bases from the ATG in 5' direction; written in italics), the oligonucleotide at the 3 'end comprises the sequence
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) 10 and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was found that the isolated gene codes for an additional amino acid. It contains the three bases TAC (coding for tyrosine), 15 before the nucleotide N429 of the cited sequence (Denoya et al., 1994).
  • the fragment was isolated from the vector with a BamHI and Xbal digest and into a correspondingly cut Bin19AR vector
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower 30 mosaic virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic virus).
  • Fragment B (259 bp) contains the transit peptide of the transketolase.
  • Fragment C contains the HPPD gene.
  • Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen, J. et al., EMBO J. 3 (1984), 35 835-846) for transcription termination.
  • a binary vector was prepared that contains both gene sequences ( Figure 13).
  • the gene sequences of the DOXS 45 and the HPPD were each cloned as BamHI fragments as described in Examples 3 and 10.
  • the vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • the pBinAR-Hyg vector mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
  • oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end.
  • the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; italics)
  • the oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC- CCGCGCCGCCTACAGGTTG-3 '(ending with base pair 1140 of the coding sequence, starting 8 base pairs 3' of the TAG stop codon; written in italics).
  • the PCR reaction was carried out using Tli polymerase (Promega GmbH, Mannheim) according to the manufacturer's instructions. 10 ng of the plasmid pBinAR-HPPD were used as template.
  • the PCR program was:
  • the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was cut out of the vector PCR script as a BamHI fragment and ligated into a correspondingly cut pBinAR vector, which additionally contains the transit peptide of transketolase, for introducing the gene product into the plastids. The plasmid pBinAR-TP-HPPD was formed ( Figure 12).
  • the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) isolated for transcription termination by means of PCR.
  • a HindIII interface was added to each of the oligonucleotides for the promoter and the terminator.
  • the sequence of the oligonucleotide which is attached to the 5 'region of the promoter is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 '-ATAAGCTTGGACAATCAGTAAATTGAACGGAG-3'.
  • the fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and according to the manufacturer's instructions in the vector PCR script (Stratagene GmbH, Heidelberg) cloned. The correctness of the sequence was checked by sequencing (SEQ-ID No. 5). From this PCR script vector, it was transferred as a Hindlll fragment into the correspondingly cut vector pBinl9 (Bevan, 1984, Nucleic 5 Acids Res. 12, 8711-8721).
  • the plasmid pBinAR-TP-DOXS was used to convert the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
  • oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAA-CGGA-G-3'.
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The accuracy
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower mosaic virus (nucleotides 6909 to 7437).
  • Fragment B contains the transit peptide of plastid transketolase.
  • Fragment C contains the gene of the HPPD.
  • Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
  • Fragment E contains the gene of the DOXS.
  • tobacco leaf disks were transformed with 45 sequences of the DOXS and the HPPD.
  • 10 ml of an overnight culture of Agrobacterium tumefaciens grown under selection were centrifuged, the supernatant was discarded and the bacteria were resuspended in the same volume of antibiotic-free medium.
  • Leaf disks of sterile plants (diameter approx. 1 cm) were bathed in this bacterial suspension in a sterile petri dish. The leaf disks were then placed in Petri dishes on MS medium (Murashige and Skoog, Physiol. Plant (1962) 15, 473) with 2% sucrose and 0.8% Bacto agar.
  • transgenic rapeseed plants which have a changed prenyl lipid content
  • the transformations were carried out with the Agrobacterium tumefaciens strain LBA4404 (Clontech GmbH, Heidelberg).
  • the binary constructs already described above with the entire cDNAs of the DOXS and the HPPD were used as binary vectors.
  • the NOS terminator sequence was replaced by the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min at 55 ° C in H0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Tween 20 ) incubated for 20 min and washed six times with sterile H 2 0 for 20 min each.
  • the seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium.
  • the roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx.
  • 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm. An overnight culture of the Agrobacterium strain was set up at 29 ° C. in Luria Broth medium with kanamycin (20 mg / 1), of which 2 ml in 50 ml Luria Broth medium without kanamycin for 4 h at 29 ° C. up to an OD 6 oo on 0.4 to 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an ODgoo of 0.3 by adding further basal medium.
  • the callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min.
  • the Agrobacteria suspension was removed, the oilseed rape explant washed with 50 ml callus induction medium for 1 min and then 100 ml callus induction medium added.
  • the co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h.
  • the co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm.
  • the washing medium with the explants was in 15 cm
  • the cDNA of DOXS (SEQ-ID No. 3) and HPPD (SEQ-ID No. 5) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
  • the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
  • Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all In some cases, the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
  • RNA 20 ⁇ g of total RNA were first mixed with 3.3 ⁇ l of 3M sodium acetate solution and 2 ⁇ l of IM magnesium sulfate solution and made up to 100 ⁇ l of final volume with DEPC water. 1 ⁇ l of RNase-free DNase (Boehringer Mannheim) was added and incubated at 37 ° C. for 45 min. After removing the enzyme by shaking with phenol / chloroform / isoamyl alcohol, the RNA was precipitated with ethanol and the pellet was taken up in 100 ⁇ l DEPC water. 2.5 ⁇ g RNA from this solution were transcribed into cDNA using a cDNA kit (Gibco, Life Technologies).
  • a cDNA kit Gibco, Life Technologies
  • the oligonucleotide at the 5 'end comprises the sequence 5' -ATGGATCCATGGCGACGACGGTTACAC C-3 'starting with the first codon of the cDNA (printed in italics), the oligonucleotide at the 3' end comprises the sequence 5 '-ATGTCGACGTGATGA- TAGATTACTAACAGAC-3 'starting with base pair 1494 of the cDNA sequence (printed in italics).
  • PCR reaction was carried out using Pfu polymerase from Strategagene GmbH, Heidelberg, according to the manufacturer's instructions. 1/8 volume of the cDNA was used as template (corresponds to 0.3 ⁇ g RNA).
  • the PCR program was:
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the fragment was checked by sequencing (SEQ ID No. 7).
  • the gene was cloned as a BamHI / SalI fragment into the correspondingly cut vector BinAR-Hyg by means of the restriction cut sections added to the sequence by the primers.
  • This contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., EMBO J. 3 (1984), 835-846) for transcription termination.
  • the plasmid imparts resistance to the antibiotic hygromycin in plants and is thus suitable for superinfecting plants with kanamycin resistance. Since the plastid transit peptide is
  • GGPPOR was also cloned, the protein should be transported to the plastids in transgenic plants.
  • the construct is shown in Figure 14.
  • the fragments have the following meaning:
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
  • Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
  • a binary vector was prepared that contains both gene sequences ( Figure 15).
  • the GGPPOR gene with the intrinsic plastid localization sequence was (as described in Example 15) as a BamHI / Sall fragment in the corresponding cloned vector pBinAR-Hyg cloned.
  • the gene of the DOXS was cloned as a BamHI fragment as described in Example 3.
  • the vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. This plasmid mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
  • the plasmid pBinAR-TP-DOXS became the 35S promoter, the trans-ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR.
  • An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence.
  • the sequence of the oligonucleotide which is attached to the promoter is 5 '-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAACGGA-.
  • the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector pBin19 (Bevan, Nucleic Acids Res. 12 (1984), 8711-8721).
  • the 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) were isolated from the plasmid pBinARHyg-GGPPOR for PCR transcription termination.
  • An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator.
  • the sequence of the oligonucleotide which is attached to the promoter is 5 '-ATTCTAGAC ⁇ TG- GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATTCTAGAGGACAA-TCAGGAGAATT 3 '.
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an Xbal fragment into the correspondingly cut vector, which already contained the sequence of the DOXS as described above.
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
  • Fragment B contains the transit peptide of the plastid transketolase.
  • Fragment E contains the gene of the DOXS.
  • Fragment D 5 contains the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
  • oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end.
  • the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; written in italics), the 30 oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC -
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of sequence 45 was checked by sequencing. It was cut out as a BamHI fragment from the vector PCR script and ligated into a correspondingly cut pBinAR vector which additionally contains the Transketolase transit peptide contains, for the introduction of the gene product in the plastids. The plasmid pBinAR-TP-p-HPPD was formed.
  • the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the p-HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid PTIACH5 (Gielen et al. 1984 ) for transcription termination by means of PCR.
  • a HindIII interface was added to each of the oligonucleotides for the promoter and the terminator.
  • the sequence of the oligonucleotide which is attached to the 5 'region of the promoter is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 ' -ATAAGCTTGGAC-AATCAGTAAATTGAACGGAG-3 '.
  • the fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. From this PCR script vector it was transferred as a HindIII fragment into the correspondingly cut vector pBin19 (Bevan, 1984, Nucleic Acids Res. 12, 8711-8721).
  • the plasmid pBinAR-TP-DOXS became the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR.
  • An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence.
  • the sequence of the oligonucleotide, which is attached to the promoter (italics) is 5'-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3 ', that of the oligonucleotide, which is attached to the terminator sequence (italics) is 5' -ATGAATTCGGACAATC ⁇ GA- GTAAATTGAAC .
  • the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector, which already contained the sequence of the HPPD as described above.
  • the 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 were isolated from the plasmid pBinARHyg-GGPPOR for transcription termination by means of PCR.
  • An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator.
  • the sequence of the oligonucleotide, which is located at the The promoter (written in italics) is 5 '-ATTCTAGACATG-GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5'-ATTCTAGAGGACAA-TCAGTAAATTGAACGGAG-3 '.
  • the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing.
  • Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
  • Fragment B contains the transit peptide of the plastid transketolase.
  • Fragment C contains the gene of the HPPD.
  • Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
  • Fragment E contains the gene of the DOXS. Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
  • the cDNA of DOXS (SEQ-ID No. 3) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
  • the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
  • Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
  • the cDNA of DOXS (SEQ-ID No. 3), HPPD (SEQ-ID No. 5) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and in rapeseed using the 35S promoter overexpressed.
  • the seed-specific promoter of the phaseolin gene was used to specifically determine the tocopherol content in the rapeseed to increase.
  • Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.

Abstract

Method for the production of plants with enhanced vitamin E biosynthesis efficiency by overproduction of a 1-deoxy-D-xylulose-5-phosphate synthase gene from Arabidopsis or E. coli.

Description

DNA-Sequenz kodierend für eine l-Deoxy-D-Xylulose-5-Phosphat Synthase und deren Überproduktion in PflanzenDNA sequence coding for an l-deoxy-D-xylulose-5-phosphate synthase and its overproduction in plants
Beschreibungdescription
Die vorliegende Erfindung betrifft die Verwendung von DNA- Sequenzen codierend für eine 1-Deoxy-D-Xylulose- 5 -Phosphat Synthase (DOXS) zur Herstellung von Pflanzen mit erhöhtem Tocopherol - , Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt, speziell die Verwendung einer DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder einer mit dieser hybridisierenden DNA- Sequenz, die Verwendung einer DNA-Sequenz SEQ ID No. 1 oder SEQ-ID No. 3 und einer DNA- Sequenz SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequen- zen kodierend für eine l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) und eine p-Hydroxyphenylpyruvat Dioxygenase (HPPD) zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden, die Verwendung einer DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3 und einer DNA- Sequenz SEQ ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen kodierend für eine l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) und eine Geranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden, die Verwendung einer DNA-Sequenz SEQ-ID No . 1 oder SEQ-ID No. 3, einer DNA-Sequenz SEQ-ID No. 5 und einer DNA-Sequenz SEQ-ID No . 7 oder mit diesen hybridisierende DNA-Sequenzen kodierend für eine l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) , eine Hydroxyphe- nylpyruvat Dioxygenase (HPPD) und eine Geranylgeranyl-Pyro- phosphat Oxidoreduktase (GGPPOR) zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/ oder Carotinoiden, Verfahren zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K- , Chlorophyll- und/oder Carotinoid- Gehalt, enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3; SEQ-ID No . 1 oder SEQ-ID No . 3 und SEQ-ID No. 5; SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 bzw. eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 5 und SEQ-ID No. 7, die derart hergestellten Pflanzen selbst, sowie die Verwendung der SEQ-ID No. 1 oder SEQ-ID No. 3 zur Herstellung eines Testsystems zur Identifizierung von Inhibitoren der DOXS.The present invention relates to the use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content, specifically the use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this, the use of a DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No. 5 or with these hybridizing DNA sequences coding for an l-deoxy-D-xylulose-5-phosphate synthase (DOXS) and a p-hydroxyphenylpyruvate dioxygenase (HPPD) for the production of plants with an increased tocopherol content, vitamin K, Chlorophylls and / or carotenoids, the use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ ID No. 7 or with these hybridizing DNA sequences coding for an l-deoxy-D-xylulose-5-phosphate synthase (DOXS) and a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for the production of plants with an increased content of tocopherols, vitamin K, chlorophylls and / or carotenoids, the use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3, a DNA sequence SEQ-ID No. 5 and a DNA sequence SEQ-ID No. 7 or with these hybridizing DNA sequences coding for an l-deoxy-D-xylulose-5-phosphate synthase (DOXS), a hydroxyphenylpyruvate dioxygenase (HPPD) and a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for the production of plants with an increased content of tocopherols, vitamin K, chlorophylls and / or carotenoids, process for the production of plants with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content, containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 and SEQ-ID No. 7, the plants themselves, and the use of SEQ-ID No. 1 or SEQ-ID No. 3 for the production of a test system for the identification of inhibitors of DOXS.
Ein wichtiges Ziel pflanzenmolekulargenetischer Arbeiten ist bisher die Erzeugung von Pflanzen mit erhöhtem Gehalt an Zuckern, Enzymen und Aminosäuren. Wirtschaftlich interessant ist jedoch auch die Entwicklung von Pflanzen mit erhöhtem Gehalt an Vitaminen, wie z.B. der Erhöhung des Tocopherol-Gehaltes . Die in der Natur vorkommenden acht Verbindungen mit Vitamin E-Ak- tivität sind Derivate des 6-Chromanols (Ullmann's Encyclopedia of Industrial Chemistry, Vol. A 27 (1996), VCH Verlagsgesellschaft, Chapter 4., 478-488, Vitamin E) . Die erste Gruppe (la-d) stammt von Tocopherol ab, die zweite Gruppe besteht aus Derivaten des Tocotrienols (2a- d) :An important goal of plant molecular genetic work so far has been the production of plants with an increased content of sugars, enzymes and amino acids. However, the development of plants with an increased vitamin content, such as, for example, increasing the tocopherol content, is also of economic interest. The eight naturally occurring compounds with vitamin E activity are derivatives of 6-chromanol (Ullmann's Encyclopedia of Industrial Chemistry, Vol. A 27 (1996), VCH Verlagsgesellschaft, Chapter 4., 478-488, vitamin E). The first group (la-d) is derived from tocopherol, the second group consists of derivatives of tocotrienol (2ad):
Figure imgf000004_0001
Figure imgf000004_0001
la, α-Tocopherol : Ri R2 = R3 = CH-; lb, ß-Tocopherol [148-03-8] : R1 = R3 = CH3 , R2 = H lc, γ-Tocopherol [54-28-4] : R1 = H, R2 = R3 = CH3 ld, δ-Tocopherol [119-13-1] : R1 = R2 = H, R3 = CH3 la, α-tocopherol: Ri R 2 = R 3 = CH-; Ib, β-tocopherol [148-03-8]: R 1 = R 3 = CH 3 , R 2 = H lc, γ-tocopherol [54-28-4]: R 1 = H, R 2 = R 3 = CH 3 id, δ-tocopherol [119-13-1]: R 1 = R 2 = H, R 3 = CH 3
Figure imgf000004_0002
Figure imgf000004_0002
2a, α-Tocotrienol [1721-51-3] : R1 = R2 = R3 = CH3 2b, ß-Tocotrienol [490-23-3] : R1 = R3 = CH3 , R2 = H2a, α-tocotrienol [1721-51-3]: R 1 = R 2 = R 3 = CH 3 2b, β-tocotrienol [490-23-3]: R 1 = R 3 = CH 3 , R 2 = H
2c, γ-Tocotrienol [14101-61-2] : R1 = H, R2 = R3 = CH3 2c, γ-tocotrienol [14101-61-2]: R 1 = H, R 2 = R 3 = CH 3
2d, δ-Tocotrienol [25612-59-3] : R1 = R2 = H, R3 = CH3 2d, δ-tocotrienol [25612-59-3]: R 1 = R 2 = H, R 3 = CH 3
Wirtschaftlich große Bedeutung besitzt α-Tocopherol .Α-Tocopherol is of great economic importance.
Der Entwicklung von Kulturpflanzen mit erhöhtem Tocopherol-Gehalt durch Gewebekultur oder Samenmutagenese und natürliche Auswahl sind Grenzen gesetzt. So muß einerseits der Tocopherol-Gehalt bereits in Gewebekultur erfaßbar sein und andererseits können nur diejenigen Pflanzen über Gewebekulturtechniken manipuliert werden, deren Regeneration zu ganzen Pflanzen aus Zellkulturen gelingt. Außerdem können Kulturpflanzen nach Mutagenese und Selektion unerwünschte Eigenschaften zeigen, die durch teilweise mehrmalige Rückkreuzungen wieder beseitigt werden müssen. Auch wäre die Erhöhung des Tocopherol-Gehaltes durch Kreuzung auf Pflanzen der selben Art beschränkt. Aus diesen Gründen ist das gentechnische Vorgehen, ein für die Tocopherol Syntheseleistung kodierendes, essentielles Biosynthesegen zu isolieren und in Kulturpflanzen gezielt zu übertragen, dem klassischen Züchtungsverfahren überlegen. Dieses Verfahren setzt voraus, daß die Biosynthese und deren Regulation bekannt ist und daß Gene, die die Biosyntheseleistung beeinflussen, identifiziert werden.There are limits to the development of crops with increased tocopherol content through tissue culture or seed mutagenesis and natural selection. On the one hand, the tocopherol content must already be detectable in tissue culture and, on the other hand, only those plants can be manipulated using tissue culture techniques whose regeneration to whole plants from cell cultures is successful. In addition, after mutagenesis and selection, crop plants can show undesirable properties which have to be eliminated by backcrossing, in some cases repeatedly. The increase in the tocopherol content by crossing would also be restricted to plants of the same type. For these reasons, the genetic engineering procedure to isolate an essential biosynthetic gene coding for the tocopherol synthesis performance and to transfer it specifically in crop plants is superior to the classic breeding method. This method assumes that biosynthesis and its regulation are known and that genes that influence biosynthesis performance are identified.
Isoprenoide oder Terpenoide bestehen aus verschiedenen Klassen lipidlöslicher Moleküle und werden teilweise oder vollständig aus Cs-Isopren-Einheiten gebildet. Reine Prenyllipide (z.B. Carotinoide) bestehen aus C-Skeletten, die ausschließlich auf Isopren-Einheiten zurückgehen, während gemischte Prenyllipide (z.B. Chlorophyll) eine Isoprenoid-Seitenkette besitzen, die mit einem aromatischen Kern verbunden ist.Isoprenoids or terpenoids consist of different classes of lipid-soluble molecules and are partially or completely formed from Cs-isoprene units. Pure prenyl lipids (e.g. carotenoids) consist of C skeletons, which are exclusively based on isoprene units, while mixed prenyl lipids (e.g. chlorophyll) have an isoprenoid side chain which is linked to an aromatic nucleus.
Ausgangspunkt der Biosynthese von Prenyllipiden sind 3 x Acetyl- CoA Einheiten, die über ß-Hydroxymethylglutaryl-CoA (HMG-CoA) und Mevalonat in die Ausgangs-Isopren-Einheit (C5) , dem Isopentenylpy- rophosphat (IPP) , umgewandelt werden. Kürzlich wurde durch in vivo Fütterungsexperimente mit C13 gezeigt, daß in verschiedenen Eubakterien, Grünalgen und pflanzlichen Chloroplasten ein Mevalo- nat-unabhängiger Weg zur Bildung von IPP beschritten wird: The starting point for the biosynthesis of prenyl lipids are 3 x acetyl-CoA units, which are converted via ß-hydroxymethylglutaryl-CoA (HMG-CoA) and mevalonate into the starting isoprene unit (C 5 ), the isopentenyl pyrophosphate (IPP). It has recently been shown by in vivo feeding experiments with C 13 that in various eubacteria, green algae and plant chloroplasts a Mevalonate-independent path to the formation of IPP is followed:
Glycerinaldehyd- 3 -Phosphat + PyruvatGlyceraldehyde-3-phosphate + pyruvate
DOXSDOXS
1 -Deoxy-D-Xylulose- 5 - Phosphat1-Deoxy-D-xylulose 5 - phosphate
1010
CarotinoideCarotenoids
Figure imgf000006_0001
Figure imgf000006_0001
PPPPPP
2525
TocopheroleTocopherols
3030
Dabei werden Hydroxyethylthiamin, das durch Decarboxylierung von Pyruvat entsteht, und Glycerinaldehyd-3-Phosphat (3-GAP) in einer durch die l-Deoxy-D-Xylulose-5-Phosphat Synthase vermitteltenHydroxyethylthiamine, which is formed by decarboxylation of pyruvate, and glyceraldehyde-3-phosphate (3-GAP) are mediated in a l-deoxy-D-xylulose-5-phosphate synthase
35 "Transketolase" -Reaktion zunächst in 1-Deoxy-D-Xylu- lose-5-phosphat umgewandelt (Schwender et al., FEBS Lett. 414 (1) ,129-134 (1997) ; Arigoni et al., Proc .Natl . Acad. Sei USA 94(2), 10600-10605 (1997); Lange et al . , Proc .Natl .Acad. Sei .USA 95(5), 2100-2104(1998); Lichtenthaler et al . , FEBS Lett. 400(3),35 "Transketolase" reaction first converted to 1-deoxy-D-xylulose-5-phosphate (Schwender et al., FEBS Lett. 414 (1), 129-134 (1997); Arigoni et al., Proc. Natl. Acad. Sci. USA 94 (2), 10600-10605 (1997); Lange et al., Proc. Natl. Acad. Sci. USA 95 (5), 2100-2104 (1998); Lichtenthaler et al., FEBS Lett. 400 (3),
40 271-274(1997). Dieses wird dann durch eine intramolekulare Umord- nung in IPP umgesetzt (Arigoni et al . , 1997). Biochemische Daten deuten darauf hin, daß der Mevalonat-Weg im Zytosol operiert und zur Bildung von Phytosterolen führt. Das Antibiotikum Mevinolin, ein spezifischer Inhibitor der Mevalonat-Bildung, führt lediglich40 271-274 (1997). This is then converted into IPP by an intramolecular rearrangement (Arigoni et al., 1997). Biochemical data indicate that the mevalonate route operates in the cytosol and leads to the formation of phytosterols. The antibiotic mevinolin, a specific inhibitor of mevalonate formation, only leads
45 zur Inhibition der Sterol-Biosynthese im Zytoplasma, während die Prenyllipid-Bildung in den Piastiden unbeeinflußt ist (Bach und Lichtenthaler, Physiol. Plant 59(1983), 50-60. Der Mevalonat- unabhängige Weg ist dagegen plastidär lokalisiert und führt vornehmlich zur Bildung von Carotinoiden und plastidären Prenyl- lipiden (Schwender et al . , 1997; Arigoni et al, 1997).45 for the inhibition of sterol biosynthesis in the cytoplasm, while the prenyl lipid formation in the plastids is unaffected (Bach and Lichtenthaler, Physiol. Plant 59 (1983), 50-60. Der Mevalonat- The independent path, on the other hand, is localized plastidically and leads primarily to the formation of carotenoids and plastidic prenyl lipids (Schwender et al., 1997; Arigoni et al, 1997).
IPP steht im Gleichgewicht mit seinem Isomer, dem Dimethylallyl Pyrophosphat (DMAPP) . Eine Kondensation von IPP mit DMAPP in Kopf-Schwanz Anlagerung ergibt das Monoterpen (Cio) Geranyl-Pyro- phosphat (GPP) . Die Addition von weiteren IPP Einheiten führt zum Sesquiterpen (Cι5) Farnesy-Pyrophosphat (FPP) und zum Diterpen (C20) Geranyl-Geranyl-Pyrophosphat (GGPP) . Die Verknüpfung zweier GGPP Moleküle führt zur Bildung der C40-Vorläufer für Carotinoide. GGPP wird durch eine Prenylketten-Hydrogenase zum Phytyl-Pyro- phosphat (PPP) umgeformt, dem Ausgangsstoff für die weitere Bildung von Tocopherolen.IPP is in equilibrium with its isomer, dimethylallyl pyrophosphate (DMAPP). A condensation of IPP with DMAPP in head-tail attachment gives the monoterpene (Cio) geranyl pyrophosphate (GPP). The addition of further IPP units leads to the sesquiterpene (Cι 5 ) Farnesy pyrophosphate (FPP) and to the diterpene (C 20 ) geranyl-geranyl pyrophosphate (GGPP). Linking two GGPP molecules leads to the formation of the C 40 precursors for carotenoids. GGPP is converted to phytyl pyrophosphate (PPP) by a prenyl chain hydrogenase, the starting material for the further formation of tocopherols.
Bei den Ringstrukturen der gemischten Prenyllipide, die zur Bildung der Vitamine E und K führen, handelt es sich um Quinone, deren Ausgangsmetabolite aus dem Shikimat-Weg stammen. Die aromatischen Aminosäuren Phenylalanin bzw. Tyrosin werden in Hydroxy- phenyl-Pyruvat umgewandelt, welches durch Dioxygenierung in Homo- gentisinsäure überführt wird. Diese wird an PPP gebunden, um den Vorläufer von α-Tocopherol und α-Tocoquinon, das 2-Methyl-6-phy- tylquinol, zu bilden. Durch Methylierungsschritte mit S-Adenosyl- methionin als Methyl-Gruppen-Donor entsteht zunächst 2, 3-Dimethyl-6-phytylquinol, dann durch Zyklisierung γ-Tocopherol und durch nochmalige Methylierung α-Tocopherol (Richter, Biochemie der Pflanzen, Georg Thieme Verlag Stuttgart, 1996) .The ring structures of the mixed prenyl lipids that lead to the formation of vitamins E and K are quinones, the starting metabolites of which come from the Shikimate pathway. The aromatic amino acids phenylalanine and tyrosine are converted into hydroxyphenyl pyruvate, which is converted into homogenisic acid by dioxygenation. This is bound to PPP to form the precursor of α-tocopherol and α-tocoquinone, 2-methyl-6-phytylquinol. Methylation steps with S-adenosylmethionine as the methyl group donor initially produce 2,3-dimethyl-6-phytylquinol, then cyclization γ-tocopherol and repeated methylation of α-tocopherol (Richter, Biochemie der Pflanzen, Georg Thieme Verlag Stuttgart , 1996).
In der Literatur finden sich Beispiele die zeigen, daß die Mani - pulation eines Enzyms den Metabolit-Fluß direktional beeinflußen kann. In Experimenten mit einer veränderten Expression der Phytoen Synthase, welche zwei GGPP-Moleküle zu 15-cis-Phytoen miteinander verknüpft, konnte ein direkter Einfluß auf die Carotinoid-Mengen dieser transgenen Tomatenpflanzen gemessen werden (Fray und Grierson, Plant Mol .Biol .22 (4) , 589-602 (1993) ; Fray et al . , Plant J., 8, 693-701(1995). Wie zu erwarten, zeigen transgene Tabakpflanzen mit verringerten Mengen an Phenylalanin- Ammonium Lyase reduzierte Phenylpropanoid-Mengen . Das Enzym Phenylalanin-Ammonium Lyase katalysiert den Abbau von Phenyl - alanin, entzieht es also der Phenylpropanoid-Biosynthese (Bäte et al.,Proc. Natl. Acad. Sei USA 91 (16): 7608-7612 (1994); Howles et al., Plant Physiol. 112. 1617-1624(1996).In the literature there are examples which show that the manipulation of an enzyme can have a directional influence on the metabolite flow. In experiments with a modified expression of phytoene synthase, which links two GGPP molecules to 15-cis-phytoene, a direct influence on the carotenoid amounts of these transgenic tomato plants could be measured (Fray and Grierson, Plant Mol. Biol .22 ( 4), 589-602 (1993), Fray et al., Plant J., 8, 693-701 (1995) As expected, transgenic tobacco plants with reduced amounts of phenylalanine ammonium lyase show reduced amounts of phenylpropanoid Phenylalanine ammonium lyase catalyzes the breakdown of phenylalanine, i.e. it removes it from phenylpropanoid biosynthesis (Bäte et al., Proc. Natl. Acad. Sei USA 91 (16): 7608-7612 (1994); Howles et al., Plant Physiol. 112. 1617-1624 (1996).
Über die Erhöhung des Metabolitflusses zur Steigerung des Toco- pherol-Gehaltes in Pflanzen durch Übeexpression einzelnerOn increasing the metabolite flow to increase the tocopherol content in plants through overexpression of individuals
Biosynthesegene ist bisher wenig bekannt. Lediglich WO 97/27285 beschreibt eine Modifikation des Tocopherol-Gehaltes durch verstärkte Expression bzw. durch Herunterregulation des Enzyms p-Hydroxyphenylpyruvatdioxygenase (HPPD) .Little is known about biosynthetic genes. Only WO 97/27285 describes a modification of the tocopherol content by increased expression or by down-regulation of the enzyme p-hydroxyphenylpyruvate dioxygenase (HPPD).
Aufgabe der vorliegenden Erfindung war die Entwicklung einer transgenen Pflanze mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und Carotinoiden.The object of the present invention was to develop a transgenic plant with an increased content of tocopherols, vitamin K, chlorophylls and carotenoids.
Die Aufgabe wurden überraschenderweise gelöst durch die Über- expression eines 1-Deoxy-D-Xylulose- 5 -Phosphat Sythase (DOXS)- Gens in den Pflanzen.The task was surprisingly achieved by overexpressing a 1-deoxy-D-xylulose-5-phosphate synthesis (DOXS) gene in the plants.
Um den Metabolit-Fluß aus dem Primärstoffwechsel in den Isopre- noid-StoffWechsel zu verstärken, wurde die Bildung von IPP als allgemeines Ausgangssubstrat für alle plastidären Isoprenoide erhöht. Zu diesem Zweck wurde in Pflanzen die Aktivität der DOXS durch Überexpression des homologen Gens (Gen aus Orgnismus der selben Art) erhöht. Dies kann auch durch die Expression eines heterologen Gens (Gens aus entfernten Organismen) erreicht werden. Nukleotidsequenzen sind aus Arabidopsis thaliana DOXS (Acc. No. U 27099), Reis (Acc. No. AF024512) und Pfefferminze (Acc. No. AF019383) beschrieben.In order to increase the metabolite flow from the primary metabolism into the isopronide metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased. For this purpose, the activity of DOXS in plants was increased by overexpression of the homologous gene (gene from organism of the same type). This can also be achieved by expressing a heterologous gene (gene from distant organisms). Nucleotide sequences are described from Arabidopsis thaliana DOXS (Acc. No. U 27099), rice (Acc. No. AF024512) and peppermint (Acc. No. AF019383).
In einem Ausführungsbeispiel 1 wird das DOXS-Gen aus Arabidopsis thaliana (SEQ-ID No.:l; Mandel et al, Plant J. 9, 649-658(1996); Acc. No. U27099) in transgenen Pflanzen verstärkt exprimiert. Eine Plastidenlokalisierung ist durch die in der Gensequenz enthaltenen Transitsignalsequenz gewährleistet. Auch geeignet als Expressionskassette ist eine DNA-Sequenz, die für ein DOXS-Gen kodiert, das mit SEQ-ID No . 1 hybridisiert und das aus anderen Organismen wie zum Beispiel E. coli (SEQ-ID No. 3) bzw. vorzugsweise aus anderen Pflanzen stammt.In an exemplary embodiment 1, the DOXS gene from Arabidopsis thaliana (SEQ ID No.:1; Mandel et al, Plant J. 9, 649-658 (1996); Acc. No. U27099) is expressed to a greater extent in transgenic plants. Plastid localization is ensured by the transit signal sequence contained in the gene sequence. A DNA sequence which codes for a DOXS gene which is identified by SEQ-ID No. 1 hybridizes and that comes from other organisms such as E. coli (SEQ-ID No. 3) or preferably from other plants.
Das nun vermehrt zur Verfügung stehende GGPP wird weiter in Richtung Tocopherole und Carotinoide umgesetzt.The GGPP, which is now increasingly available, is being further converted towards tocopherols and carotenoids.
Die effiziente Bildung von Carotinoiden ist essentiell für die Photosynthese, wobei sie neben den Chlorophyllen als "Lichtsammler-Komplexe" zur besseren Ausnutzung der Photonenenergie dienen (Heldt, Pflanzenbiochemie. Spektrum Akademischer Verlag Heidelberg Berlin Oxford, 1996) . Zusätzlich erfüllen Carotinoide wichtige Schutzfunktionen gegen Sauerstoff-Radikale wie den Singulett-Sauerstoff , den sie wieder in den Grundzustand zurückführen können (Asada, 1994; Demming-Adams und Adams, Trends in Plant Sciences 1; 21-26(1996). Es wurde eine 1-Deoxy-D-Xylu- lose-5-Phosphat Synthase defekte Arabidopsis thaliana Mutante isoliert, die einen "Albino-Phänotyp" zeigt (Mandel et al, 1996). Daraus ist abzuleiten, daß eine verringerte Menge an Carotinoiden in den Piastiden negative Auswirkungen auf die Pflanze hat.The efficient formation of carotenoids is essential for photosynthesis, and in addition to chlorophylls they serve as "light collector complexes" for better use of photon energy (Heldt, Plant Biochemistry. Spectrum Academic Publishing House Heidelberg Berlin Oxford, 1996). In addition, carotenoids perform important protective functions against oxygen radicals, such as singlet oxygen, which they can return to the ground state (Asada, 1994; Demming-Adams and Adams, Trends in Plant Sciences 1; 21-26 (1996) 1-Deoxy-D-xyllos-5-phosphate synthase defective Arabidopsis thaliana mutant isolated, which shows an "albino phenotype" (Mandel et al, 1996). From this it can be deduced that a reduced amount of carotenoids in the plastids has negative effects on the plant.
Die Aufgabe wurden auch gelöst durch die Überexpression eines l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) -Gens und eines p-Hydroxyphenylpyruvat Dioxygenase (HPPD) -Gens in den Pflanzen, siehe Abbildung 1.The problem was also solved by overexpressing an l-deoxy-D-xylulose-5-phosphate synthase (DOXS) gene and a p-hydroxyphenylpyruvate dioxygenase (HPPD) gene in the plants, see Figure 1.
Um den Metabolit-Fluß aus dem Primärstoffwechsel in den Isopre- noid-Stoffwechsel zu verstärken, wurde die Bildung von IPP als allgemeines Ausgangssubstrat für alle plastidären Isoprenoide erhöht. Zu diesem Zweck wurde in transgenen Tabak- und Rapspflanzen die Aktivität der DOXS durch Überexpression der DOXS aus E.coli erhöht. Dies kann durch Expression homologer oder anderer hetero- loger Gene erreicht werden.In order to increase the metabolite flow from the primary metabolism to the isoprenoid metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased. For this purpose, the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
Das nun vermehrt zur Verfügung stehende D- 1 -Desoxy-Xylulose- 5 -Phosphat wird weiter in Richtung Tocopherole und Carotinoide umgesetzt .The now increasingly available D-1-deoxy-xylulose-5-phosphate is further converted towards tocopherols and carotenoids.
Darüberhinaus verstärkt die Bildung von Homogentisinsäure den Metabolitfluß weiter in Richtung von Phytylquinonen und damit Tocopherol, siehe Abbildung 1. Homogentisinsäure wird gebildet aus p-Hydroxyphenylpyruvat durch das Enzym p-Hydroxyphenylpyruvat Dioxygenase (HPPD) . cDNAs , die für dieses Enzym kodieren, wurden aus verschiedenen Organismen wie beispielsweise aus Mikroorganismen, aus Pflanzen und aus dem Menschen beschrieben.In addition, the formation of homogentisic acid further increases the metabolite flow in the direction of phytylquinones and thus tocopherol, see Figure 1. Homogentisic acid is formed from p-hydroxyphenyl pyruvate by the enzyme p-hydroxyphenyl pyruvate dioxygenase (HPPD). cDNAs coding for this enzyme have been described from various organisms such as, for example, from microorganisms, from plants and from humans.
In Ausführungsbeispiel 11 wurde erstmals das HPPD-Gen aus Strep- tomyces avermitilis (Denoya et al . , J. Bacteriol. 176(1994),In embodiment 11, the HPPD gene from Streptomyces avermitilis (Denoya et al., J. Bacteriol. 176 (1994),
5312-5319; SEQ-ID No. 5) zusammen mit der DOXS aus E.coli SEQ-ID No. 3 in Pflanzen und pflanzlichen Piastiden überexprimiert.5312-5319; SEQ ID No. 5) together with the DOXS from E.coli SEQ-ID No. 3 overexpressed in plants and plant plastids.
Die Erhöhung der plastidären IPP Bildung führt zur verstärkten Bildung aller plastidären Isoprenoide. Die erhöhte Bereitstellung von Homogentisinsäure gewährleistet, daß genügend Substrat für die Bildung von Tocopherolen in den Piastiden zur Verfügung steht. Dieses nun vermehrt zur Verfügung stehende Homogentisat kann in den transgenen Pflanzen seinerseits mit der durch die Überexpression der DOXS erhöhten Menge an Phytyldiphosphat (PPP) umgesetzt werden. PPP nimmt dabei eine Schlüsselstellung ein, da es einerseits als Ausgangssubstrat für Chlorophylle und Phyllo- quinone, andererseits für Tocopherole dient.The increase in plastid IPP formation leads to the increased formation of all plastid isoprenoids. The increased provision of homogentisic acid ensures that sufficient substrate is available for the formation of tocopherols in the plastids. This now increasingly available homogenate can in turn be implemented in the transgenic plants with the increased amount of phytyl diphosphate (PPP) due to the overexpression of the DOXS. PPP plays a key role in this, as it serves on the one hand as a starting substrate for chlorophylls and phylloquinones and on the other hand for tocopherols.
Die Herstellung der transgenen Pflanzen erfolgt durch Transformation der Pflanzen mit einem das DOXS-und das HPPD-Gen enthaltenden Konstrukt. Als Modellpflanzen für die Produktion von Tocopherolen, Vitamin K, Chlorophyllen und Carotinoiden wurden Tabak und Raps eingesetzt.The transgenic plants are produced by transforming the plants with a construct containing the DOXS and HPPD genes. As model plants for the production of Tocopherols, vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
Gegenstand der Erfindung ist auch die Verwendung der DNA-Sequen- zen SEQ-ID No . 1 oder SEQ-ID No. 3 und SEQ-ID No. 5, die für eine DOXS bzw. HPPD oder deren funktioneile Äquivalente kodieren, zur Herstellung einer Pflanze mit erhöhtem Tocopherol-, Vitamin K- , Chlorophyll- und/oder Carotinoid-Gehalt. Die Nukleinsäuresequen- zen können dabei z.B. DNA- oder cDNA-Sequenzen sein. Zur Inser- tion in eine Expressionskassette geeignete kodierende Sequenzen sind beispielsweise solche, die für eine DOXS bzw. HPPD kodieren und die dem Wirt die Fähigkeit zur Überproduktion von Tocopherol verleihen.The invention also relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5, which code for a DOXS or HPPD or their functional equivalents, for producing a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content. The nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or HPPD and which give the host the ability to overproduce tocopherol.
Die Expressionskassetten beinhalten außerdem regulative Nuklein- säuresequenzen, welche die Expression der kodierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevorzugten Ausführungsform umfaßt eine Expressionskassette stromaufwärts, d.h. am 5' -Ende der kodierenden Sequenz, einen Promotor und stromabwärts, d.h. am 3 '-Ende, ein Polyadenylierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mit der dazwischenliegenden kodierenden Sequenz für das DOXS- bzw. HPPD-Gen operativ verknüpft sind.The expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell. According to a preferred embodiment, an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS or HPPD gene.
Die Herstellung einer Expressionskassette erfolgt durch Fusion eines geeigneten Promotors mit einer geeigneten DOXS- bzw. HPPD- DNA Sequenz und vorzugsweise einer zwischen Promotor und DOXS- bzw. HPPD DNA-Sequenz inserierten DNA, die für ein chloropla- stenspezifisches Transitpeptid kodiert, sowie einem Polyadenylie- rungssignal nach gängigen Rekombinations- und Klonierungs- techniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987) beschrieben sind.An expression cassette is produced by fusing a suitable promoter with a suitable DOXS or HPPD DNA sequence and preferably a DNA inserted between the promoter and DOXS or HPPD DNA sequence which codes for a chloroplast-specific transit peptide, and a polyadenyly - Signaling according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
Es können auch Expressionskassetten verwendet werden, deren DNA- Sequenz für ein DOXS- bzw. HPPD-Fusionsprotein kodiert, wobei ein Teil des Fusionsproteins ein Transitpeptid ist, das die Translo- kation des Polypeptides steuert. Bevorzugt sind für die Chloro- plasten spezifische Transitpeptide, welche nach Translokation des DOXS- bzw. HPPD-Gens in die Chloroplasten vom DOXS- bzw. HPPD- Teil enzymatisch abgespalten werden. Insbesondere bevorzugt ist das Transitpeptid, das von der plastidären Transketolase (TK) oder einem funktioneilen Äquivalent dieses Transitpeptids (z.B. dem Transitpeptid der kleinen Untereinheit der Rubisco oder derExpression cassettes whose DNA sequence codes for a DOXS or HPPD fusion protein can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or HPPD part after translocation of the DOXS or HPPD gene into the chloroplasts. The transit peptide which is derived from plastid transketolase (TK) is particularly preferred. or a functional equivalent of this transit peptide (e.g. the transit peptide of the Rubisco small subunit or the
Ferredoxin NADP Oxidoreduktase) abgeleitet ist.Ferredoxin NADP oxidoreductase) is derived.
Vorzugsweise wird die fusionierte Expressionskassette, die für ein DOXS-Gen und ein HPPD-Gen kodiert, in einen Vektor, beispielsweise pBinl9, kloniert, der geeignet ist, Agrobacterium tumefaciens zu transformieren.The fused expression cassette, which codes for a DOXS gene and an HPPD gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
Ein weiterer Gegenstand der Erfindung betrifft die Verwendung einer Expressionskassette enthaltend DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No . 5 oder mit diesen hybridisierende DNA-Sequenzen zur Transformation von Pflanzen, -zellen, -geweben oder Pflanzenteilen. Vorzugsweise ist Ziel der Verwendung die Erhöhung des Tocopherol-, Vitamin K- , Chlorophyll- und Carotinoid-Gehaltes der Pflanze.Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants. The aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
Dabei kann je nach Wahl des Promotors die Expression spezifisch in den Blättern, in den Samen oder anderen Teilen der Pflanze erfolgen. Solche transgenen Pflanzen, deren Vermehrungsgut, sowie deren Pflanzenzellen, -gewebe oder -teile sind ein weiterer Gegenstand der vorliegenden Erfindung.Depending on the choice of the promoter, the expression can take place specifically in the leaves, in the seeds or in other parts of the plant. Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
Gegenstand der Erfindung sind außerdem transgene Pflanzen, trans- formiert mit einer Expressionskassette enthaltend die Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequenzen, sowie transgene Zellen, Gewebe, Teile und Vermehrungsgut solcher Pflanzen. Besonders bevorzugt sind dabei transgene Kulturpflanzen, wie z.B. Gerste, Weizen, Roggen, Mais, Hafer, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Hanf, Kartoffel, Tabak, Tomate, Raps, AI - falfa, Salat und die verschiedenen Baum-, Nuß- und Weinspezies.The invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or hybridizing with these DNA sequences, as well as transgenic cells, tissues, parts and propagation material of such plants. Transgenic crop plants, such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
Weitere Gegenstände der Erfindung sind:Further objects of the invention are:
Verfahren zur Transformation einer Pflanze dadurch gekennzeichnet, daß man Expressionskassetten enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und eine DNA-Sequenz SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequenzen in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzen einbringt.Process for transforming a plant, characterized in that expression cassettes containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No. 5 or with these hybridizing DNA sequences in a plant cell, in callus tissue, an entire plant or protoplasts of plants.
Verwendung der DNA-Sequenz SEQ-ID No . 1 oder SEQ-ID No. 3 und SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequenzen zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vita- min K-, Chlorophyll- und/oder Carotinoid-Gehalt durch Expression einer DOXS und einer HPPD DNA-Sequenz in Pflanzen.Use of the DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or with these hybridizing DNA sequences for the production of plants with increased tocopherol, vitamin min K, chlorophyll and / or carotenoid content by expression of a DOXS and an HPPD DNA sequence in plants.
Die Aufgabe wurden auch gelöst durch die Überexpression eines l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) -Gens und eines Ge- ranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) -Gens in den Pflanzen, siehe Abbildung 1.The problem was also solved by overexpressing an l-deoxy-D-xylulose-5-phosphate synthase (DOXS) gene and a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) gene in the plants, see Figure 1.
Um den Metabolit-Fluß aus dem Primärstoffwechsel in den Isopre- noid-Stoffwechsel zu verstärken, wurde die Bildung von IPP als allgemeines Ausgangssubstrat für alle plastidären Isoprenoide erhöht. Zu diesem Zweck wurde in transgenen Tabak- und Raps- pflanzen die Aktivität der DOXS durch Überexpression der DOXS aus E.coli erhöht. Dies kann durch Expression homologer oder anderer heterologer Gene erreicht werden.In order to increase the metabolite flow from the primary metabolism to the isoprenoid metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased. For this purpose, the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
Um das nun vermehrt zur Verfügung stehende GGPP in Richtung Tocopherole und Carotinoide umzusetzen, wird in einem weiteren erfindungswesentlichen Schritt zusätzlich die Aktivität des En- zyms Geranylgeranyl-Pyrophosphat Oxidoreduktase durch Über- expression eines entsprechenden Gens gesteigert. Durch diese Maßnahme wird eine verstärkte Bildung von Phytylpyrophosphat durch verstärkte Umsetzung von Geranylgeranyl-Pyrophosphat zu Phytylpyrophosphat erreicht.In order to convert the increasingly available GGPP towards tocopherols and carotenoids, the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased in a further step of the invention by overexpression of a corresponding gene. Through this measure, an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
Hierzu wird beispielsweise das GGPPOR-Gen aus Arabidopsis thaliana (SEQ-ID No. 7) in transgenenen Pflanzen verstärkt expri- iert. Um eine Plastidenlokalisation zu gewährleisten ist der Arabidopsis GGPPOR eine Transitsignalsequenz vorangestellt. Auch geeignet als Expressionskassette ist eine DNA- Sequenz, die für ein GGPPOR-Gen codiert, das mit SEQ-ID No. 7 hybridisiert und das aus anderen Organismen bzw. aus anderen Pflanzen stammt.For this purpose, for example, the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants. In order to ensure plastid localization, the Arabidopsis GGPPOR is preceded by a transit signal sequence. Also suitable as an expression cassette is a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants.
In Ausführungsbeispiel 15 ist die Klonierung des GGPPOR-Gens aus Arabidopsis thaliana beschrieben.Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
Die Erhöhung der plastidären l-Deoxy-D-Xylulose-5-Phosphat und Phytylpyrophosphat Bildung führt zur verstärkten Bildung aller plastidären Isoprenoide, so daß genügend Substrat für die Bildung von Tocopherolen, Chlorophyllen, Vitamin K und Phylloquinonen in den Piastiden zur Verfügung steht.The increase in plastid l-deoxy-D-xylulose-5-phosphate and phytyl pyrophosphate formation leads to the increased formation of all plastid isoprenoids, so that there is sufficient substrate for the formation of tocopherols, chlorophylls, vitamin K and phylloquinones in the plastids.
Die Herstellung der transgenen Pflanzen erfolgt durch Transformation der Pflanzen mit einem das DOXS-und das GGPPOR-Gen ent- haltenden Konstrukt. Als Modellpflanzen für die Produktion von Tocopherolen, Vitamin K, Chlorophyllen und Carotinoiden wurden Tabak und Raps eingesetzt.The transgenic plants are produced by transforming the plants with a construct containing the DOXS and GGPPOR genes. As model plants for the production of Tocopherols, vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
Gegenstand der Erfindung ist die Verwendung der DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 die für eine DOXS bzw. GGPPOR oder deren funktioneile Äquivalente kodieren, zur Herstellung einer Pflanze mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt. Die Nukleinsäuresequen- zen können dabei z.B. DNA- oder cDNA-Sequenzen sein. Zur Inser- tion in eine Expressionskassette geeignete kodierende Sequenzen sind beispielsweise solche, die für eine DOXS bzw. GGPPOR kodieren und die dem Wirt die Fähigkeit zur Überproduktion von Tocopherol verleihen.The invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 which code for a DOXS or GGPPOR or their functional equivalents, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content. The nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or GGPPOR and which give the host the ability to overproduce tocopherol.
Die Expressionskassetten beinhalten außerdem regulative Nuklein- säuresequenzen, welche die Expression der kodierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevorzugten Ausführungsform umfaßt eine Expressionskassette stromaufwärts, d.h. am 5 '-Ende der kodierenden Sequenz, einen Promotor und stromabwärts, d.h. am 3 '-Ende, ein Polyadenylierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mit der dazwischenliegenden kodierenden Sequenz für das DOXS- bzw. GGPPOR-Gen operativ verknüpft sind. Unter einer operativen Verknüpfung versteht man die sequenzielle Anordnung von Promotor, kodierender Sequenz, Termi- nator und ggf. weiterer regulativer Elemente derart, daß jedes der regulativen Elemente seine Funktion bei der Expression der kodierenden Sequenz bestimmungsgemäß erfüllen kann. Die zur operativen Verknüpfung bevorzugten aber nicht darauf beschränkten Sequenzen sind Targeting-Sequenzen zur Gewährleistung der subzel- lulären Lokalisation im Apoplasten, in der Vakuole, in Piastiden, im Mitochondrium, im Endoplasmatischen Retikulum (ER), im Zellkern, in Ölkörperchen oder anderen Kompartimenten und Translationsverstärker wie die 5 ' -Führungssequenz aus dem Tabak-Mosaik- Virus (Gallie et al . , Nucl. Acids Res. 15 (1987), 8693 -8711).The expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell. According to a preferred embodiment, an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and, if appropriate, further regulatory elements which are operatively linked to the intervening coding sequence for the DOXS or GGPPOR gene. An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence. The sequences preferred but not limited to the operative linkage are targeting sequences to ensure the sub-cellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or other compartments and Translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
Beispielhaft kann die pflanzliche Expressionskassette in den Tabak-Transformationsvektor pBinAR-Hyg eingebaut werden. Abb. 2 zeigt die Tabaktransformationsvektoren pBinAR-Hyg mit 35S-Promo- tor (A) bzw. pBinAR-Hyg mit samenspezifischem Promotor Phaseolin 796 (B) :As an example, the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg. Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
HPT: Hygromycin-Phosphotransferase OCS: Octopin-Synthase-Terminator PNOS : Nopalin-Synthase-Promotor - außerdem sind solche Restriktionsschnittstellen eingezeichnet, die nur einmal den Vektor schneiden. Als Promotoren der Expressionskassette ist grundsätzlich jeder Promotor geeignet, der die Expression von Fremdgenen in Pflanzen steuern kann. Vorzugsweise verwendet man insbesondere einen pflanzlichen Promotor oder einen Promotor, der einem Pflanzenvi- rus entstammt. Insbesondere bevorzugt ist der CaMV 35S-Promotor aus dem Blumenkohl-Mosaik-Virus (Franck et al . , Cell 21 (1980), 285 - 294) . Dieser Promotor enthält bekanntlich unterschiedliche ErkennungsSequenzen für transkriptionale Effektoren, die in ihrer Gesamtheit zu einer permanenten und konstitutiven Expression des eingeführten Gens führen (Benfey et al . , EMBO J. 8 (1989), 2195-2202) .HPT: hygromycin phosphotransferase OCS: octopine synthase terminator PNOS: nopalin synthase promoter - in addition, restriction sites are shown that only cut the vector once. In principle, any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette. A plant promoter or a promoter which originates from a plant virus is preferably used. The CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294). As is known, this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
Die Expressionskassette kann auch einen chemisch induzierbaren Promotor enthalten, durch den die Expression des exogenen DOXS- bzw. GGPPOR-Gens in der Pflanze zu einem bestimmten Zeitpunkt gesteuert werden kann. Derartige Promotoren wie z.B. der PRPl-Promotor (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366) , ein durch Salizylsäure induzierbarer Promotor (WO 95/19443) , ein durch Benzenesulfonamid-induzierbarer (EP-A 388186), ein durch Tetrazyklin-induzierbarer (Gatz et al., (1992) Plant J. 2, 397-404), ein durch Abscisinsäure-induzier- barer (EP-A 335528) bzw. ein durch Ethanol- oder Cyclohexanon-in- duzierbarer (WO 93/21334) Promotor können u.a. verwendet werden.The expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS or GGPPOR gene in the plant can be controlled at a specific point in time. Such promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186), one inducible by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one inducible by abscisic acid (EP-A 335528) or inducible by ethanol or cyclohexanone ( WO 93/21334) promoters can include be used.
Weiterhin sind insbesonders solche Promotoren bevorzugt, die die Expression in Geweben oder Pflanzenteilen sicherstellen, in denen die Biosynthese von Tocopherol bzw. dessen Vorstufen stattfindet. Insbesondere zu nennen sind Promotoren, die eine blattspezifische Expression gewährleisten. Zu nennen sind der Promotor der cyto- solischen FBPase aus Kartoffel oder der ST-LSI Promotor aus Kartoffel (Stockhaus et al . , EMBO J. 8 (1989), 2445 - 245).Furthermore, promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular. The promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
Die Herstellung einer Expressionskassette erfolgt durch Fusion eines geeigneten Promotors mit einer geeigneten DOXS- bzw. GGPPOR-DNA Sequenz und vorzugsweise einer zwischen Promotor und DOXS- bzw. GGPPOR-DNA-Sequenz inserierten DNA, die für ein chlo- roplastenspezifisches Transitpeptid kodiert, sowie einem Polyadenylierungssignal nach gängigen Rekombinations- und Klonierungs- techniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel, F.M. et al., Current Protocols in Molecu- lar Biology, Greene Publishing Assoc. and Wiley-Interscience (1987) beschrieben sind. Es können auch Expressionskassetten verwendet werden, deren DNA- Sequenz für ein DOXS- bzw. GGPPOR-Fusionsprotein kodiert, wobei ein Teil des Fusionsproteins ein Transitpeptid ist, das die Translokation des Polypeptides steuert. Bevorzugt sind für die Chloroplasten spezifische Transitpeptide, welche nach Translokation des DOXS- bzw. GGPPOR-Gens in die Chloroplasten vom DOXS- bzw. GGPPOR-Teil enzymatisch abgespalten werden. Insbesondere bevorzugt ist das Transitpeptid, das von der plastidären Trans - ketolase (TK) oder einem funktioneilen Äquivalent dieses Transit - peptids (z.B. dem Transitpeptid der kleinen Untereinheit derAn expression cassette is produced by fusing a suitable promoter with a suitable DOXS or GGPPOR DNA sequence and preferably a DNA which is inserted between the promoter and DOXS or GGPPOR DNA sequence and which codes for a chloroplast-specific transit peptide and one Polyadenylation signal according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in TJ Silhavy, ML Berman and LW Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, FM et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987). Expression cassettes can also be used, the DNA sequence of which codes for a DOXS or GGPPOR fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or GGPPOR part after translocation of the DOXS or GGPPOR gene into the chloroplasts. Particularly preferred is the transit peptide derived from plastid transketolase (TK) or a functional equivalent of this transit peptide (eg the transit peptide of the small subunit of the
Rubisco oder der Ferredoxin NADP Oxidoreduktase) abgeleitet ist.Rubisco or the ferredoxin NADP oxidoreductase) is derived.
Vorzugsweise wird die fusionierte Expressionskassette, die für ein DOXS-Gen bzw. ein GGPPOR-Gen kodiert, in einen Vektor, beispielsweise pBinl9, kloniert, der geeignet ist, Agrobacterium tumefaciens zu transformieren.The fused expression cassette, which codes for a DOXS gene or a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
Ein weiterer Gegenstand der Erfindung betrifft die Verwendung einer Expressionskassette enthaltend DNA-Sequenzen SEQ ID No. 1 oder SEQ ID No. 3, SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen zur Transformation von Pflanzen, -zellen, -geweben oder Pflanzenteilen. Vorzugsweise ist Ziel der Verwendung die Erhöhung des Tocopherol-, Vitamin K-, Chlorophyll- und Carotinoid- Gehaltes der Pflanze.Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ ID No. 1 or SEQ ID No. 3, SEQ ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants. The aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
Dabei kann je nach Wahl des Promotors die Expression spezifisch in den Blättern, in den Samen oder anderen Teilen der Pflanze erfolgen. Solche transgenen Pflanzen, deren Vermehrungsgut, sowie deren Pflanzenzellen, -gewebe oder -teile sind ein weiterer Ge- genstand der vorliegenden Erfindung.Depending on the choice of the promoter, the expression can take place specifically in the leaves, in the seeds or in other parts of the plant. Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
Gegenstand der Erfindung sind außerdem transgene Pflanzen, transformiert mit einer Expressionskassette enthaltend die Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen, sowie transgene Zellen, Gewebe, Teile und Vermehrungsgut solcher Pflanzen. Besonders bevorzugt sind dabei transgene Kulturpflanzen, wie z.B. Gerste, Weizen, Roggen, Mais, Hafer, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Hanf, Kartoffel, Tabak, Tomate, Raps, AI - falfa, Salat und die verschiedenen Baum-, Nuß- und Weinspezies.The invention also relates to transgenic plants transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants. Transgenic crop plants, such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
Weitere Gegenstände der Erfindung sind:Further objects of the invention are:
Verfahren zur Transformation einer Pflanze dadurch gekenn- zeichnet, daß man Expressionskassetten enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder eine DNA-Sequenz SEQ-ID No. 3 und eine SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequen- zen in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzen einbringt.Process for transforming a plant is characterized in that expression cassettes containing a DNA sequence SEQ-ID No. 1 or a DNA sequence SEQ-ID No. 3 and a SEQ ID No. 7 or DNA sequences hybridizing with these zen into a plant cell, into callus tissue, an entire plant or protoplasts of plants.
Verwendung der DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt durch Expression einer DOXS und einer GGPPOR DNA-Sequenz in Pflanzen.Use of the DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or with these hybridizing DNA sequences for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content by expression of a DOXS and a GGPPOR DNA sequence in plants.
Die Aufgabe wurden auch gelöst durch die Überexpression eines l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) -Gens, eines p-Hydroxyphenylpyruvat Dioxygenase (HPPD) -Gens und eines Geranylgera- nylpyrophosphat Oxidoreduktase (GGPPOR) -Gens in den Pflanzen, siehe Abbildung 1.The problem was also solved by overexpressing an l-deoxy-D-xylulose-5-phosphate synthase (DOXS) gene, a p-hydroxyphenylpyruvate dioxygenase (HPPD) gene and a geranylgeranylpyrophosphate oxidoreductase (GGPPOR) gene in the Plants, see Figure 1.
Um den Metabolit-Fluß aus dem Primärstoffwechsel in den Isopre- noid-Stoffwechsel zu verstärken, wurde die Bildung von IPP als allgemeines Ausgangssubstrat für alle plastidären Isoprenoide erhöht. Zu diesem Zweck wurde in transgenen Tabak- und Rapspflanzen die Aktivität der DOXS durch Überexpression der DOXS aus E.coli erhöht. Dies kann auch durch Expression homologer oder anderer heterologer DOXS-Gene - wie zum Beispiel einer DNA- Sequenz SEQ-ID No. 1 - erreicht werden.In order to increase the metabolite flow from the primary metabolism to the isoprenoid metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased. For this purpose, the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can also be done by expressing homologous or other heterologous DOXS genes - such as a DNA sequence SEQ-ID No. 1 - can be achieved.
Das nun vermehrt zur Verfügung stehende D-1-Desoxy-Xylu- lose-5-Phosphat wird weiter in Richtung Geranylgeranylpyrophosp- hat umgesetzt.The now increasingly available D-1-deoxy-xylulose-5-phosphate is further converted in the direction of geranylgeranyl pyrophosphate.
Um das vermehrt zur Verfügung stehende GGPP in Richtung Toco- pherole und Carotinoide umzusetzen, wird in einem weiteren erfindungswesentlichen Schritt zusätzlich die Aktivität des Enzyms Geranylgeranyl-Pyrophosphat Oxidoreduktase durch Über- expression eines entsprechenden homologen oder heterologen Gens gesteigert. Durch diese Maßnahme wird eine verstärkte Bildung von Phytylpyrophosphat durch verstärkte Umsetzung von Geranylgeranyl- Pyrophosphat zu Phytylpyrophosphat erreicht.In order to convert the increasingly available GGPP towards tocopherols and carotenoids, the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased by overexpression of a corresponding homologous or heterologous gene in a further step which is essential to the invention. Through this measure, an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
Hierzu wird beispielsweise das GGPPOR-Gen aus Arabidopsis thaliana (SEQ-ID No. 7) in transgenen Pflanzen verstärkt exprimiert. Um eine Plastidenlokalisation zu gewährleisten ist der Arabidopsis GGPPOR eine Transitsignalsequenz vorangestellt. Auch geeignet als Expressionskassette ist eine DNA-Sequenz, die für ein GGPPOR- Gen codiert, das mit SEQ-ID No. 7 hybridisiert und das aus anderen Organismen bzw. aus anderen Pflanzen stammt. In Ausführungsbeispiel 15 ist die Klonierung des GGPPOR-Gens aus Arabidopsis thaliana beschrieben.For this purpose, for example, the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants. In order to ensure plastid localization, the Arabidopsis GGPPOR is preceded by a transit signal sequence. Also suitable as an expression cassette is a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants. Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
Um das vermehrt zur Verfügung stehende PPP in Richtung Toco- pherole und Carotinoide umzusetzen, wird in einem weiteren erfindungswesentlichen Schritt zusätzlich die Aktivität des Enzyms p-Hydroxyphenylpyruvat Dioxygenase (HPPD) durch Über- expression eines entsprechenden homologen oder heterologen Gens gesteigert. Durch diese Maßnahme wird eine verstärkte Bildung von Homogentisinsäure durch verstärkte Umsetzung von Hydroxyphenylpy- ruvat in Homogentisinsäure erreicht.In order to convert the increasingly available PPP towards tocopherols and carotenoids, the activity of the enzyme p-hydroxyphenylpyruvate dioxygenase (HPPD) is additionally increased in a further step of the invention by overexpression of a corresponding homologous or heterologous gene. This measure leads to an increased formation of homogentisic acid by an increased conversion of hydroxyphenylpyruvate into homogentisic acid.
cDNAs, die für dieses Enzym kodieren, wurden aus verschiedenen Organismen wie beispielsweise aus Mikroorganismen, aus Pflanzen und aus dem Menschen beschrieben.cDNAs coding for this enzyme have been described from various organisms such as, for example, from microorganisms, from plants and from humans.
In Ausführungsbeispiel 10 wird die Klonierung des HPPD-Gens aus Streptomyces avermitilis beschrieben (Denoya et al . , J. Bacte- riol. 176(1994), 5312-5319; SEQ-ID No. 5). Um eine Plastidenloka- lisation zu gewährleisten ist der HPPD aus Streptomyces eine Transitsignalsequenz vorangestellt. Auch geeignet als Expressionskassette ist eine DNA-Sequenz, die für ein HPPD-Gen codiert, das mit SEQ-ID No. 5 hybridisiert und das aus anderen Organismen bzw. aus Pflanzen stammt.In embodiment 10, the cloning of the HPPD gene from Streptomyces avermitilis is described (Denoya et al., J. Bacteriol. 176 (1994), 5312-5319; SEQ ID No. 5). In order to ensure plastid localization, the HPPD from Streptomyces is preceded by a transit signal sequence. Also suitable as an expression cassette is a DNA sequence which codes for an HPPD gene which is identified by SEQ-ID No. 5 hybridizes and that comes from other organisms or plants.
Die Erhöhung der plastidären D-l-Desoxy-Xylulose-5-Phosphat, der Phytylpyrophosphat und der Homogentisinsäure Bildung führt zur verstärkten Bildung aller plastidären Isoprenoide. Die erhöhte Bereitstellung dieser Vorstufen gewährleistet, daß genügend Sub- strat für die Bildung von Tocopherolen, Chlorophylle, Vitamin K und Phylloquinone in den Piastiden zur Verfügung steht.The increase in the D-1-deoxy-xylulose-5-phosphate, the phytyl pyrophosphate and the homogentisic acid formation leads to the increased formation of all plastid isoprenoids. The increased availability of these precursors ensures that there is sufficient substrate available for the formation of tocopherols, chlorophylls, vitamin K and phylloquinones in the plastids.
Die Herstellung der erfindungsgemäßen transgenen Pflanzen erfolgt durch Transformation der Pflanzen mit einem das DOXS-, das HPPD- Gen und das GGPPOR-Gen enthaltenden Konstrukt (Beispiel 17) . Als Modellpflanzen für die Produktion von Tocopherolen, Vitamin K, Chlorophyllen und Carotinoiden wurden Tabak und Raps eingesetzt.The transgenic plants according to the invention are produced by transforming the plants with a construct containing the DOXS, the HPPD gene and the GGPPOR gene (Example 17). Tobacco and rapeseed were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
Gegenstand der Erfindung ist die Verwendung der DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No . 3, SEQ-ID No . 5 und SEQ-ID No. 7, die für eine DOXS, eine HPPD und eine GGPPOR oder deren funktio- nelle Äquivalente kodieren, zur Herstellung einer Pflanze mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid- Gehalt. Die Nukleinsäuresequenzen können dabei z.B. DNA- oder cDNA-Sequenzen sein. Zur Insertion in eine Expressionskassette geeignete kodierende Sequenzen sind beispielsweise solche, die für eine DOXS, eine HPPD und eine GGPPOR kodieren und die dem Wirt die Fähigkeit zur Überproduktion von Tocopherol verleihen.The invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7, which code for a DOXS, an HPPD and a GGPPOR or their functional equivalents, for the production of a plant with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content. The nucleic acid sequences can be, for example, DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which encode for a DOXS, an HPPD and a GGPPOR and which give the host the ability to overproduce tocopherol.
Die Expressionskassetten beinhalten außerdem regulative Nuklein- säuresequenzen, welche die Expression der kodierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevorzugten Ausführungsform umfaßt eine Expressionskassette stromaufwärts, d.h. am 5 '-Ende der kodierenden Sequenz, einen Promotor und stromabwärts, d.h. am 3 '-Ende, ein Polyadenylierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mit der dazwischenliegenden kodierenden Sequenz für das DOXS-, das HPPD- bzw. das GGPPOR-Gen operativ verknüpft sind. Unter einer operativen Verknüpfung versteht man die sequenzielle Anordnung von Promotor, kodierender Sequenz, Terminator und ggf. weiterer regulativer Elemente der- art, daß jedes der regulativen Elemente seine Funktion bei der Expression der kodierenden Sequenz bestimmungsgemäß erfüllen kann. Die zur operativen Verknüpfung bevorzugten aber nicht darauf beschränkten Sequenzen sind Targeting-Sequenzen zur Gewährleistung der subzellulären Lokalisation im Apoplasten, in der Va- kuole, in Piastiden, im Mitochondrium, im Endoplasmatischen Reti- kulum (ER), im Zellkern, in Ölkörperchen oder anderen Komparti- menten und Translationsverstärker wie die 5 ' -Führungssequenz aus dem Tabak-Mosaik-Virus (Gallie et al . , Nucl. Acids Res . 15 (1987) , 8693 -8711) .The expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell. According to a preferred embodiment, an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS, the HPPD or the GGPPOR gene. An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements such that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence. The sequences preferred but not limited to the operative linkage are targeting sequences to ensure the subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or others Compartments and translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
Beispielhaft kann die pflanzliche Expressionskassette in den Tabak-Transformationsvektor pBinAR-Hyg eingebaut werden. Abb. 2 zeigt die Tabaktransformationsvektoren pBinAR-Hyg mit 35S-Promo- tor (A) bzw. pBinAR-Hyg mit samenspezifischem Promotor Phaseolin 796 (B) :As an example, the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg. Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
HPT: Hygromycin-Phosphotransferase OCS: Octopin-Synthase-Terminator PNOS: Nopalin-Synthase-Promotor - außerdem sind solche Restriktionsschnittstellen eingezeichnet, die nur einmal den Vektor schneiden.HPT: hygromycin phosphotransferase OCS: octopine synthase terminator PNOS: nopalin synthase promoter - in addition, restriction sites are shown that only cut the vector once.
Als Promotoren der Expressionskassette ist grundsätzlich jeder Promotor geeignet, der die Expression von Fremdgenen in Pflanzen steuern kann. Vorzugsweise verwendet man insbesondere einen pflanzlichen Promotor oder einen Promotor, der einem Pflanzenvirus entstammt. Insbesondere bevorzugt ist der CaMV 35S-Promotor aus dem Blumenkohl-Mosaik-Virus (Franck et al . , Cell 21 (1980), 285 - 294). Dieser Promotor enthält bekanntlich unterschiedliche Erkennungssequenzen für transkriptionale Effektoren, die in ihrer Gesamtheit zu einer permanenten und konstitutiven Expression des eingeführten Gens führen (Benfey et al . , EMBO J. 8 (1989), 2195-2202) .In principle, any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette. In particular, a plant promoter or a plant virus-derived promoter is preferably used. The CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294). As is known, this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
Die Expressionskassette kann auch einen chemisch induzierbaren Promotor enthalten, durch den die Expression des exogenen DOXS-, HPPD-, bzw. GGPPOR-Gens in der Pflanze zu einem bestimmten Zeitpunkt gesteuert werden kann. Derartige Promotoren wie z.B. der PRPl-Promotor (Ward et al . , Plant. Mol. Biol. 22 (1993), 361-366) , ein durch Salizylsäure induzierbarer Promotor (WO 95/19443) , ein durch Benzenesulfonamid-induzierbarerThe expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS, HPPD or GGPPOR gene in the plant can be controlled at a specific point in time. Such promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a salicylic acid-inducible promoter (WO 95/19443), a benzene-sulfonamide-inducible promoter
(EP-A 388186), ein durch Tetrazyklin-induzierbarer (Gatz et al . , (1992) Plant J. 2, 397-404), ein durch Abscisinsäure-induzier- barer (EP-A 335528) bzw. ein durch Ethanol- oder Cyclohexanon-in- duzierbarer (WO 93/21334) Promotor können u.a. verwendet werden.(EP-A 388186), one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or that by ethanol or cyclohexanone-inducible (WO 93/21334) promoter can include be used.
Weiterhin sind insbesonders solche Promotoren bevorzugt, die die Expression in Geweben oder Pflanzenteilen sicherstellen, in denen die Biosynthese von Tocopherol bzw. dessen Vorstufen stattfindet. Insbesondere zu nennen sind Promotoren, die eine blattspezifische Expression gewährleisten. Zu nennen sind der Promotor der cyto- solischen FBPase aus Kartoffel oder der ST-LSI Promotor aus Kartoffel (Stockhaus et al . , EMBO J. 8 (1989), 2445 - 245).Furthermore, promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular. The promoter of the cytosolic FBPase from potato or the ST-LSI promoter from potato are to be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
Die Herstellung einer Expressionskassette erfolgt durch Fusion eines geeigneten Promotors mit einer geeigneten DOXS-, HPPD- bzw. GGPPOR-DNA Sequenz und vorzugsweise einer zwischen Promotor und DOXS-, HPPD- bzw. GGPPOR-DNA-Sequenz inserierten DNA, die für ein chloroplastenspezifisches Transitpeptid kodiert, sowie einem Polyadenylierungssignal nach gängigen Rekombinations- und Klonierungstechniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Inter- science (1987) beschrieben sind.An expression cassette is produced by fusing a suitable promoter with a suitable DOXS, HPPD or GGPPOR DNA sequence and preferably a DNA inserted between promoter and DOXS, HPPD or GGPPOR DNA sequence, which is suitable for a chloroplast-specific transit peptide encoded, and a polyadenylation signal according to common recombination and cloning techniques, such as those described in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al., Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Inter-science (1987).
Es können auch Expressionskassetten verwendet werden, deren DNA- Sequenz für ein DOXS-, HPPD- bzw. GGPPOR-Fusionsprotein kodiert, wobei ein Teil des Fusionsproteins ein Transitpeptid ist, das die Translokation des Polypeptides steuert. Bevorzugt sind für die Chloroplasten spezifische Transitpeptide, welche nach Translokation des DOXS-, HPPD- bzw. GGPPOR-Gens in die Chloroplasten vom DOXS-, HPPD- bzw. GGPPOR-Teil enzymatisch abgespalten werden.Expression cassettes whose DNA sequence codes for a DOXS, HPPD or GGPPOR fusion protein can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS, HPPD or GGPPOR part after translocation of the DOXS, HPPD or GGPPOR gene into the chloroplast.
Insbesondere bevorzugt ist das Transitpeptid, das von der plastidären Transketolase (TK) oder einem funktionellen Äquivalent die- ses Transitpeptids (z.B. dem Transitpeptid der kleinen Untereinheit der Rubisco oder der Ferredoxin NADP Oxidoreduktase) abgeleitet ist.The transit peptide which is derived from plastid transketolase (TK) or a functional equivalent is particularly preferred. This transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is derived.
Vorzugsweise wird die fusionierte Expressionskassette, die für ein DOXS-Gen, ein HPPD-Gen und ein GGPPOR-Gen kodiert, in einen Vektor, beispielsweise pBinl9 , kloniert, der geeignet ist, Agrobacterium tumefaciens zu transformieren.The fused expression cassette, which codes for a DOXS gene, an HPPD gene and a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
Ein weiterer Gegenstand der Erfindung betrifft die Verwendung einer Expressionskassette enthaltend DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3, SEQ-ID No. 5 und SEQ-ID No . 7 oder mit diesen hybridisierende DNA-Sequenzen zur Transformation von Pflanzen, -zellen, -geweben oder Pflanzenteilen. Vorzugsweise ist Ziel der Verwendung die Erhöhung des Tocopherol-, Vitamin K- , Chlorophyll- und Carotinoid-Gehaltes der Pflanze.Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants. The aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
Dabei kann je nach Wahl des Promotors die Expression spezifisch in den Blättern, in den Samen oder anderen Teilen der Pflanze er- folgen. Solche transgenen Pflanzen, deren Vermehrungsgut, sowie deren Pflanzenzellen, -gewebe oder -teile sind ein weiterer Gegenstand der vorliegenden Erfindung.Depending on the choice of the promoter, the expression can take place specifically in the leaves, in the seeds or in other parts of the plant. Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
Gegenstand der Erfindung sind außerdem transgene Pflanzen, trans- formiert mit einer Expressionskassette enthaltend die Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3, SEQ-ID No. 5 und SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen, sowie transgene Zellen, Gewebe, Teile und Vermehrungsgut solcher Pflanzen. Besonders bevorzugt sind dabei transgene Kulturpflanzen, wie z.B. Ger- ste, Weizen, Roggen, Mais, Hafer, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Hanf, Kartoffel, Tabak, Tomate, Raps, Alfalfa, Salat und die verschiedenen Baum-, Nuß- und Weinspezies .The invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants. Transgenic crop plants, such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various tree, nut and wine species.
Weitere Gegenstände der Erfindung sind:Further objects of the invention are:
Verfahren zur Transformation einer Pflanze dadurch gekennzeichnet, daß man Expressionskassetten enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3, eine DNA-Sequenz SEQ-ID No. 5 und eine DNA-Sequenz SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzen einbringt.Process for transforming a plant, characterized in that expression cassettes containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3, a DNA sequence SEQ-ID No. 5 and a DNA sequence SEQ-ID No. 7 or with these hybridizing DNA sequences in a plant cell, in callus tissue, an entire plant or protoplasts of plants.
- Verwendung der DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3, SEQ-ID No. 5 und SEQ-ID No . 7 oder mit diesen hybridisierende DNA-Sequenzen zur Herstellung von Pflanzen mit erhöhtem Toco- pherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt durch Expression einer DOXS-, einer HPPD- und einer GGPPOR- DNA-Sequenz in Pflanzen.- Use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or DNA sequences hybridizing with these for the production of plants with increased toco pherol, vitamin K, chlorophyll and / or carotenoid content by expression of a DOXS, an HPPD and a GGPPOR DNA sequence in plants.
Zusätzliche Aufgabe der vorliegenden Erfindung war daher dieAn additional object of the present invention was therefore
Entwicklung eines Testsystems zur Identifizierung von Inhibitoren der DOXS.Development of a test system for the identification of inhibitors of DOXS.
Diese Aufgabe wurde gelöst durch die Expression eines DOXS-Gens aus Arabidopsis oder E. coli bzw. damit hybridisierende DNA-Sequenzen und anschließende Testung von Chemikalien auf Hemmung der DOXS-Enzymaktivität .This object was achieved by the expression of a DOXS gene from Arabidopsis or E. coli or DNA sequences hybridizing therewith and subsequent testing of chemicals for inhibition of DOXS enzyme activity.
Die Herstellung der transgenen Pflanzen erfolgt durch Transforma- tion der Pflanzen mit einem das DOXS-Gen enthaltenden Konstrukt. Als Modellpflanzen für die Produktion von Tocopherolen, Vitamin K, Chlorophyllen und Carotinoiden wurden Arabidopsis und Raps eingesetzt.The transgenic plants are produced by transforming the plants with a construct containing the DOXS gene. Arabidopsis and oilseed rape were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
Die Klonierung des vollständigen DOXS-Gens aus Arabidopsis erfolgt über die Isolierung der für das DOXS-Gen spezifischen cDNA (SEQ-ID No . 1) .The complete DOXS gene from Arabidopsis is cloned by isolating the cDNA specific for the DOXS gene (SEQ-ID No. 1).
Gegenstand der Erfindung ist die Verwendung der DNA- Sequenz SEQ ID No. 1 oder SEQ-ID No. 3 die für eine DOXS oder deren funktio- nelles Äquivalent kodiert, zur Herstellung einer Pflanze mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid- Gehalt. Die Nukleinsäuresequenz kann dabei z.B. eine DNA- oder eine cDNA-Sequenz sein. Zur Insertion in eine Expressionskassette geeignete kodierende Sequenzen sind beispielsweise solche, die für eine DOXS kodieren und die dem Wirt die Fähigkeit zur Überproduktion von Tocopherol verleihen.The invention relates to the use of the DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 which codes for a DOXS or its functional equivalent, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content. The nucleic acid sequence can e.g. be a DNA or a cDNA sequence. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS and which give the host the ability to overproduce tocopherol.
Die Expressionskassetten beinhalten außerdem regulative Nuklein- säuresequenzen, welche die Expression der kodierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevorzugten Ausführungsform umfaßt eine Expressionskassette stromaufwärts, d.h. am 5' -Ende der kodierenden Sequenz, einen Promotor und stromabwärts, d.h. am 3 '-Ende, ein Polyadenylierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mit der dazwischenliegenden kodierenden Sequenz für das DOXS-Gen operativ verknüpft sind. Unter einer operativen Verknüpfung versteht man die sequenzielle Anordnung von Promotor, kodierender Sequenz, Terminator und ggf. weiterer regulativer Elemente derart, daß jedes der regulativen Elemente seine Funktion bei der Expression der kodierenden Sequenz bestimmungsgemäß erfüllen kann. Die zur operativen Verknüpfung bevorzugten aber nicht darauf beschränkten Sequenzen sind Targeting-Sequenzen zur Gewährleistung der subzellulären Lokalisation im Apoplasten, in der Vakuole, in Piastiden, im Mitochondrium, im Endoplasmatischen Retikulum (ER) , im Zellkern, in Ölkörperchen oder anderen Kompartimenten und Translationsver- stärker wie die 5' -Führungssequenz aus dem Tabak-Mosaic-Virus (Gallie et al . , Nucl. Acids Res . 15 (1987) 8693 -8711).The expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell. According to a preferred embodiment, an expression cassette comprises upstream, ie at the 5 'end of the coding sequence, a promoter and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which match the coding sequence for the DOXS gene in between are operationally linked. An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence. The sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil bodies or other compartments and translation enhancers like the 5 'guiding sequence from tobacco Mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987) 8693-8711).
Beispielhaft kann die pflanzliche Expressionskassette in den Tabak-Transformationsvektor pBinAR-Hyg eingebaut werden. Abb. zeigt die Tabaktransformationsvektoren pBinAR-Hyg mit 35S-Promo- tor (A) bzw. pBinAR-Hyg mit samenspezifischem Promotor Phaseolin 796 (B) :As an example, the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg. Fig. Shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
HPT: Hygromycin-Phosphotransferase - OCS: Octopin-Synthase-Terminator PNOS : Nopalin-Synthase-Promotor außerdem sind solche Restriktionsschnittstellen eingezeichnet, die nur einmal den Vektor schneiden.HPT: hygromycin phosphotransferase - OCS: octopine synthase terminator PNOS: nopalin synthase promoter also such restriction sites are shown that only cut the vector once.
Als Promotoren der Expressionskassette ist grundsätzlich jeder Promotor geeignet, der die Expression von Fremdgenen in Pflanzen steuern kann. Vorzugsweise verwendet man insbesondere einen pflanzlichen Promotor oder einen Promotor, der einem Pflanzen- virus entstammt. Insbesondere bevorzugt ist der CaMV 35S-Promotor aus dem Blumenkohl-Mosaik-Virus (Franck et al., Cell 21 (1980), 285 - 294) . Dieser Promotor enthält bekanntlich unterschiedliche Erkennungssequenzen für transkriptionale Effektoren, die in ihrer Gesamtheit zu einer permanenten und konstitutiven Expression des eingeführten Gens führen (Benfey et al . , EMBO J. 8 (1989), 2195 - 2202) .In principle, any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette. In particular, a plant promoter or a promoter derived from a plant virus is preferably used. The CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294). As is known, this promoter contains different recognition sequences for transcriptional effectors which, in their entirety, lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
Die Expressionskassette kann auch einen chemisch induzierbaren Promotor enthalten, durch den die Expression des exogenen DOXS- Gens in der Pflanze zu einem bestimmten Zeitpunkt gesteuert wer- den kann. Derartige Promotoren wie z.B. der PRPl-Promotor (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), ein durch Salizylsäure induzierbarer Promotor (WO 95/19443), ein durch Benzenesul- fonamid-induzierbarer (EP-A 388186) , ein durch Tetrazyklin- induzierbarer (Gatz et al . , (1992) Plant J. 2, 397-404), ein durch Abscisinsäure-induzierbarer (EP-A 335528) bzw. ein durch Ethanol- oder Cyclohexanon-induzierbarer (WO 93/21334) Promotor können u.a. verwendet werden.The expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS gene in the plant can be controlled at a specific point in time. Such promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186 ), one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or one that can be induced by ethanol or cyclohexanone (WO 93 / 21334) Promoter can include be used.
Weiterhin sind insbesonders solche Promotoren bevorzugt, die die Expression in Geweben oder Pflanzenteilen sicherstellen, in denen die Biosynthese von Tocopherol bzw. dessen Vorstufen stattfindet. Insbesondere zu nennen sind Promotoren, die eine blattspezifische Expression gewährleisten. Zu nennen sind der Promotor der cyto- solischen FBPase aus Kartoffel oder der ST-LSI Promotor aus Kartoffel (Stockhaus et al . , EMBO J. 8 (1989) 2445 - 245).Furthermore, promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that are leaf-specific are particularly noteworthy Ensure expression. The promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989) 2445-245).
Mit Hilfe eines samenspezifischen Promotors konnte ein Fremdprotein stabil bis zu einem Anteil von 0,67 % des gesamten löslichen Samenproteins in den Samen transgener Tabakpflanzen expri- miert werden (Fiedler und Conrad, Bio/Technology 10 (1995) , 1090-1094). Die Expressionskassette kann daher beispielsweise einen samenspezifischen Promotor (bevorzugt den Phaseolin-With the help of a seed-specific promoter, a foreign protein could be stably expressed up to a proportion of 0.67% of the total soluble seed protein in the seeds of transgenic tobacco plants (Fiedler and Conrad, Bio / Technology 10 (1995), 1090-1094). The expression cassette can therefore, for example, be a seed-specific promoter (preferably the phaseolin
Promotor (US 5504200), den USP- (Baumlein, H. et al . Mol. Gen. Genet. (1991) 225 (3), 459 - 467) oder LEB4-Promotor (Fiedler und Conrad, 1995) ) , das LEB4-Signalpeptid, das zu exprimierende Gen und ein ER-Retentionssignal enthalten. Der Aufbau einer derar- tigen Kassette ist in der Abbildung 2 schematisch beispielhaft dargestellt.Promoter (US 5504200), the USP- (Baumlein, H. et al. Mol. Gen. Genet. (1991) 225 (3), 459-467) or LEB4 promoter (Fiedler and Conrad, 1995)), the LEB4 Signal peptide containing the gene to be expressed and an ER retention signal. The structure of such a cassette is shown schematically as an example in Figure 2.
Die Herstellung einer Expressionskassette erfolgt durch Fusion eines geeigneten Promotors mit einer geeigneten DOXS-DNA Sequenz und vorzugsweise einer zwischen Promotor und DOXS-DNA-Sequenz inserierten DNA, die für ein chloroplastenspezifisches Transitpeptid kodiert, sowie einem Polyadenylierungssignal nach gängigen Rekombinations- und Klonierungstechniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel, F.M. et al . , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987) beschrieben sind.An expression cassette is produced by fusing a suitable promoter with a suitable DOXS-DNA sequence and preferably a DNA inserted between promoter and DOXS-DNA sequence, which codes for a chloroplast-specific transit peptide, and a polyadenylation signal according to common recombination and cloning techniques, such as those for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
Insbesondere bevorzugt sind Sequenzen, die ein Targeting in den Apoplasten, in Piastiden, in die Vakuole, in das Mitochondrium, in das Endoplasmatische Retikulum (ER) oder durch ein Fehlen entsprechender operativer Sequenzen einen Verbleib im Komparti- ment des Entstehens, dem Zytosol, gewährleisten (Kermode, Crit. Rev. Plant Sei. 15, 4 (1996), 285 - 423). Für die Menge der Proteinakkumulation in transgenen Pflanzen besonders förderlich erwiesen hat sich eine Lokalisation im ER (Schouten et al . , Plant Mol. Biol. 30 (1996), 781 - 792).Sequences are particularly preferred which ensure targeting in the apoplasts, in plastids, in the vacuole, in the mitochondrion, in the endoplasmic reticulum (ER) or in the absence of corresponding operative sequences to ensure that they remain in the compartment of formation, the cytosol (Kermode, Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792).
Es können auch Expressionskassetten verwendet werden, deren DNA- Sequenz für ein DOXS-Fusionsprotein kodiert, wobei ein Teil des Fusionsproteins ein Transitpeptid ist, das die Translokation des Polypeptides steuert. Besonders bevorzugt sind für die Chloroplasten spezifische Transitpeptide, welche nach Translokation des DOXS-Gens in die Chloroplasten vom DOXS-Teil enzymatisch abge- spalten werden. Insbesondere bevorzugt ist das Transitpeptid, das von der plastidären Transketolase (TK) oder einem funktioneilen Äquivalent dieses Transitpeptids (z.B. dem Transitpeptid der kleinen Untereinheit der Rubisco oder der Ferredoxin NADP Oxido- reduktase) abgeleitet ist.Expression cassettes can also be used, the DNA sequence of which codes for a DOXS fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Particularly preferred for the chloroplasts are specific transit peptides which, after translocation of the DOXS gene into the chloroplasts, are enzymatically removed from the DOXS part. will split. The transit peptide which is derived from the plastidic transketolase (TK) or a functional equivalent of this transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is particularly preferred.
Die inserierte Nukleotid-Sequenz kodierend für eine DOXS kann synthetisch hergestellt oder natürlich gewonnen sein oder eine Mischung aus synthetischen und natürlichen DNA-Bestandteilen enthalten, sowie aus verschiedenen heterologen DOXS-Genabschnit- ten verschiedener Organismen bestehen. Im allgemeinen werden synthetische Nukleotid-Sequenzen mit Kodons erzeugt, die von Pflanzen bevorzugt werden. Diese von Pflanzen bevorzugten Kodons können aus Kodons mit der höchsten Proteinhäufigkeit bestimmt werden, die in den meisten interessanten Pflanzenspezies exprimiert werden. Bei der Präparation einer Expressionskassette können verschiedene DNA-Fragmente manipuliert werden, um eine Nukleotid-Sequenz zu erhalten, die zweckmäßigerweise in der korrekten Richtung liest und die mit einem korrekten Leseraster ausgestattet ist. Für die Verbindung der DNA-Fragmente miteinander können an die Fragmente Adaptoren oder Linker angesetzt werden.The inserted nucleotide sequence coding for a DOXS can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components, as well as consist of different heterologous DOXS gene sections of different organisms. In general, synthetic nucleotide sequences with codons are generated which are preferred by plants. These codons preferred by plants can be determined from codons with the highest protein frequency, which are expressed in most interesting plant species. When preparing an expression cassette, various DNA fragments can be manipulated in order to obtain a nucleotide sequence which expediently reads in the correct direction and which is equipped with a correct reading frame. To connect the DNA fragments to one another, adapters or linkers can be attached to the fragments.
Zweckmäßigerweise können die Promotor- und die Terminator-Regio- nen in Transkriptionsrichtung mit einem Linker oder Polylinker, der eine oder mehrere Restriktionsstellen für die Insertion dieser Sequenz enthält, versehen werden. In der Regel hat der Linker 1 bis 10, meistens 1 bis 8, vorzugsweise 2 bis 6 Restriktions- stellen. Im allgemeinen hat der Linker innerhalb der regulatori- sehen Bereiche eine Größe von weniger als 100 bp, häufig weniger als 60 bp, mindestens jedoch 5 bp. Der Promotor kann sowohl nativ bzw. homolog als auch fremdartig bzw. heterolog zur Wirtspflanze sein. Die Expressionskassette beinhaltet in der 5 ' -3 ' -Transkriptionsrichtung den Promotor, eine DNA-Sequenz die für ein DOXS-Gen codiert und eine Region für die transkriptionale Termination. Verschiedene Terminationsbereiche sind gegeneinander beliebig austauschbar.The promoter and terminator regions can expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence. As a rule, the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites. In general, the linker has a size of less than 100 bp within the regulatory areas, often less than 60 bp, but at least 5 bp. The promoter can be native or homologous as well as foreign or heterologous to the host plant. The expression cassette contains in the 5 '-3' transcription direction the promoter, a DNA sequence which codes for a DOXS gene and a region for the transcriptional termination. Different termination areas are interchangeable.
Ferner können Manipulationen, die passende Restriktionsschnit- tstellen bereitstellen oder die überflüssige DNA oder Restriktionsschnittstellen entfernen, eingesetzt werden. Wo Insertionen, Deletionen oder Substitutionen wie z.B. Transitionen und Trans - Versionen in Frage kommen, können in vitro-Mutagenese, "primerre- pair" , Restriktion oder Ligation verwendet werden. Bei geeigneten Manipulationen, wie z.B. Restriktion, "chewing-back" oder Auffül- len von Überhängen für "bluntends" , können komplementäre Enden der Fragmente für die Ligation zur Verfügung gestellt werden.Manipulations which provide suitable restriction sites or which remove unnecessary DNA or restriction sites can also be used. Where insertions, deletions or substitutions such as transitions and trans versions are possible, in vitro mutagenesis, "primer pair", restriction or ligation can be used. With suitable manipulations, such as restriction, "chewing-back" or replenishment len of overhangs for "bluntends", complementary ends of the fragments can be provided for the ligation.
Von Bedeutung für den erfindungsgemäßen Erfolg kann u.a. das Anhängen des spezifischen ER-Retentionssignals SEKDEL sein (Schouten, A. et al . Plant Mol. Biol. 30 (1996), 781 - 792), die durchschnittliche Expressionshöhe wird damit verdreifacht bis vervierfacht. Es können auch andere Retentionssignale, die natürlicherweise bei im ER lokalisierten pflanzlichen und tierischen Proteinen vorkommen, für den Aufbau der Kassette eingesetzt werden.Of importance for the success according to the invention can i.a. the attachment of the specific ER retention signal SEKDEL (Schouten, A. et al. Plant Mol. Biol. 30 (1996), 781-792), the average expression level is thus tripled to quadrupled. Other retention signals, which occur naturally in plant and animal proteins located in the ER, can also be used to construct the cassette.
Bevorzugte Polyadenylierungssignale sind pflanzliche Polyadeny- lierungssignale, vorzugsweise solche, die im wesentlichen T-DNA- Polyadenylierungssignale aus Agrobacterium tumefaciens, insbesondere des Gens 3 der T-DNA (Octopin Synthase) des Ti-Plasmids pTiACH5 entsprechen (Gielen et al . , EMBO J. 3 (1984) 835 ff) oder funktionelle Äquivalente.Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984) 835 ff) or functional equivalents.
Eine Expressionskassette kann beispielsweise einen konstitutiven Promotor (bevorzugt den CaMV 35 S-Promotor) , das LeB4-Signalpep- tid, das zu exprimierende Gen und das ER-Retentionssignal enthalten. Als ER-Retentionssignal wird bevorzugt die Aminosäuresequenz KDEL (Lysin, Asparaginsäure, Glutaminsäure, Leucin) verwendet.An expression cassette can contain, for example, a constitutive promoter (preferably the CaMV 35 S promoter), the LeB4 signal peptide, the gene to be expressed and the ER retention signal. The amino acid sequence KDEL (lysine, aspartic acid, glutamic acid, leucine) is preferably used as the ER retention signal.
Vorzugsweise wird die fusionierte Expressionskassette, die für ein DOXS-Gen kodiert, in einen Vektor, beispielsweise pBinl9, kloniert, der geeignet ist, Agrobacterium tumefaciens zu transformieren. Mit einem solchen Vektor transformierte Agrobakterien können dann in bekannter Weise zur Transformation von Pflanzen, insbesondere von Kulturpflanzen, wie z.B. von Tabakpflanzen, verwendet werden, indem beispielsweise verwundete Blätter oder Blattstücke in einer Agrobakterienlösung gebadet und anschließend in geeigneten Medien kultiviert werden. Die Transformation von Pflanzen durch Agrobakterien ist unter anderem bekannt aus F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, herausgegeben von S.D. Kung und R. Wu, Academic Press, 1993, S. 15 - 38. Aus den transformierten Zellen der verwundeten Blätter bzw. Blattstücke können in bekannter Weise transgene Pflanzen regeneriert werden, die ein in die Expressionskassette integriertes Gen für die Expression eines DOXS-Gens enthalten.The fused expression cassette which codes for a DOXS gene is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens. Agrobacteria transformed with such a vector can then be used in a known manner to transform plants, in particular crop plants, such as e.g. of tobacco plants can be used, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media. The transformation of plants by agrobacteria is known, among other things, from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. From the transformed cells of the wounded leaves or leaf pieces, transgenic plants can be regenerated in a known manner which contain a gene integrated into the expression cassette for the expression of a DOXS gene contain.
Zur Transformation einer Wirtspflanze mit einer für eine DOXS kodierenden DNA wird eine Expressionskassette als Insertion in einen rekombinanten Vektor eingebaut, dessen Vektor-DNA zusätzliche funktioneile Regulationssignale, beispielsweise Sequenzen für Replikation oder Integration enthält. Geeignete Vektoren sind unter anderem in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Kap. 6/7, S. 71 - 119 (1993) beschrieben.To transform a host plant with a DNA coding for a DOXS, an expression cassette is inserted as an insert into a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example Contains sequences for replication or integration. Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
Unter Verwendung der oben zitierten Rekombinations- und Klonierungstechniken können die Expressionskassetten in geeignete Vektoren kloniert werden, die ihre Vermehrung, beispielsweise in E. coli , ermöglichen. Geeignete Klonierungsvektoren sind u.a. pBR332, pUC-Serien, Ml3mp-Serien und pACYC184. Besonders geeignet sind binäre Vektoren, die sowohl in E. coli als auch in Agrobakterien replizieren können.Using the recombination and cloning techniques cited above, the expression cassettes can be cloned into suitable vectors that allow their proliferation, for example in E. coli. Suitable cloning vectors include pBR332, pUC series, Ml3mp series and pACYC184. Binary vectors which can replicate both in E. coli and in agrobacteria are particularly suitable.
Ein weiterer Gegenstand der Erfindung betrifft die Verwendung einer Expressionskassette enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3; SEQ-ID No. 1 oder SEQ-ID No . 3 und SEQ-ID No. 5; SEQ-ID No . 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 bzw. eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3 und SEQ-ID No. 5 und SEQ-ID No. 7, oder mit diesen hybridisierende DNA-Se- quenzen zur Transformation von Pflanzen, -zellen, -geweben oder Pflanzenteilen. Vorzugsweise ist Ziel der Verwendung die Erhöhung des Tocopherol-, Vitamin K-, Chlorophyll- und Carotinoid-Gehaltes der Pflanze.Another object of the invention relates to the use of an expression cassette containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 and SEQ-ID No. 7, or with these hybridizing DNA sequences for the transformation of plants, cells, tissues or parts of plants. The aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
Dabei kann je nach Wahl des Promotors die Expression spezifisch in den Blättern, in den Samen oder anderen Teilen der Pflanze erfolgen. Solche transgenen Pflanzen, deren Vermehrungsgut sowie deren Pflanzenzellen, -gewebe oder -teile sind ein weiterer Gegenstand der vorliegenden Erfindung.Depending on the choice of the promoter, the expression can take place specifically in the leaves, in the seeds or in other parts of the plant. Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
Die Expressionskassette kann darüberhinaus auch zur Transformation von Bakterien, Cyanobakterien, Hefen, filamentösen Pilzen und Algen mit dem Ziel einer Erhöhung der Tocopherol-, Vitamin K- , Chlorophyll und/oder Carotinoid-Produktion eingesetzt werden.The expression cassette can also be used to transform bacteria, cyanobacteria, yeast, filamentous fungi and algae with the aim of increasing tocopherol, vitamin K, chlorophyll and / or carotenoid production.
Die Übertragung von Fremdgenen in das Genom einer Pflanze wird als Transformation bezeichnet. Es werden dabei die beschriebenen Methoden zur Transformation und Regeneration von Pflanzen aus Pflanzengeweben oder Pflanzenzellen zur transienten oder stabilen Transformation genutzt. Geeignete Methoden sind die Protoplasten- transformation durch Polyethylenglykol-induzierte DNA-Aufnahme, das biolistische Verfahren mit der Genkanone - die sogenannte particle bombardment Methode, die Elektroporation, die Inkubation trockener Embryonen in DNA-haltiger Lösung, die Mikroinjektion und der durch Agrobacterium vermittelte Gentransfer. Die genannten Verfahren sind beispielsweise in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, herausgegeben von S.D. Kung und R. Wu, Academic Press (1993) 128 - 143 sowie in Potrykus Annu. Rev. Plant Phy- siol. Plant Molec. Biol. 42 (1991) 205 - 225) beschrieben. Vorzugsweise wird das zu exprimierende Konstrukt in einen Vektor kloniert, der geeignet ist, Agro acteriu/n tumefaciens zu transformieren, beispielsweise pBinl9 (Bevan et al., Nucl. Acids Res . 12 (1984) 8711).The transfer of foreign genes into the genome of a plant is called transformation. The methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene cannon - the so-called particle bombardment method, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and the gene transfer mediated by Agrobacterium. The methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The construct to be expressed is preferably cloned into a vector which is suitable for transforming Agro acteriu / n tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
Mit einer Expressionskassette transformierte Agrobakterien können ebenfalls in bekannter Weise zur Transformation von Pflanzen, insbesondere von Kulturpflanzen, wie Getreide, Mais, Hafer, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Hanf, Kartoffel, Tabak, Tomate, Raps, Alfalfa, Salat und den verschiedenen Baum-, Nuß- und Weinspezies, verwendet werden, z.B. indem verwundete Blätter oder Blattstücke in einer Agrobakterienlosung gebadet und anschließend in geeigneten Medien kultiviert werden.Agrobacteria transformed with an expression cassette can also be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, oats, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes, rape, Alfalfa, lettuce and the various tree, nut and wine species can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
Funktioneil äquivalente Sequenzen, die für ein DOXS-Gen kodieren, sind solche Sequenzen, welche trotz abweichender Nukleotidsequenz noch die gewünschten Funktionen besitzen. Funktionelle Äquivalente umfassen somit natürlich vorkommende Varianten der hierin beschriebenen Sequenzen sowie künstliche, z.B. durch chemische Synthese erhaltene, an den Kodon-Gebrauch einer Pflanze angepaßte, künstliche Nukleotid-Sequenzen.Functionally equivalent sequences which code for a DOXS gene are those sequences which, despite a different nucleotide sequence, still have the desired functions. Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon use of a plant.
Unter einem funktionellen Äquivalent versteht man insbesondere auch natürliche oder künstliche Mutationen einer ursprünglich isolierten für eine DOXS kodierende Sequenz, welche weiterhin die gewünschte Funktion zeigen. Mutationen umfassen Substitutionen, Additionen, Deletionen, Vertauschungen oder Insertionen eines oder mehrerer Nukleotidreste. Somit werden beispielsweise auch solche Nukleotidsequenzen durch die vorliegende Erfindung mit umfaßt, welche man durch Modifikation der DOXS -Nukleotidsequenz erhält. Ziel einer solchen Modifikation kann z.B. die weitere Eingrenzung der darin enthaltenen kodierenden Sequenz oder z.B. auch die Einfügung weiterer Restriktionsenzym-Schnittstellen sein.A functional equivalent is also understood to mean, in particular, natural or artificial mutations in an originally isolated sequence coding for a DOXS, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues. Thus, for example, the present invention also encompasses those nucleotide sequences which are obtained by modifying the DOXS nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also be the insertion of further restriction enzyme interfaces.
Funktionelle Äquivalente sind auch solche Varianten, deren Funktion, verglichen mit dem Ausgangsgen bzw. Genfragment, abgeschwächt oder verstärkt ist.Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
Außerdem sind artifizielle DNA-Sequenzen geeignet, solange sie, wie oben beschrieben, die gewünschte Eigenschaft beispielsweise der Erhöhung des Tocopherol-Gehaltes in der Pflanze durchIn addition, artificial DNA sequences are suitable as long as they have the desired property, for example, of increasing the tocopherol content in the plant, as described above
Uberexpression des DOXS-Gens in Kulturpflanzen vermitteln. Solche artifiziellen DNA-Sequenzen können beispielsweise durch Rücküber- setzung mittels Molecular Modelling konstruierter Proteine, die DOXS Aktivität aufweisen oder durch in vi tro-Selektion ermittelt werden. Besonders geeignet sind kodierende DNA-Sequenzen, die durch Rückübersetzung einer Polypeptidsequenz gemäß der für die Wirtspflanze spezifischen Kodon-Nutzung erhalten wurden. Die spezifische Kodon-Nutzung kann ein mit pflanzengenetischen Methoden vertrauter Fachmann durch Computerauswertungen anderer, bekannter Gene der zu transformierenden Pflanze leicht ermitteln.Mediate overexpression of the DOXS gene in crop plants. Such artificial DNA sequences can be Setting of proteins constructed using molecular modeling, which have DOXS activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence according to the codon usage specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
Als weitere geeignete äquivalente Nukleinsäure-Sequenzen sind zu nennen Sequenzen, welche für Fusionsproteine kodieren, wobei Bestandteil des Fusionsproteins ein pflanzliches DOXS-Polypeptid oder ein funktioneil äquivalenter Teil davon ist. Der zweite Teil des Fusionsproteins kann z.B. ein weiteres Polypeptid mit enzyma- tischer Aktivität sein oder eine antigene Polypeptidsequenz mit deren Hilfe ein Nachweis auf DOXS-Expression möglich ist (z.B. myc-tag oder his-tag) . Bevorzugt handelt es sich dabei jedoch um eine regulative Proteinsequenz, wie z.B. ein Signal- oder Transitpeptid, das das DOXS-Protein an den gewünschten Wirkort leitet.Other suitable equivalent nucleic acid sequences are sequences which code for fusion proteins, part of the fusion protein being a plant DOXS polypeptide or a functionally equivalent part thereof. The second part of the fusion protein can e.g. be another polypeptide with enzymatic activity or an antigenic polypeptide sequence that can be used to detect DOXS expression (e.g. myc-tag or his-tag). However, this is preferably a regulatory protein sequence, such as e.g. a signal or transit peptide that directs the DOXS protein to the desired site of action.
Gegenstand der Erfindung sind aber auch die erfindungsgemäß erzeugten Expressionsprodukte sowie Fusionsproteine aus einem Transitpeptid und einem Polypeptid mit DOXS-Aktivität .However, the invention also relates to the expression products and fusion proteins produced according to the invention from a transit peptide and a polypeptide with DOXS activity.
Erhöhung des Tocopherol-, Vitamin K-, Chlorophyll und/oder Caro- tinoid-Gehaltes bedeutet im Rahmen der vorliegenden Erfindung die künstlich erworbene Fähigkeit einer erhöhten Biosyntheseleistung dieser Verbindungen durch funktionelle Überexpression des DOXS- Gens in der Pflanze gegenüber der nicht gentechnisch modifizierten Pflanze für die Dauer mindestens einer Pflanzengeneration.In the context of the present invention, increasing the tocopherol, vitamin K, chlorophyll and / or carotenoid content means the artificially acquired ability to increase the biosynthetic capacity of these compounds by functional overexpression of the DOXS gene in the plant compared to the non-genetically modified plant for the duration of at least one generation of plants.
Der Biosyntheseort von Tocopherol ist im allgemeinen das Blattgewebe, so daß eine blattspezifische Expression des DOXS-Gens sinnvoll ist. Es ist jedoch naheliegend, daß die Tocopherol-Bio- synthese nicht auf das Blattgewebe beschränkt sein muß, sondern auch in allen übrigen Teilen der Pflanze - beispielsweise in fetthaltigen Samen - gewebespezifisch erfolgen kann.The tocopherol biosynthesis site is generally the leaf tissue, so that leaf-specific expression of the DOXS gene is useful. However, it is obvious that the tocopherol biosynthesis need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant - for example in fatty seeds.
Darüberhinaus ist eine konstitutive Expression des exogenen DOXS- Gens von Vorteil. Andererseits kann aber auch eine induzierbare Expression wünschenswert erscheinen.In addition, constitutive expression of the exogenous DOXS gene is advantageous. On the other hand, inducible expression may also appear desirable.
Die Wirksamkeit der Expression des transgen exprimierten DOXS- Gens kann beispielsweise in vi tro durch Sproßmeristemvermehrung ermittelt werden. Zudem kann eine in Art und Höhe veränderte Expression des DOXS-Gens und deren Auswirkung auf die Tocopherol- Biosyntheseleistung an Testpflanzen in Gewächshausversuchen getestet werden.The effectiveness of the expression of the transgenically expressed DOXS gene can be determined, for example, in vitro by proliferation of the shoot meristem. In addition, a change in the type and level of expression of the DOXS gene and its effect on the tocopherol Biosynthetic performance can be tested on test plants in greenhouse experiments.
Gegenstand der Erfindung sind außerdem transgene Pflanzen, transformiert mit einer Expressionskassette enthaltend dieThe invention also relates to transgenic plants transformed with an expression cassette containing the
Sequenz SEQ-ID No.l oder SEQ-ID No. 3; SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-No. 5; SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7 bzw. eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 5 und SEQ-ID No. 7, oder mit diesen hybridisierende DNA- Sequenzen, sowie transgene Zellen, Gewebe, Teile und Vermehrungsgut solcher Pflanzen. Besonders bevorzugt sind dabei transgene Kulturpflanzen, wie z.B. Gerste, Weizen, Roggen, Mais, Hafer, Soja, Reis, Baumwolle, Zuckerrübe, Canola, Sonnenblume, Flachs, Hanf, Kartoffel, Tabak, Tomate, Raps, Alfalfa, Salat und die verschiedenen Baum-, Nuß- und Weinspezies.Sequence SEQ-ID No. 1 or SEQ-ID No. 3; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-No. 5; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 and SEQ-ID No. 7, or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants. Transgenic crop plants, such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rape, alfalfa, lettuce and the various tree, nut and wine species.
Pflanzen im Sinne der Erfindung sind mono- und dikotyle Pflanzen oder Algen.Plants in the sense of the invention are mono- and dicotyledonous plants or algae.
Um effiziente Hemmstoffe der DOXS finden zu können, ist es notwendig, geeignete Testsysteme, mit denen Inhibitor-Enzym- Bindungsstudien durchgeführt werden können, zur Verfügung zu stellen. Hierzu wird beispielsweise die komplette cDNA-Sequenz der DOXS aus Arabidopsis in einen Expressionsvektor (pQE, Qiagen) kloniert und in E. coli überexprimiert .In order to find efficient inhibitors of DOXS, it is necessary to provide suitable test systems with which inhibitor-enzyme binding studies can be carried out. For this purpose, for example, the complete cDNA sequence of the Arabidopsis DOXS is cloned into an expression vector (pQE, Qiagen) and overexpressed in E. coli.
Das mit Hilfe der Expressionskassette exprimierte DOXS-Protein eignet sich besonders zur Auffindung von für die DOXS spezifischen Hemmstoffen.The DOXS protein expressed with the aid of the expression cassette is particularly suitable for the detection of inhibitors specific for the DOXS.
Dazu kann die DOXS beispielsweise in einem Enzymtest eingesetzt werden, bei dem die Aktivität der DOXS in An- und Abwesenheit des zu testenden Wirkstoffs ermittelt wird. Aus dem Vergleich der beiden Aktivitätsbestimmungen läßt sich eine qualitative und quantitative Aussage über das Hemmverhalten des zu testenden Wirkstoffes machen. Methoden zur Aktivitätsbestimmung der DOXS sind beschrieben (Putra et. al . , Tetrahedron Letters 39 (1998), 23-26; Sprenger et al., PNAS 94 (1997), 12857-12862).For this purpose, the DOXS can be used, for example, in an enzyme test in which the activity of the DOXS is determined in the presence and absence of the active substance to be tested. By comparing the two activity determinations, a qualitative and quantitative statement can be made about the inhibitory behavior of the active substance to be tested. Methods for determining the activity of DOXS are described (Putra et. Al., Tetrahedron Letters 39 (1998), 23-26; Sprenger et al., PNAS 94 (1997), 12857-12862).
Mit Hilfe des erfindungsgemäßen Testsystems kann eine Vielzahl von chemischen Verbindungen schnell und einfach auf hemmende Eigenschaften überprüft werden. Das Verfahren gestattet es, reproduzierbar aus einer großen Anzahl von Substanzen gezielt solche mit großer Wirkstärke auszuwählen, um mit diesen Substan- zen anschließend weitere, dem Fachmann geläufige vertiefte Prüfungen durchzuführen. Durch Überexpression der für eine DOXS kodierenden Gensequenz SEQ-ID No. 1 oder SEQ-ID No . 3 in einer Pflanze kann prinzipiell eine erhöhte Resistenz gegenüber Inhibitoren der DOXS erreicht werden. Die derart hergestellten transgenen Pflanzen sind eben- falls Gegenstand der Erfindung.With the help of the test system according to the invention, a large number of chemical compounds can be checked quickly and easily for inhibitory properties. The method makes it possible to selectively reproducibly select those with great potency from a large number of substances in order to subsequently carry out further in-depth tests known to the person skilled in the art with these substances. By overexpression of the gene sequence coding for a DOXS SEQ-ID No. 1 or SEQ-ID No. 3 In principle, increased resistance to DOXS inhibitors can be achieved in a plant. The transgenic plants produced in this way are also the subject of the invention.
Weitere Gegenstände der Erfindung sind:Further objects of the invention are:
Verfahren zur Transformation einer Pflanze dadurch gekenn- zeichnet, daß man eine Expressionskassette enthaltend eineProcess for transforming a plant is characterized in that an expression cassette containing a
DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder eine mit dieser hybridisierende DNA-Sequenz in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzen einbringt.DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or introduces a hybridizing DNA sequence into a plant cell, into callus tissue, an entire plant or plant protoplasts.
Verwendung einer Pflanze zur Herstellung pflanzlicher DOXS.Using a plant to make plant DOXS.
Verwendung der Expressionskassette enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder eine mit dieser hy- bridisierende DNA- Sequenz zur Herstellung von Pflanzen mit erhöhter Resistenz gegenüber Inhibitoren der DOXS durch verstärkte Expression einer DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder eine mit dieser hybridisierende DNA Sequenz.Use of the expression cassette containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a hybridizing DNA sequence for the production of plants with increased resistance to inhibitors of DOXS by increased expression of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this.
- Verwendung der DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder einer mit dieser hybridisierenden DNA- Sequenz zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K- , Chlorphyll- und/oder Carotinoid-Gehalt durch Expression einer DOXS DNA-Sequenz in Pflanzen.- Use of the DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a hybridizing with this DNA sequence for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content by expression of a DOXS DNA sequence in plants.
Verwendung der Expressionskassette enthaltend eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder eine mit dieser hybridisierenden DNA Sequenz zur Herstellung eines Testsystems zur Identifizierung von Inhibitoren der DOXS.Use of the expression cassette containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this to produce a test system for identifying inhibitors of DOXS.
Die Erfindung wird durch die nun folgenden Beispiele erläutert, ist aber nicht auf diese beschränkt:The invention is illustrated by the following examples, but is not limited to these:
Allgemeine KlonierungsverfahrenGeneral cloning procedures
Die im Rahmen der vorliegenden Erfindung durchgeführten Klonie- rungsschritte wie z.B. Restriktionsspaltungen, Agarose-Gel- elektrophorese, Reinigung von DNA-Fragmenten, Transfer von Nukleinsäuren auf Nitrozellulose und Nylonmembranen, Verknüpfen von DNA-Fragmenten, Transformation von E. coli Zellen, Anzucht von Bakterien, Vermehrung von Phagen und Sequenzanalyse rekombi- nanter DNA wurden wie bei Sambrook et al . (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6) beschrieben durchgeführt .The cloning steps carried out in the context of the present invention, such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking of DNA fragments, transformation of E. coli cells, cultivation of bacteria Multiplication of phages and sequence analysis of recombinant DNA were carried out as in Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6).
Die im folgenden verwendeten Bakterienstämme (E. coli , XL-I Blue) wurden von Stratagene bezogen. Der zur Pflanzentransformation verwendete Agrobakterienstamm (Agrobacterium tumefaciens, C58C1 mit dem Plasmid pGV2260 oder pGV3850kann) wurde von Deblaere et al. in (Nucl. Acids Res . 13 (1985) 4777) beschrieben. Alternativ können auch der Agrobakterienstamm LBA4404 (Clontech) oder andere geeignete Stämme eingesetzt werden. Zur Klonierung können die Vektoren pUC19 (Yanish-Perron, Gene 33 (1985) , 103 - 119) pBluescript SK- (Stratagene) , pGEM-T (Promega) , pZerO (Invitrogen) , pBinl9 (Bevan et al . , Nucl. Acids Res. 12 (1984), 8711 - 8720) und pBinAR (Höfgen und Willmitzer, Plant Science 66 (1990) , 221 - 230) benutzt werden.The bacterial strains used below (E. coli, XL-I Blue) were obtained from Stratagene. The agrobacterial strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850 can) was developed by Deblaere et al. in (Nucl. Acids Res. 13 (1985) 4777). Alternatively, the LBA4404 agrobacterial strain (Clontech) or other suitable strains can be used. For cloning, the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBluescript SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl. Acids Res. 12 (1984), 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990), 221-230).
Sequenzanalyse rekombinanter DNASequence analysis of recombinant DNA
Die Sequenzierung rekombinanter DNA-Moleküle erfolgte mit einem Laserfluoreszenz-DNA-Sequenzierer der Firma Licor (Vertrieb durch MWG Biotech, Ebersbach) nach der Methode von Sanger (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1977), 5463 - 5467).The sequencing of recombinant DNA molecules was carried out using a laser fluorescence DNA sequencer from Licor (sold by MWG Biotech, Ebersbach) according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1977), 5463 - 5467).
Beispiel 1example 1
Herstellung der Arabidopsis thaliana DOXS-Transformationskon- strukteProduction of Arabidopsis thaliana DOXS transformation constructs
Das Arabisopsis thaliana DOXS Gen wurde wie in Mandel et al . (1996) beschrieben als vollständige cDNA in den Vektor pBluescript KS- (Stratagene) kloniert.The Arabisopsis thaliana DOXS gene was described in Mandel et al. (1996) described as a complete cDNA cloned into the vector pBluescript KS- (Stratagene).
Zur Herstellung von Überexpressionskonstrukten wurde ein 2.3 kb Fragment (mit F-23-C bezeichnet) über die pBluescript KS- Hincll (blunt-end) und Sacl Schnittstellen isoliert. Diese Sequenz enthält die vollständige DOXS-cDNA inklusive Chloroplastentransit- peptid vom ATG- Startcodons bis zu einer EcoRl- Schnittstelle, die 80 bp stromabwärts des Stopcodons liegt. Dieses Fragment wurde über die Schnittstellen Smal (blunt-end) und Sacl in den pBIN 19 3X35S Vektor (Abbildung 3) kloniert (Bevan et al . , 1980), der den 35S Promotor des Cauliflower Mosaik Virus (Franck et al . , Cell 21(1), 285-294 (1980)) dreimal hintereinander angeordnet enthält.To produce overexpression constructs, a 2.3 kb fragment (labeled F-23-C) was isolated via the pBluescript KS-Hincll (blunt-end) and Sacl interfaces. This sequence contains the complete DOXS cDNA including chloroplast transit peptide from the ATG start codon to an EcoRI interface that is 80 bp downstream of the stop codon. This fragment was cloned via the Smal (blunt-end) and SacI interfaces into the pBIN 19 3X35S vector (Figure 3) (Bevan et al., 1980), which is the 35S promoter of the Cauliflower Mosaic Virus (Franck et al., Cell 21 (1), 285-294 (1980)) three times in a row.
Zur Herstellung von Antisense-Konstrukten wurde ein Bereich des 3' -Endes der cDNA (mit F-23-C Antisense bezeichnet) in den oben erwähnten pBIN19 - 3X35S -Vektor kloniert. Ein Teil des 5' -Bereichs der DOXS-cDNA in pBluescript KS- wurde über Hincll und die DOXS- interne Bglll Schnittstelle verdaut und das entstandene Fragment entfernt. (Abbildung 4). Die Bglll -Schnittstelle wurde über die Klenow-fill-in Reaktion (Klenow-Polymerase; Röche; nach Reaktion nach Herstellerprotokoll) aufgefüllt, so daß ein "blunt-end" ent- steht. Die nun kompatiblen Enden (Bglll - "blunt-end" und Hinein wurden ligiert. Nun wurde der 3 '-Bereich der DOXS-cDNA über Kpnl und Xbal (beide Schnittstellen liegen im Polylinker von pBluescript KS-5'- und 3'- der DOXS-cDNA) in Antisense-Orientierung in den oben beschriebenen pBINl9 -Vektor in Antisense-Orientierung kloniert.To produce antisense constructs, a region of the 3 'end of the cDNA (designated F-23-C antisense) was cloned into the pBIN19-3X35S vector mentioned above. Part of the 5 'area of the DOXS cDNA in pBluescript KS- was via Hincll and the DOXS- digested internal Bglll interface and removed the resulting fragment. (Figure 4). The BglII interface was filled in via the Klenow fill-in reaction (Klenow polymerase; Röche; after reaction according to the manufacturer's protocol), so that a "blunt end" occurs. The now compatible ends (Bglll - "blunt-end" and in were ligated. Now the 3 'region of the DOXS cDNA was via Kpnl and Xbal (both interfaces are in the polylinker of pBluescript KS-5'- and 3'- der DOXS cDNA) in antisense orientation was cloned into the pBIN19 vector described above in antisense orientation.
Die Transformationen von Arabidopsis thaliana Pflanzen mit den oben beschriebenen Konstrukten erfolgten mit Agrobakterium tumefaciens mit der Vakuum-Infiltrationsmethode (Bent et al., Science 265 (1994), 1856-1860). Mehrere unabhängige Transformanden wurden pro Konstrukt isoliert. Jeder Buchstabe (siehe Tabelle 1) bedeutet eine unabhängige transfomierte Linie. Aus der daraus erhaltenen Tl -Generation wurden Pflanzen auf Homo-oder Heterozy- gotie untersucht. Mehrere Pflanzen jeder Linie wurden gekreuzt, um eine Segregationsanalyse durchzuführen. Die Nummer in der Tabelle 1 entspricht der individuellen Pflanze, welche für weitere Analysen ausgewählt wurde. Es wurden sowohl homo- als auch hete- rozygote Linien erhalten. Die Segregationsanalyse der erhaltenen Linien ist in der folgenden Tabelle 1 dargestellt:The transformations of Arabidopsis thaliana plants with the constructs described above were carried out with Agrobacterium tumefaciens using the vacuum infiltration method (Bent et al., Science 265 (1994), 1856-1860). Several independent transformants were isolated per construct. Each letter (see Table 1) means an independent transformed line. From the Tl generation obtained from this, plants were examined for homo- or heterozygosity. Several plants from each line were crossed to perform a segregation analysis. The number in Table 1 corresponds to the individual plant that was selected for further analysis. Both homo- and heterozygote lines were obtained. The segregation analysis of the lines obtained is shown in Table 1 below:
Tabelle 1. Segregationsanalyse der transgenen DOXS-T2-PflanzenTable 1. Segregation analysis of the transgenic DOXS-T2 plants
Figure imgf000032_0001
Beispiel 2
Figure imgf000032_0001
Example 2
Isolierung genomischer DNA des Bakteriums Escherichia coli XL1 Blue 5Isolation of genomic DNA from the bacterium Escherichia coli XL1 Blue 5
Eine Kultur von Escherichia coli XL1 Blue wurde in 300 ml Luria Broth-Medium für 12 Stunden bei 37°C angezogen. Aus dieser Kultur wurde die genomische DNA des Bakteriums isoliert, indem diese zunächst bei 5000 Umdrehungen in einer Sorvall RC50-Fuge pelletiertA culture of Escherichia coli XL1 Blue was grown in 300 ml Luria Broth medium for 12 hours at 37 ° C. The genomic DNA of the bacterium was isolated from this culture by first pelleting at 5000 revolutions in a Sorvall RC50 fugue
10 wurde. Anschliessend wurde das Pellet in 1/30 Volumen der Ursprungskultur Lysis-Puffer (25 mM EDTA, 0,5% SDS; 50 mM Tris HC1, pH 8,0) resuspendiert. Ein gleiches Volumen Phenol/Chloroform/ Isoamylalkohol (25:24:1) wurde zugegeben und bei 70 Grad 10 Minuten inkubiert. Anschliessend wurde in einer Heraeus Untertisch-Turned 10. The pellet was then resuspended in 1/30 volume of the original culture lysis buffer (25 mM EDTA, 0.5% SDS; 50 mM Tris HC1, pH 8.0). An equal volume of phenol / chloroform / isoamyl alcohol (25: 24: 1) was added and incubated at 70 degrees for 10 minutes. Subsequently, in a Heraeus under-table
15 Zentrifuge bei 3500 U 15 Minuten die wässrige Phase von der phenolischen getrennt. Der wässrige Überstand wurde mit 2,5 Volumen Ethanol und 1/10 Volumen 8 M Lithiumchlorid versetzt und die Nukleinsäuren bei Raumtemperatur für 10 Minuten gefällt. Das Pellet wurde anschliessend in 400 μl TE/RNAse aufgenommen und bei15 centrifuge at 3500 U for 15 minutes the aqueous phase separated from the phenolic. The aqueous supernatant was mixed with 2.5 volumes of ethanol and 1/10 volumes of 8 M lithium chloride and the nucleic acids were precipitated at room temperature for 10 minutes. The pellet was then taken up in 400 ul TE / RNAse and at
20 37 Grad für 10 Minuten inkubiert. Die Lösung wurde erneut mit einem Volumen Phenol/Chloroform/Isoamylalkohol (25:24:1) ausgeschüttelt und der Überstand gefällt mit 2,5 Volumen Ethanol und 1/10 Volumen 8 M Lithiumchlorid. Das Pellet wurde anschliessend mit 80% Ethanol gewaschen und in 400 μl TE/RNAse aufgenommen.20 37 degrees incubated for 10 minutes. The solution was again shaken with a volume of phenol / chloroform / isoamyl alcohol (25: 24: 1) and the supernatant was precipitated with 2.5 volumes of ethanol and 1/10 volumes of 8 M lithium chloride. The pellet was then washed with 80% ethanol and taken up in 400 μl TE / RNAse.
2525
Beispiel 3Example 3
Isolierung der DOXS aus E. coliIsolation of the DOXS from E. coli
30 Von der DNA-Sequenz der DOXS (Acc. Number AF035440) wurden für eine PCR Oligonukleotide abgeleitet, denen am 5 ' -Ende eine BamHI und am 3 ' -Ende eine Xbal bzw. eine weitere BamHI Restriktions - Schnittstelle angefügt wurde. Das Oligonukleotid am 5' Ende umfaßt die Sequenz 5 ' -A1GGATCCATGAGTTTT-GATATTGCCAAATAC-3 '30 For the PCR, oligonucleotides were derived from the DNA sequence of the DOXS (Acc. Number AF035440), to which a BamHI at the 5 'end and an Xbal or another BamHI restriction site were added at the 3' end. The oligonucleotide at the 5 'end comprises the sequence 5' -A1GGATCCATGAGTTTT-GATATTGCCAAATAC-3 '
35 (Nukleotide 1-24 der DNA-Sequenz; kursiv geschrieben) beginnend mit dem ATG-Startcodon des Gens, das Oligonukleotid am 3 ' -Ende umfaßt die Sequenz 5 ' - ATTCT AG ATTATGCCAGCCAGGCCTTG- 3 ' bzw. 5'-ATG- GATCCTTATGCCAGCCAGGCCTTG-3 ' (Nukleotide 1845-1863 der revers komplementären DNA-Sequenz; kursiv geschrieben) beginnend mit dem35 (nucleotides 1-24 of the DNA sequence; written in italics) starting with the ATG start codon of the gene, the oligonucleotide at the 3 'end comprises the sequence 5' - ATTCT AG ATTATGCCAGCCAGGCCTTG- 3 'or 5'-ATG-GATCCTTATGCCAGCCAGGCCTTG -3 '(nucleotides 1845-1863 of the reverse complementary DNA sequence; written in italics) starting with the
40 Stop-Kodon des Gens. Die PCR-Reaktion mit den beiden BamHI enthaltenden Oligonukleotiden wurde durchgeführt mit der Pfu- Polymerase (Stratagene GmbH, Heidelberg) nach Herstellerangaben. Als Template wurden 500 ng der genomischen DNA aus E. coli eingesetzt. Das PCR-Programm lautete:40 stop codon of the gene. The PCR reaction with the two BamHI-containing oligonucleotides was carried out with the Pfu polymerase (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template. The PCR program was:
4545
5 Zyklen: 4 sec 94°C, 30 sec 52°C, 2 min 72°C; 5 Zyklen: 4 sec 94°C, 30 sec 48°C, 2 min 72°C; 25 Zyklen: 4 sec 94°C, 30 sec 44°C, 2 min 72°C5 cycles: 4 sec 94 ° C, 30 sec 52 ° C, 2 min 72 ° C; 5 cycles: 4 sec 94 ° C, 30 sec 48 ° C, 2 min 72 ° C; 25 cycles: 4 sec 94 ° C, 30 sec 44 ° C, 2 min 72 ° C
Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script (Stratagene GmbH, Heidelberg) kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung festgestellt. Das Fragment wurde BamHI aus dem PCR-Script-Vektor isoliert und in einen entsprechend geschnittenen Binl9-Vektor ligiert, der zusätzlich das Transitpeptid der Transketolase aus Kartoffel hinter dem CaMV 35S Promotor enthält. Das Transitpeptid gewährleistet die plastidäre Lokalisierung. Die Konstrukte sind in Abbildung 5 und 6 dargestellt und die Fragmente haben die folgende Bedeutung:The fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was determined by sequencing. The BamHI fragment was isolated from the PCR script vector and ligated into a correspondingly cut Bin19 vector which additionally contains the transit peptide of the potato transketolase behind the CaMV 35S promoter. The transit peptide ensures plastid localization. The constructs are shown in Figures 5 and 6 and the fragments have the following meaning:
Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- Mosaik-Virus (Nukleotide 6909 bis 7437 des Cauliflower-Mosaik-Vi - rus) . Fragment B (259 bp) beinhaltet das Transitpeptid der Transketolase. Fragment E beinhaltet das Gen der DOXS. Fragment D (192 bp) enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionster - mination.Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus). Fragment B (259 bp) contains the transit peptide of the transketolase. Fragment E contains the gene of the DOXS. Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
Die PCR-Reaktion mit den 5 ' -BamHI und 3 ' -Xbal enthaltenden Oligo- nukleotiden wurde durchgeführt mit Taq-Polymerase (Takara, Sosei Co., Ltd.) nach Herstellerangaben. Als Template wurden 500 ng der genomischen DNA aus E. coli eingesetzt. Das PCR-Programm lautete:The PCR reaction with the oligonucleotides containing 5 '-BamHI and 3' -Xbal was carried out using Taq polymerase (Takara, Sosei Co., Ltd.) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template. The PCR program was:
5 Zyklen: 4 sec 94°C, 4 sec 50°C, 2 min 30°C 5 Zyklen: 4 sec 94°C, 30 sec 46°C, 2 min 68°C 25 Zyklen: 4 sec 94°C, 30 sec 42°C, 2 min 68°C5 cycles: 4 sec 94 ° C, 4 sec 50 ° C, 2 min 30 ° C 5 cycles: 4 sec 94 ° C, 30 sec 46 ° C, 2 min 68 ° C 25 cycles: 4 sec 94 ° C, 30 sec 42 ° C, 2 min 68 ° C
Das Fragment wurde mit dem Gene-Clean-Kit gereinigt und in den Vektor pGemT (Promega GmbH, Mannheim) ligiert. Es wurde als BamHI/Xbal-Fragment in einen entsprechend geschnittenen pBinl9AR- Vektor hinter den CaMV 35S Promotor kloniert. Die Sequenz wurde durch Sequenzierung überprüft ( SEQ-ID No. 3) .Dabei wurden zwei nicht konservative Basenaustausche festgestellt, die im Vergleich zur veröffentlichten Sequenz zur Veränderung der Aminosäure 152 (Asparagin) in Valin und Aminosäure 330 (Cystein) in Tryptophan führen.The fragment was purified using the gene clean kit and ligated into the vector pGemT (Promega GmbH, Mannheim). It was cloned as a BamHI / Xbal fragment into a correspondingly cut pBinl9AR vector behind the CaMV 35S promoter. The sequence was checked by sequencing (SEQ-ID No. 3) and two non-conservative base changes were found, which lead to a change in amino acid 152 (asparagine) in valine and amino acid 330 (cysteine) in tryptophan compared to the published sequence.
Beispiel 4Example 4
Nachweis erhöhter DOXS-RNA-Mengen in transgenen PflanzenDetection of increased DOXS RNA levels in transgenic plants
Gesamt RNA aus 15 Tage alten Keimlingen verschiedener transgener Linien, welche das DOXS-Überexpressionskonstrukt besitzen, wurde nach der Methode von Logeman et al., Anal .Biochem. 163, 16-20 (1987) extrahiert, in einem 1.2% Agarosegel aufgetrennt, auf Filter transferiert und mit einem 2.1 kb langen DOXS-Fragment als Sonde hybridisiert (Abbildung 7) .Total RNA from 15 day old seedlings of different transgenic lines, which have the DOXS overexpression construct, was determined according to the method of Logeman et al., Anal. Biochem. 163, 16-20 (1987) extracted, separated in a 1.2% agarose gel, transferred to filters and hybridized with a 2.1 kb long DOXS fragment as a probe (Figure 7).
Beispiel 5Example 5
Nachweis erhöhter DOXS-Protein-Mengen in transgenen PflanzenDetection of increased DOXS protein levels in transgenic plants
Gesamtprotein (Abbildung 8) aus 15 Tage alten Keimlingen verschiedener, unabhängiger transgener Pflanzen, welche das DOXS- Überexpressionskonstrukt besitzen, wurde isoliert und mit einem polyklonalen Anti-DOXS-Antikörper (IgG) in einer Westernanalyse detektiert (Abbildung 9).Whole protein (Figure 8) from 15 day old seedlings of different, independent transgenic plants, which have the DOXS overexpression construct, was isolated and detected with a polyclonal anti-DOXS antibody (IgG) in a Western analysis (Figure 9).
Beispiel 6Example 6
Messung des Carotinoid- und ChlorophyllgehaltsMeasurement of the carotenoid and chlorophyll content
Die Bestimmung der Gesamtcarotinoid- und Chlorophyllmengen wurde wie in Lichtenthaler und Wellburn (1983) beschrieben mit 100% Acetonextrakten durchgeführt. Die Ergebnisse der Mehrfachmessungen der transgenen Linien, welche das DOXS-Überexpressionskon- strukt besitzen, sind in der folgenden Tabelle 2 dargestellt.The total carotenoid and chlorophyll amounts were determined as described in Lichtenthaler and Wellburn (1983) with 100% acetone extracts. The results of the multiple measurements of the transgenic lines which have the DOXS overexpression construct are shown in Table 2 below.
Tabelle 2: Gesamtcarotinoid- und Chlorophyllgehalt der transgenen DOXS-LinienTable 2: Total carotenoid and chlorophyll content of the transgenic DOXS lines
Figure imgf000035_0001
Beispiel 7
Figure imgf000035_0001
Example 7
Transformation von RapsRapeseed transformation
Die Herstellung der transgenen Rapspflanzen orientiert sich an einem Protokoll von Bade, JB und Damm, B (in Gene, Transfer to Plants, Potrykus, I. und Spangenberg, G. , eds , Springer Lab Manual, Springer Verlag, 1995, 30-38), in welchem auch die Zusammensetzung der verwendeten Medien angegeben sind. Die Trans - formationen erfolgten mit dem Agrobacterium Stamm LBA4404 (Clon- tech) . Als binäre Vektoren wurden die bereits oben beschriebenen pBIN19 -Konstrukte mit der gesamten DOXS-cDNA verwendet. In diesen pBIN-Vektoren wurde die NOS -Terminatorsequenz durch die OCR-Ter- minatorsequenz ersetzt. Brassica napus Samen wurden mit 70 % (v/v) Ethanol oberflächensteril gemacht, 10 min in 55°C H20 gewaschen, in l%iger Hypochlorit -Lösung (25 % v/v Teepol, 0,1 % v/v Twenn 20) für 20 min inkubiert und sechsmal mit sterilem H0 für jeweils 20 min gewaschen. Die Samen wurden drei Tage auf Filterpapier getrocknet und 10-15 Samen in einem Glasskolben mit 15 ml Keimungsmedium zur Keimung gebracht. Von mehreren Keimlingen (ca. 10 cm groß) wurden die Wurzeln und Apices entfernt und die verbleibenden Hypokotyle in ca. 6 mm lange Stücke geschnitten. Die so gewonnenen ca. 600 Explante werden 30 min mit 50 ml Basal- medium gewaschen und in einen 300 ml Kolben überführt. Nach Zu- gäbe von 100 ml Kallus -Induktionsmedium wurden die Kulturen für 24 h bei 100 U/min inkubiert.The production of the transgenic rape plants is based on a protocol by Bade, JB and Damm, B (in Gene, Transfer to Plants, Potrykus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30-38 ), which also gives the composition of the media used. The transformations were carried out with the Agrobacterium strain LBA4404 (Clontech). The pBIN19 constructs already described above with the entire DOXS cDNA were used as binary vectors. In these pBIN vectors, the NOS terminator sequence was replaced by the OCR terminator sequence. Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min in 55 ° CH 2 0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Twenn 20 ) incubated for 20 min and washed six times with sterile H0 for 20 min each. The seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium. The roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx. 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm.
Vom Agrobacterium- Stamm wurde eine Übernachtkultur bei 29°C in LB mit Kanamycin (20 mg/1) angesetzt, davon 2 ml in 50 ml LB ohne Kanamycin für 4 h bei 29°C bis zu einer OD60o von 0,4-0,5 inkubiert. Nach der Pelletierung der Kultur bei 2000 U/min für 25 min wurde das Zellpellet in 25 ml Basalmedium resuspendiert. Die Konzentration der Bakterien in der Lösung wurde durch Zugabe von weiterem Basalmedium auf eine OD600 von 0.3 eingestellt.An overnight culture of the Agrobacterium strain was set up at 29 ° C. in LB with kanamycin (20 mg / l), of which 2 ml in 50 ml LB without kanamycin for 4 h at 29 ° C. up to an OD 60 o of 0.4- 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an OD600 of 0.3 by adding further basal medium.
Aus den Raps -Explanten wurde das Kallus - Induktionsmedium mit sterilen Pipetten entfernt, 50 ml Agrobacterium-Lösung hinzugefügt, vorsichtig gemischt und für 20 min inkubiert. Die Agrobacterien- Suspension wurde entfernt, die Raps -Explante für 1 min mit 50 ml Kallus -Induktionsmedium gewaschen und anschließend 100 ml Kallus - Induktionsmedium hinzugefügt. Die Co- Kultivierung wurde für 24 h auf einem Rotationsschüttler bei 100 U/min durchgeführt. Die Co- Kultivierung wurde durch Wegnahme des Kallus -Induktionsmediums gestoppt und die Explante zweimal für jeweils 1 min mit 25 ml und zweimal für 60 min mit jeweils 100 ml Waschmedium bei 100 U/min gewaschen. Das Waschmedium mit den Explanten wurde in 15 cm Pe- trischalen überführt und das Medium mit sterilen Pipetten ent- fernt. Zur Regeneration wurden jeweils 20-30 Explanten in 90 mm Petrischalen überführt, welche 25 ml Sproß -Induktionsmedium mit Kanamycin enthielten. Die Petrischalen wurden mit 2 Lagen Leuko- por verschlossen und bei 25°C und 2000 lux bei Photoperioden von 16/8 H inkubiert. Alle 12 Tage wurde die sich entwickelnden Kalli auf frische Petrischalen mit Sproß -Induktionsmedium überführt. Alle weiteren Schritte zur Regeneration ganzer Pflanzen wurde wie von Bade, J.B. und Damm, B. (in Gene Transfer to Plants, Potry- kus, I. und Spangenberg, G.,eds, Springer Lab Manual, Springer Verlag, 1995, 30-38) beschrieben durchgeführt.The callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min. The Agrobacteria suspension was removed, the oilseed rape explants were washed for 1 min with 50 ml callus induction medium and then 100 ml callus induction medium was added. The co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h. The co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm. The washing medium with the explants was transferred to 15 cm petri dishes and the medium was removed using sterile pipettes. distant. For regeneration, 20-30 explants were transferred to 90 mm petri dishes containing 25 ml shoot induction medium with kanamycin. The petri dishes were closed with two layers of leucopore and incubated at 25 ° C and 2000 lux for 16/8 H photoperiods. Every 12 days, the developing calli was transferred to fresh petri dishes with sprout induction medium. All further steps for the regeneration of whole plants were carried out as by Bade, JB and Damm, B. (in Gene Transfer to Plants, Potrycus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30- 38).
Beispiel 8Example 8
Steigerung der Tocopherolbiosynthese in RapsIncrease in tocopherol biosynthesis in oilseed rape
Die cDNA der DOXS (SEQ-ID No . 1) wurde mit einem CaMV35S -Promotor versehen und in Raps unter Verwendung des 35S-Promotors überex- primiert. Parallel dazu wurde der samenspezifische Promotor des Phaseolingenes verwednet, um den Tocopherolgehalt spezifisch im Rapssamen zu erhöhen. Mit den entsprechenden Konstrukten transfo- mierte Rapspflanzen wurden im Gewächshaus angezogen. Anschließend wurde der α-Tocopherolgehalt der Gesamtpflanze bzw. der Samen der Pflanze bestimmt. In allen Fällen war die α-Tocopherolkonzentra- tion im Vergleich zur nicht transfomierten Pflanze erhöht.The cDNA of DOXS (SEQ-ID No. 1) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter. In parallel, the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed. Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The α-tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the α-tocopherol concentration was increased compared to the non-transformed plant.
Beispiel 9Example 9
Nachweis der Expression der DOXS aus E. coli in transgenen Tabak- pflanzenEvidence of the expression of DOXS from E. coli in transgenic tobacco plants
Von Pflanzen, die das Konstrukt pBinAR HPPD-DOXS enthielten, wurden Blattscheiben mit einem Durchmesser von 0,9 cm aus völlig entfalteten Blättern genommen und in flüssig Stickstoff eingefroren. Das Blattmaterial wurde in einem HEPES-KOH-Puffer, der Pro- teinase- Inhibitoren enthielt homogenisiert und aus dem Extrakt mit dem Protein-Assay von Bio-Rad nach Herstellerangaben die Proteinkonzentration bestimmt. 45 μg Protein wurden von jedem Extrakt mit einem Volumen Auftragpuffer (Laemmli, 1970) versetzt und 5 min bei 95°C inkubiert. Anschließend wurden die Proteine auf einem 12,5 prozentigen SDS-PAGE Gel aufgetrennt. Danach wurden die Proteine mittels Semi-dry Elektroblots auf Porablotmembran (Machery und Nagel) übertragen. Die Detektion des DOXS -Proteins erfolgte mittels eines Antikörpers gegen die E. coli DOXS aus Kaninchen. Die Farbreaktion basiert auf der Bindung eines Sekunda- ren Antikörpers und einer alkalischen Phosphatase, die NBT/BCIP zu einem Farbstoff umsetzt. Sekundärer Antikörper und alkalische Phosphatase stammen von Pierce, die Durchführung erfolgte nach Herstellerangaben.Leaf disks with a diameter of 0.9 cm were taken from completely unfolded leaves from plants which contained the construct pBinAR HPPD-DOXS and were frozen in liquid nitrogen. The leaf material was homogenized in a HEPES-KOH buffer which contained proteinase inhibitors and the protein concentration was determined from the extract using the Bio-Rad protein assay according to the manufacturer's instructions. 45 μg protein of each extract were mixed with a volume of application buffer (Laemmli, 1970) and incubated for 5 min at 95 ° C. The proteins were then separated on a 12.5 percent SDS-PAGE gel. The proteins were then transferred to Porablot membrane (Machery and Nagel) using semi-dry electroblots. The DOXS protein was detected by means of an antibody against the E. coli DOXS from rabbits. The color reaction is based on the binding of a secondary antibody and an alkaline phosphatase, which converts NBT / BCIP into a dye. Secondary antibody and alkaline Phosphatase are from Pierce and were carried out according to the manufacturer's instructions.
Die Abbildung 10 zeigt den Nachweis des DOXS -Proteins in Blättern 5 transgener Pflanzen. 1: Marker; 2: Pflanze 10; 3:62; 4: 63; 5: 69; 7:71; 8:112; 9:113; 10:116; 11:WT1; 12:WT2; 13 : lOOng rekombi - nantes Protein; 14:50 ng rekombinantes Protein; 15: 10 ng rekombinantes Protein.Figure 10 shows the detection of the DOXS protein in leaves of 5 transgenic plants. 1: marker; 2: plant 10; 3:62; 4: 63; 5: 69; 7:71; 8: 112; 9: 113; 10: 116; 11: WT1; 12: WT2; 13: 100 recombinant protein; 14:50ng recombinant protein; 15:10 ng recombinant protein.
10 Beispiel 1010 Example 10
Klonierung des Gens einer HPPD aus Streptomyces avermitilis U11864Cloning of an HPPD gene from Streptomyces avermitilis U11864
15 Isolierung genomischer DNA des Bakteriums Streptomyces avermitilis U11864:15 Isolation of genomic DNA of the bacterium Streptomyces avermitilis U11864:
Eine Kultur von Streptomyces avermitilis U11864 wurde in 300 ml YEME-Medium (5 g Malz-Extrakt, 2 g Hefe-Extrakt, 2 g Glukose) fürA culture of Streptomyces avermitilis U11864 was made in 300 ml of YEME medium (5 g malt extract, 2 g yeast extract, 2 g glucose)
20 96 h bei 28°C angezogen. Aus dieser Kultur wurde die genomische DNA des Bakteriums isoliert, indem diese zunächst bei 5000 U in einer Sorvall RC5C-Fuge pelletiert wurde. Anschliessend wurde das Pellet in 1/30 Volumen Lysis-Puffer (25 mM EDTA, 0,5 % SDS, 50 mM Tris-HCl, pH 8.0) resuspendiert. Ein gleiches Volumen Phenol/20 96 h at 28 ° C. The genomic DNA of the bacterium was isolated from this culture by first pelleting it at 5000 U in a Sorvall RC5C fugue. The pellet was then resuspended in 1/30 volume of lysis buffer (25 mM EDTA, 0.5% SDS, 50 mM Tris-HCl, pH 8.0). An equal volume of phenol /
25 Chloroform/Isoamylalkohol (25:24:1) wurde zugegeben und bei 70°C 10 Minuten inkubiert. Anschliessend wurde in einer Heraeus Untertisch-Zentrifuge bei 3500 U 15 Minuten die wässrige Phase von der phenolischen getrennt. Der wässrige Überstand wurde mit 2,5 Volumen Ethanol und 1/10 Volumen 8 M Lithiumchlorid versetzt und die25 chloroform / isoamyl alcohol (25: 24: 1) was added and incubated at 70 ° C for 10 minutes. The aqueous phase was then separated from the phenolic in a Heraeus under-table centrifuge at 3500 U for 15 minutes. The aqueous supernatant was mixed with 2.5 volumes of ethanol and 1/10 volumes of 8 M lithium chloride and the
30 Nukleinsäuren bei Raumtemperatur für 10 Minuten gefällt. Das Pellet wurde anschliessend in 400 μl TE/RNAse aufgenommen und bei 37 Grad für 10 Minuten inkubiert. Die Lösung wurde erneut mit einem Volumen Phenol/Chloroform/Isoamylalkohol (25:24:1) ausgeschüttelt und der Überstand gefällt mit 2,5 Volumen Ethanol und 1/10 Volu-30 nucleic acids precipitated at room temperature for 10 minutes. The pellet was then taken up in 400 μl TE / RNAse and incubated at 37 degrees for 10 minutes. The solution was shaken again with a volume of phenol / chloroform / isoamyl alcohol (25: 24: 1) and the supernatant was precipitated with 2.5 volumes of ethanol and 1/10 volume.
35 men 8 M Lithiumchlorid. Das Pellet wurde anschließend mit 80% Ethanol gewaschen und in 400 μl TE/RNAse aufgenommen.35 men 8 M lithium chloride. The pellet was then washed with 80% ethanol and taken up in 400 ul TE / RNAse.
Von der DNA-Sequenz der HPPD aus Streptomyces avermitilis (Denoya et al, 1994; Acc. Number U11864) wurden für eine PCR Oligo-From the DNA sequence of the HPPD from Streptomyces avermitilis (Denoya et al, 1994; Acc. Number U11864), oligo-
40 nukleotide abgeleitet, denen am 5 '-Ende eine BamHI und am 3 ' -Ende eine Xbal Restriktionsschnittstelle angefügt worden war. Das Oligonukleotid am 5 '-Ende umfasst die Sequenz 5 ' -GGATCCAGCGGA - CAAGCCAAC-3 ' (37 bis 55 Basen vom ATG in 5' -Richtung entfernt; kursiv geschrieben), das Oligonukleotid am 3 ' -Ende umfaßt die40 nucleotides were derived, to which a BamHI had been added at the 5 'end and an Xbal restriction site at the 3' end. The oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCAGCGGA - CAAGCCAAC-3 '(37 to 55 bases from the ATG in 5' direction; written in italics), the oligonucleotide at the 3 'end comprises the sequence
45 Sequenz 5 ' -TCTAGA TTATGCCAGCCAGGCCTTG-3 ' (Nukleotide 1845-1863 der revers komplementären DNA-Sequenz; Kursiv geschrieben). Die PCR-Reaktion wurde durchgeführt mit Pfu-Polymerase (Stratagene GmbH, Heidelberg) nach Herstellerangaben. Als Vorlage wurden 400 ng der genomischen DNA eingesetzt. Das PCR-Programm lautete:45 Sequence 5 '-TCTAGA TTATGCCAGCCAGGCCTTG-3' (nucleotides 1845-1863 of the reverse complementary DNA sequence; written in italics). The PCR reaction was carried out with Pfu polymerase (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. 400 ng of the genomic DNA were used as template. The PCR program was:
5 5 Zyklen: 4 sec 94°C, 30 sec 54°C, 2 min 72°C 5 Zyklen: 4 sec 94°C, 30 sec 52°C, 2 min 72°C 25 Zyklen: 4 sec 94°C, 30 sec 50°C, 2 min 72°C5 5 cycles: 4 sec 94 ° C, 30 sec 54 ° C, 2 min 72 ° C 5 cycles: 4 sec 94 ° C, 30 sec 52 ° C, 2 min 72 ° C 25 cycles: 4 sec 94 ° C, 30 sec 50 ° C, 2 min 72 ° C
Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) 10 gereinigt und nach Herstellerangeben in den Vektor PCR-Script (Stratagene GmbH, Heidelberg) kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Dabei wurde festgestellt, daß das isolierte Gen für eine zusätzliche Aminosäure kodiert. Es enthält die drei Basen TAC (kodierend für Tyrosin) , 15 vor dem Nukleotid N429 der zitierten Sequenz (Denoya et al., 1994) .The fragment was purified using a gene clean kit (Dianova GmbH, Hilden) 10 and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was found that the isolated gene codes for an additional amino acid. It contains the three bases TAC (coding for tyrosine), 15 before the nucleotide N429 of the cited sequence (Denoya et al., 1994).
Das Fragment wurde mit einem BamHI und Xbal Verdau aus dem Vektor isoliert und in einen entsprechend geschnittenen Binl9AR-VektorThe fragment was isolated from the vector with a BamHI and Xbal digest and into a correspondingly cut Bin19AR vector
20 hinter den CaMV 35S Promotor ligiert, zur Expression des Gens im Zytosol. Aus dem gleichen PCR-Script-Vektor wurde das Gen als BamHI-Fragment isoliert und in einen entsprechend geschnittenen pBinl9-Vektor ligiert, der hinter dem CaMV 35S Promotor noch zusätzlich das Transitpeptid der plastidären Transketolase ausLigated 20 behind the CaMV 35S promoter, for expression of the gene in the cytosol. The gene was isolated as a BamHI fragment from the same PCR script vector and ligated into a correspondingly cut pBinl9 vector, which additionally exits the transit peptide of the plastid transketolase behind the CaMV 35S promoter
25 Kartoffel enthält. Das Transitpeptid gewährleistet die plastidäre Lokalisierung. Die Konstrukte sind in Abbildung 11 und 12 dargestellt und die Fragmente haben folgende Bedeutung:Contains 25 potatoes. The transit peptide ensures plastid localization. The constructs are shown in Figures 11 and 12 and the fragments have the following meaning:
Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- 30 Mosaik-Virus (Nukleotide 6909 bis 7437 des Cauliflower-Mosaik-Vi - rus) . Fragment B (259 bp) beinhaltet das Transitpeptid der Transketolase. Fragment C beinhaltet das Gen der HPPD. Fragment D (192 bp) enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen, J. et al . , EMBO J. 3 (1984), 35 835-846) zur Transkriptionstermination.Fragment A (529 bp) contains the 35S promoter of the Cauliflower 30 mosaic virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic virus). Fragment B (259 bp) contains the transit peptide of the transketolase. Fragment C contains the HPPD gene. Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen, J. et al., EMBO J. 3 (1984), 35 835-846) for transcription termination.
Beispiel 11Example 11
Herstellung von Konstrukten zur Pflanzentransformation mit DOXS 40 und HPPD -DNA- SequenzenProduction of constructs for plant transformation with DOXS 40 and HPPD-DNA sequences
Zur Herstellung von Pflanzen, welche transgen für die DOXS und die HPPD sind, wurde ein binärer Vektor angefertigt, der beide Gensequenzen enthält (Abbildung 13) . Die Gensequenzen der DOXS 45 und der HPPD wurden jeweils als BamHI-Fragmente wie in Beispiel 3 und 10 beschrieben kloniert. Der Vektor pBinAR-Hyg enthält den 35S-Promotor des Blumenkohlmosaikvirus und das Polyadenylierungs- signal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al., 1984) zur Transkriptionstermination. Der pBinAR-Hyg Vektor vermittelt in Pflanzen Resistenz gegen das Antibiotikum Hygromy- cin und ist so geeignet, Pflanzen mit Kanamycinresistenz zu su- perinfizieren.For the production of plants that are transgenic for the DOXS and the HPPD, a binary vector was prepared that contains both gene sequences (Figure 13). The gene sequences of the DOXS 45 and the HPPD were each cloned as BamHI fragments as described in Examples 3 and 10. The vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. The pBinAR-Hyg vector mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
Zur Klonierung der HPPD in Vektoren, welche zusätzlich noch eine andere cDNA enthalten, wurden für eine PCR Oligonukleotide abgeleitet, denen am 5 '-Ende und am 3 ' -Ende eine BamHI Restriktions - Schnittstelle angefügt worden war. Das Oligonukleotid am 5 '-Ende umfaßt die Sequenz 5' -GGATCCTCCAGCGGACAAGCCAAC-3 ' (Nukleotide 37 bis 55 vom ATG in 5'-Richtung entfernt; Kursiv geschrieben), das Oligonukleotid am 3 ' -Ende umfaßt die Sequenz 5'-ATGGATC- CCGCGCCGCCTACAGGTTG-3 ' (endend mit Basenpaar 1140 der kodierenden Sequenz, beginnend 8 Basenpaare 3' des TAG Stop-Codons; Kursiv geschrieben) . Die PCR-Reaktion wurde durchgeführt mit Tli- Polymerase (Promega GmbH, Mannheim) nach Herstellerangaben. Als Template wurden 10 ng des Plasmids pBinAR-HPPD eingesetzt. Das PCR-Programm lautete:To clone the HPPD into vectors which additionally contain another cDNA, oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end. The oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; italics), the oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC- CCGCGCCGCCTACAGGTTG-3 '(ending with base pair 1140 of the coding sequence, starting 8 base pairs 3' of the TAG stop codon; written in italics). The PCR reaction was carried out using Tli polymerase (Promega GmbH, Mannheim) according to the manufacturer's instructions. 10 ng of the plasmid pBinAR-HPPD were used as template. The PCR program was:
5 Zyklen: 94°C 4 sec, 68°C 30 sec, 72°C 2 min 5 Zyklen: 94°C 4 sec, 64°C 30 sec, 72°C 2 min 25 Zyklen: 94°C 4 sec, 60°C 30 sec, 72°C 2 min5 cycles: 94 ° C 4 sec, 68 ° C 30 sec, 72 ° C 2 min 5 cycles: 94 ° C 4 sec, 64 ° C 30 sec, 72 ° C 2 min 25 cycles: 94 ° C 4 sec, 60 ° C 30 sec, 72 ° C 2 min
Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script (Stratagene GmbH, Heidelberg) kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus dem Vektor PCR- Script wurde es als BamHI-Fragment ausgeschnitten und in einen entsprechend geschnittenen pBinAR-Vektor ligiert, der zusätzlich das Transitpeptid der Transketolase enthält, zur Einführung des Genprodukts in den Piastiden. Es entstand das Plasmid pBinAR-TP- HPPD (Abbildung 12) .The fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was cut out of the vector PCR script as a BamHI fragment and ligated into a correspondingly cut pBinAR vector, which additionally contains the transit peptide of transketolase, for introducing the gene product into the plastids. The plasmid pBinAR-TP-HPPD was formed (Figure 12).
Zur Klonierung wurde aus dem Plasmid pBinAR-TP-HPPD der 35S-Pro- motor, das Transketolase-Transitpeptid, das HPPD-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al., 1984) zur Transkriptionstermination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und den Terminator wurde jeweils eine Hindlll-Schnittstelle angefügt. Die Sequenz des Oligonukleotids , welches sich an den 5 '-Bereich des Promotors (kursiv geschrieben) anlagert, lautet 5'-ATAAGCTT- CATGGAGTCAAA-GATTCAAATAGA-3 ' , die des Oligonukleotids, welches sich an die Terminationssequenz (kursiv geschrieben) anlagert lautet 5 ' -ATAAGCTTGGACAATCAGTAAATTGAACGGAG-3 ' . Das erhaltene Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script (Stratagene GmbH, Heidelberg) kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft (SEQ-ID No. 5) . Aus diesem PCR-Script-Vektor wurde es als Hindlll-Fragment in den entsprechend geschnittenen Vektor pBinl9 (Bevan, 1984, Nucleic 5 Acids Res. 12, 8711-8721) übertragen.For cloning, the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) isolated for transcription termination by means of PCR. A HindIII interface was added to each of the oligonucleotides for the promoter and the terminator. The sequence of the oligonucleotide which is attached to the 5 'region of the promoter (italics) is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 '-ATAAGCTTGGACAATCAGTAAATTGAACGGAG-3'. The fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and according to the manufacturer's instructions in the vector PCR script (Stratagene GmbH, Heidelberg) cloned. The correctness of the sequence was checked by sequencing (SEQ-ID No. 5). From this PCR script vector, it was transferred as a Hindlll fragment into the correspondingly cut vector pBinl9 (Bevan, 1984, Nucleic 5 Acids Res. 12, 8711-8721).
Aus dem Plasmid pBinAR-TP-DOXS wurde der 35S-Promotor, das Trans - ketolase-Transitpeptid, das DOXS-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . ,The plasmid pBinAR-TP-DOXS was used to convert the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
10 1984) zur Transkriptionstermination mittels PCR isoliert. Den10 1984) for transcription termination by means of PCR. The
Oligonukleotiden für den Promotor und die Terminatorsequenz wurde jeweils eine EcoRI-Schnittstelle angefügt. Die Sequenz des Oligonukleotids, welches sich an den Promotor (kursiv geschrieben) anlagert lautet 5 ' -ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3 ' , die desAn EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence. The sequence of the oligonucleotide that attaches to the promoter (italics) is 5 '-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3', that of the
15 Oligonukleotids, welches sich an die Terminatorsequenz (kursiv geschrieben) anlagert lautet 5 ' -ATGAATTCGGACAATCAGTAAATTGAA-CGGA- G-3'. Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR- Script (Stratagene GmbH, Heidelberg) kloniert. Die Richtigkeit15 oligonucleotide, which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAA-CGGA-G-3'. The fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The accuracy
20 der Sequenz wurde durch Sequenzierung überprüft (SEQ-ID No. 3) . Aus dem PCR-Script Vektor wurde es als EcoRI-Fragment in den entsprechend geschnittenen Vektor pBinl9 (Bevan, 1984) übertragen.20 of the sequence was checked by sequencing (SEQ-ID No. 3). From the PCR script vector, it was transferred as an EcoRI fragment into the correspondingly cut vector pBin19 (Bevan, 1984).
Aus dem PCR-Script Vektor wurde es als Xbal-Fragment in den 25 entsprechend geschnittenen Vektor übertragen, der wie oben beschrieben bereits die Sequenz der HPPD enthielt. Es entstand das Konstrukt pBinAR-HPPD-DOXS (Abbildung 13), dessen Fragmente folgende Bedeutung haben:From the PCR script vector, it was transferred as an Xbal fragment into the correspondingly cut vector, which, as described above, already contained the sequence of the HPPD. The construct pBinAR-HPPD-DOXS (Figure 13) was created, the fragments of which have the following meaning:
30 Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- Mosaik-Virus (Nukleotide 6909 bis 7437) . Fragment B enthält das Transitpeptid der plastidären Transketolase. Fragment C enthält das Gen der HPPD. Fragment D enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al.,Fragment A (529 bp) contains the 35S promoter of the Cauliflower mosaic virus (nucleotides 6909 to 7437). Fragment B contains the transit peptide of plastid transketolase. Fragment C contains the gene of the HPPD. Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
35 1984) zur Transkriptionstermination. Fragment E enthält das Gen der DOXS.35 1984) for transcription termination. Fragment E contains the gene of the DOXS.
Beispiel 12Example 12
40 Herstellung von transgenen Tabakpflanzen (Nicotiana tabacum L. cv. Samsun NN)40 Production of transgenic tobacco plants (Nicotiana tabacum L. cv. Samsun NN)
Für die Herstellung transgener Tabakpflanzen, die einen veränderten Prenyllipidgehalt aufweisen, wurden Tabakblattscheiben mit 45 Sequenzen der DOXS und der HPPD transformiert. Zur Transformation von Tabakpflanzen wurden 10 ml einer unter Selektion gewachsenen Übernachtkultur von Agrobacterium tumefaciens abzentrifugiert, der Überstand verworfen und die Bakterien in gleichem Volumen Antibiotika-freien Mediums resuspendiert. In einer sterilen Petrischale wurden Blattscheiben steriler Pflanzen (Durchmesser ca. 1 cm) in dieser Bakteriensuspension gebadet. Anschließend wurden die Blattscheiben in Petrischalen auf MS-Medium (Murashige und Skoog, Physiol. Plant (1962) 15, 473) mit 2% Saccharose und 0.8% Bacto-Agar ausgelegt. Nach 2-tägiger Inkubation im Dunkeln bei 25°C wurden sie auf MS-Medium mit 100mg/l Kanamycin, 500mg/l Claforan, lmg/l Benzylaminopurin (BAP) , 0.2mg/l Naphtylessigsäure (NAA) , 1.6% Glukose und 0.8% Bacto-Agar übertragen und die Kultivierung (16 Stunden Licht / 8 Stunden Dunkelheit) fortgesetzt. Wachsende Sprosse wurden auf hormonfreies MS-Medium mit 2% Saccharose, 250mg/l Claforan und 0.8% Bacto-Agar überführt.For the production of transgenic tobacco plants that have a modified prenyl lipid content, tobacco leaf disks were transformed with 45 sequences of the DOXS and the HPPD. To transform tobacco plants, 10 ml of an overnight culture of Agrobacterium tumefaciens grown under selection were centrifuged, the supernatant was discarded and the bacteria were resuspended in the same volume of antibiotic-free medium. Leaf disks of sterile plants (diameter approx. 1 cm) were bathed in this bacterial suspension in a sterile petri dish. The leaf disks were then placed in Petri dishes on MS medium (Murashige and Skoog, Physiol. Plant (1962) 15, 473) with 2% sucrose and 0.8% Bacto agar. After 2 days incubation in the dark at 25 ° C, they were on MS medium with 100mg / l kanamycin, 500mg / l claforan, 1mg / l benzylaminopurine (BAP), 0.2mg / l naphthylacetic acid (NAA), 1.6% glucose and 0.8 % Bacto agar transferred and cultivation continued (16 hours light / 8 hours dark). Growing shoots were transferred to hormone-free MS medium with 2% sucrose, 250 mg / l Claforan and 0.8% Bacto agar.
Beispiel 13Example 13
Herstellung von transgenen Rapspflanzen (Brassica napus)Production of transgenic oilseed rape plants (Brassica napus)
Die Herstellung der transgenen Rapspflanzen, die einen veränder- ten Prenyllipidgehalt aufweisen, orientierte sich an einem Protokoll von Bade, J.B. und Damm, B. (in Gene Transfer to Plants, Potrykus, I. und Spangenberg, G. , eds , Springer Lab Manual, Springer Verlag, 1995, 30-38), in welchem auch die Zusammensetzungen der verwendeten Medien und Puffer angegeben sind.The production of the transgenic rapeseed plants, which have a changed prenyl lipid content, was based on a protocol by Bade, J.B. and Damm, B. (in Gene Transfer to Plants, Potrykus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30-38), in which the compositions of the media and buffers used are also given .
Die Transformationen erfolgten mit dem Agrobacterium tumefaciens Stamm LBA4404 (Clontech GmbH, Heidelberg) . Als binäre Vektoren wurden die bereits oben beschriebenen binären Konstrukte mit den gesamten cDNAs der DOXS und der HPPD verwendet. In allen hier verwendeten binären Vektoren wurde die NOS-Terminatorsequenz durch das Polyadenylierungssignal des Gens 3 der T-DNA des Ti- Plasmids pTIACH5 (Gielen et al., 1984) zur Transkriptionstermination ersetzt. Brassica napus Samen wurden mit 70% (v/v) Ethanol oberflächensteril gemacht, 10 min bei 55°C in H0 gewaschen, in l%iger Hypochlorit-Lösung (25% v/v Teepol, 0,1% v/v Tween 20) für 20 min inkubiert und sechsmal mit sterilem H20 für jeweils 20 min gewaschen. Die Samen wurden drei Tage auf Filterpapier getrocknet und 10-15 Samen in einem Glasskolben mit 15 ml Keimungsmedium zur Keimung gebracht. Von mehreren Keimlingen (ca. 10 cm groß) wurden die Wurzeln und Apices entfernt und die verbleibenden Hypokotyle in ca. 6 mm lange Stücke geschnitten. Die so gewonnenen ca. 600 Explante werden 30 min mit 50 ml Basalmedium gewaschen und in einen 300 ml Kolben überführt. Nach Zugabe von 100 ml Kallus-In- duktionsmedium wurden die Kulturen für 24 h bei 100 U/min inkubiert. Vom Agrobacterium-Stamm wurde eine Übernachtkultur bei 29°C in Luria Broth-Medium mit Kanamycin (20 mg/1) angesetzt, davon 2 ml in 50 ml Luria Broth-Medium ohne Kanamycin für 4 h bei 29°C bis zu einer OD6oo on 0,4 - 0,5 inkubiert. Nach der Pelletierung der Kultur bei 2000 U/min für 25 min wurde das Zellpellet in 25 ml Basalmedium resuspendiert. Die Konzentration der Bakterien in der Lösung wurde durch Zugabe von weiterem Basalmedium auf eine ODgoo von 0.3 eingestellt.The transformations were carried out with the Agrobacterium tumefaciens strain LBA4404 (Clontech GmbH, Heidelberg). The binary constructs already described above with the entire cDNAs of the DOXS and the HPPD were used as binary vectors. In all binary vectors used here, the NOS terminator sequence was replaced by the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min at 55 ° C in H0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Tween 20 ) incubated for 20 min and washed six times with sterile H 2 0 for 20 min each. The seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium. The roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx. 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm. An overnight culture of the Agrobacterium strain was set up at 29 ° C. in Luria Broth medium with kanamycin (20 mg / 1), of which 2 ml in 50 ml Luria Broth medium without kanamycin for 4 h at 29 ° C. up to an OD 6 oo on 0.4 to 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an ODgoo of 0.3 by adding further basal medium.
Aus den Raps-Explanten wurde das Kallus-Induktionsmedium mit sterilen Pipetten entfernt, 50 ml Agrobacterium-Lösung hinzugefügt, vorsichtig gemischt und für 20 min inkubiert. Die Agrobacterien- Suspension wurde entfernt, die Raps-Explante für 1 min mit 50 ml Kallus-Induktionsmedium gewaschen und anschließend 100 ml Kallus- Induktionsmedium hinzugefügt. Die Co-Kultivierung wurde für 24 h auf einem Rotationsschüttler bei 100 U/min durchgeführt. Die Co- Kultivierung wurde durch Wegnahme des Kallus-Induktionsmediums gestoppt und die Explante zweimal für jeweils 1 min mit 25 ml und zweimal für 60 min mit jeweils 100 ml Waschmedium bei 100 U/min gewaschen. Das Waschmedium mit den Explanten wurde in 15 cmThe callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min. The Agrobacteria suspension was removed, the oilseed rape explant washed with 50 ml callus induction medium for 1 min and then 100 ml callus induction medium added. The co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h. The co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm. The washing medium with the explants was in 15 cm
Petrischalen überführt und das Medium mit sterilen Pipetten entfernt.Transfer petri dishes and remove the medium with sterile pipettes.
Zur Regeneration wurden jeweils 20-30 Explante in 90 mm Petri- schalen überführt, welche 25 ml Sproß-Induktionsmedium mit Kanamycin enthielten. Die Petrischalen wurden mit 2 Lagen Leukopor verschlossen und bei 25°C und 2000 lux bei Photoperioden von 16 Stunden Licht/8 Stunden Dunkelheit inkubiert. Alle 12 Tage wurden die sich entwickelnden Kalli auf frische Petrischalen mit Sproß- Induktionsmedium überführt. Alle weiteren Schritte zur Regeneration ganzer Pflanzen wurde wie von Bade, J.B. und Damm, B. (in Gene Transfer to Plants, Potrykus, I. und Spangenberg, G., eds , Springer Lab Manual, Springer Verlag, 1995, 30-38) beschrieben durchgeführt .For regeneration, 20-30 explants each were transferred to 90 mm petri dishes which contained 25 ml shoot induction medium with kanamycin. The petri dishes were closed with 2 layers of leucopor and incubated at 25 ° C. and 2000 lux with photoperiods of 16 hours light / 8 hours dark. Every 12 days, the developing calli were transferred to fresh petri dishes with shoot induction medium. All further steps for the regeneration of whole plants were carried out as described by Bade, J.B. and Damm, B. (described in Gene Transfer to Plants, Potrykus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30-38).
Beispiel 14Example 14
Steigerung der Tocopherolbiosynthese in RapsIncrease in tocopherol biosynthesis in oilseed rape
Die cDNA der DOXS (SEQ-ID No. 3) und der HPPD (SEQ-ID No. 5) wurde mit einem CaMV35S-Promotor versehen und in Raps unter Verwendung des 35S-Promotors überexprimiert . Parallel dazu wurde der samenspezifische Promotor des Phaseolingenes verwendet, um den Tocopherolgehalt spezifisch im Rapssamen zu erhöhen. Mit den entsprechenden Konstrukten transformierte Rapspflanzen wurden im Gewächshaus angezogen. Anschließend wurde der α-Tocopherolgehalt der Gesamtpflanze bzw. der Samen der Pflanze bestimmt. In allen Fällen war die α-Tocopherolkonzentration im Vergleich zur nicht transfomierten Pflanze erhöht.The cDNA of DOXS (SEQ-ID No. 3) and HPPD (SEQ-ID No. 5) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter. In parallel, the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed. Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The α-tocopherol content of the whole plant or the seeds of the plant was then determined. In all In some cases, the α-tocopherol concentration was increased compared to the non-transformed plant.
Beispiel 15Example 15
Klonierung des Gens einer GGPPOR aus Arabidopsis thalianaCloning of a GGPPOR gene from Arabidopsis thaliana
Isolierung von Gesamt-RNA aus voll entfalteten Blättern von Arabidopsis thaliana:Isolation of total RNA from fully unfolded Arabidopsis thaliana leaves:
Voll entfaltete Blätter von Arabidopsis thaliana wurden geerntet und in flüssigem Stickstoff eingefroren. Das Material wurde anschließend im Mörser pulverisiert und in Z6-Puffer (8 M Guani - dium-hydrochlorid, 20 mM MES, 20 mM EDTA pH 7,0) aufgenommen. Die Suspension wurde in Reaktionsgefäße überführt und mit einem Volumen Phenol/Chloroform/Isoamylalkohol 25:24:1 ausgeschüttelt. Nach 10 minütiger Zentrifugation bei 15000 U/min wurde der Überstand in ein neues Reaktionsgefäß überführt und mit 1/20 Volumen IN Essigsäure und 0,7 Volumen Ethanol (absolut) die RNA gefällt. Nach erneuter Zentrifugation wurde das Pellet zunächst mit 3M Natriumacetatlösung gewaschen und nach einer weiteren Zentrifugation in 70% Ethanol. Anschließend wurde das Pellet in DEPC- Wasser gelöst und die RNA-Konzentration photometrisch bestimmt.Fully unfolded Arabidopsis thaliana leaves were harvested and frozen in liquid nitrogen. The material was then pulverized in a mortar and taken up in Z6 buffer (8 M guanidium hydrochloride, 20 mM MES, 20 mM EDTA pH 7.0). The suspension was transferred to reaction vessels and shaken with a volume of phenol / chloroform / isoamyl alcohol 25: 24: 1. After centrifugation at 15,000 rpm for 10 minutes, the supernatant was transferred to a new reaction vessel and the RNA was precipitated with 1/20 volume IN acetic acid and 0.7 volume ethanol (absolute). After centrifugation again, the pellet was first washed with 3M sodium acetate solution and after a further centrifugation in 70% ethanol. The pellet was then dissolved in DEPC water and the RNA concentration was determined photometrically.
Herstellung von cDNA aus gesamt RNA voll entfalteter Blätter von A. thaliana:Production of cDNA from RNA of fully unfolded leaves of A. thaliana:
20 μg Gesamt-RNA wurden zunächst mit 3,3 μl 3M Natriumacetat-lö- sung und 2 μl IM Magnesiumsulfatlösung versetzt und auf 100 μl Endvolumen mit DEPC Wasser aufgefüllt. Dazu wurde 1 μl RNase freie DNase (Boehringer Mannheim) gegeben und 45 min bei 37°C inkubiert. Nach Entfernen des Enzyms durch Ausschütteln mit Phenol/Chloroform/Isoamylalkohol wurde die RNA mit Ethanol gefällt und das Pellet in 100 μl DEPC Wasser aufgenommen. 2,5 μg RNA aus dieser Lösung wurden mittels eines cDNA-Kits (Gibco, Life Technologies) in cDNA umgeschrieben.20 μg of total RNA were first mixed with 3.3 μl of 3M sodium acetate solution and 2 μl of IM magnesium sulfate solution and made up to 100 μl of final volume with DEPC water. 1 μl of RNase-free DNase (Boehringer Mannheim) was added and incubated at 37 ° C. for 45 min. After removing the enzyme by shaking with phenol / chloroform / isoamyl alcohol, the RNA was precipitated with ethanol and the pellet was taken up in 100 μl DEPC water. 2.5 μg RNA from this solution were transcribed into cDNA using a cDNA kit (Gibco, Life Technologies).
Von der DNA-Sequenz der Geranylgeranyl-Pyrophosphat Oxidoreduktase (Keller et al , Eur . J.Biochem. (1998) 251 (1-2) , 413-417) ; Acces- sion Number Y14044) wurden für eine PCR Oligonukleotide abgeleitet, denen am 5 ' -Ende eine BamHI und am 3 ' -Ende eine Sall Restriktionsschnittstelle angefügt worden war. Das Oligonukleotid am 5 '-Ende umfaßt die Sequenz 5 ' -ATGGATCCATGGCGACGACGGTTACAC C-3 ' beginnend mit dem ersten Kodon der cDNA (kursiv gedruckt) , das Oligonukleotid am 3 ' -Ende umfaßt die Sequenz 5 ' -ATGTCGACGTGATGA- TAGATTACTAACAGAC-3 ' beginnend mit dem Basenpaar 1494 der cDNA Sequenz (kursiv gedruckt) .From the DNA sequence of geranylgeranyl pyrophosphate oxidoreductase (Keller et al, Eur. J. Biochem. (1998) 251 (1-2), 413-417); Accession Number Y14044) were derived for a PCR oligonucleotides to which a BamHI had been added at the 5 'end and a Sall restriction site at the 3' end. The oligonucleotide at the 5 'end comprises the sequence 5' -ATGGATCCATGGCGACGACGGTTACAC C-3 'starting with the first codon of the cDNA (printed in italics), the oligonucleotide at the 3' end comprises the sequence 5 '-ATGTCGACGTGATGA- TAGATTACTAACAGAC-3 'starting with base pair 1494 of the cDNA sequence (printed in italics).
Die PCR-Reaktion wurde durchgeführt mit Pfu-Polymerase von Stra- tagene GmbH, Heidelberg nach Herstellerangaben. Als Template wurde 1/8 Volumen der cDNA eingesetzt (entspricht 0,3 μg RNA). Das PCR-Programm lautete:The PCR reaction was carried out using Pfu polymerase from Strategagene GmbH, Heidelberg, according to the manufacturer's instructions. 1/8 volume of the cDNA was used as template (corresponds to 0.3 μg RNA). The PCR program was:
5 Zyklen: 94°C für 4 sec, 48°C für 30 sec, 72°C für 2 min 5 Zyklen: 94°C für 4 sec, 46°C für 30 sec, 72°C für 2 min 25 Zyklen: 94°C für 4 sec, 44°C für 30 sec, 72°C für 2 min5 cycles: 94 ° C for 4 sec, 48 ° C for 30 sec, 72 ° C for 2 min 5 cycles: 94 ° C for 4 sec, 46 ° C for 30 sec, 72 ° C for 2 min 25 cycles: 94 ° C for 4 sec, 44 ° C for 30 sec, 72 ° C for 2 min
Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit des Fragments wurde durch Sequenzierung überprüft (SEQ ID No. 7) . Mittels der durch die Primer an die Sequenz angefügten Restriktions - schnittsteilen wurde das Gen als BamHl/Sall-Fragment in den entsprechend geschnittenen Vektor BinAR-Hyg kloniert. Dieser enthält den 35S-Promotor des Blumenkohlmosaikvirus und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al., EMBO J. 3 (1984) , 835-846) zur Transkriptionstermination. Das Plasmid vermittelt in Pflanzen Resistenz gegen das Antibiotikum Hygromycin und ist so geeignet, Pflanzen mit Kanamycinresi - stenz zu superinfizieren. Da das Plastidentransitpeptid derThe fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the fragment was checked by sequencing (SEQ ID No. 7). The gene was cloned as a BamHI / SalI fragment into the correspondingly cut vector BinAR-Hyg by means of the restriction cut sections added to the sequence by the primers. This contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., EMBO J. 3 (1984), 835-846) for transcription termination. The plasmid imparts resistance to the antibiotic hygromycin in plants and is thus suitable for superinfecting plants with kanamycin resistance. Since the plastid transit peptide is
GGPPOR mitkloniert wurde, sollte das Protein in transgenen Pflanzen in die Piastiden transportiert werden. Das Konstrukt ist in Abbildung 14 dargestellt. Die Fragmente haben die folgende Bedeutung :GGPPOR was also cloned, the protein should be transported to the plastids in transgenic plants. The construct is shown in Figure 14. The fragments have the following meaning:
Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- Mosaik-Virus (Nukleotide 6909 bis 7437 des Cauliflower-Mosaik-Vi - rus) . Fragment D enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination. Fragment F enthält das Gen der GGPPOR inklusive der intrinsischen Plastidentransitsequenz .Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus). Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
Beispiel 16Example 16
Herstellung von Konstrukten zur Pflanzentransformation mit DOXS und GGPPOR SequenzenProduction of constructs for plant transformation with DOXS and GGPPOR sequences
Zur Herstellung von Pflanzen, welche transgen für die DOXS und die GGPPOR sind wurde ein binärer Vektor angefertigt, der beide Gensequenzen enthält (Abbildung 15) . Das GGPPOR-Gen mit der intrinsischen Plastidenlokalisationssequenz wurde (wie in Beispiel 15 beschrieben) als BamHI/Sall-Fragment in den entsprechend geschnittenen Vektor pBinAR-Hyg kloniert. Das Gen der DOXS wurde als BamHI-Fragment wie in Beispiel 3 beschrieben kloniert. Der Vektor pBinAR-Hyg enthält den 35S-Promotor des Blumenkohlmosaik- virus und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination. Dieses Plasmid vermittelt in Pflanzen Resistenz gegen das Antibiotikum Hygromycin und ist so geeignet, Pflanzen mit Kanamycinresistenz zu superinfizieren.For the production of plants that are transgenic for the DOXS and the GGPPOR, a binary vector was prepared that contains both gene sequences (Figure 15). The GGPPOR gene with the intrinsic plastid localization sequence was (as described in Example 15) as a BamHI / Sall fragment in the corresponding cloned vector pBinAR-Hyg cloned. The gene of the DOXS was cloned as a BamHI fragment as described in Example 3. The vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. This plasmid mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
Aus dem Plasmid pBinAR-TP-DOXS wurde der 35S-Promotor, das Trans - ketolase-Transitpeptid, das DOXS-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und die Terminatorsequenz wurde jeweils eine EcoRI-Schnittstelle angefügt. Die Sequenz des Oligonukleotids, welches sich an den Promotor (kursiv geschrieben) anlagert lautet 5 ' -ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3 ' , die des Oligonukleotids, welches sich an die Terminatorsequenz (kursiv geschrieben) anlagert lautet 5' -ATGAATTCGGACAATCAGTAAATTGAACGGA- G-3'. Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR- Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus dem PCR- Script Vektor wurde es als EcoRI-Fragment in den entsprechend geschnittenen Vektor pBinl9 (Bevan, Nucleic Acids Res .12 (1984) , 8711-8721) übertragen.The plasmid pBinAR-TP-DOXS became the 35S promoter, the trans-ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR. An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence. The sequence of the oligonucleotide which is attached to the promoter (italics) is 5 '-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAACGGA-. The fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector pBin19 (Bevan, Nucleic Acids Res. 12 (1984), 8711-8721).
Aus dem Plasmid pBinARHyg-GGPPOR wurde der 35S-Promotor, das GGPPOR-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und den Terminator wurde jeweils eine Xbal-Schnittstelle angefügt. Die Sequenz des Oligonukleotids, welches sich an den Promotor (kursiv geschrieben) anlagert lautet 5 ' -ATTCTAGACÄTG- GAGTCAAA-GATTCAAATAGA-3 ' , die des Oligonukleotids, welches sich an die Terminatorsequenz (Kursiv geschrieben) anlagert lautet 5 ' -ATTCTAGAGGACAA-TCAGTAAATTGAACGGAG-3 ' . Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus dem PCR-Script Vektor wurde es als Xbal-Fragment in den entsprechend geschnittenen Vektor übertragen, welcher bereits wie oben beschrieben die Sequenz der DOXS enthielt. Es entstand das Konstrukt pBinAR-DOXS-GGPPOR (Abbildung 15) , dessen Fragmente folgende Bedeutung haben: Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- Mosaik-Virus (Nukleotide 6909 bis 7437 des Cauliflower-Mosaik-Vi - rus) . Fragment B enthält das Transitpeptid der plastidären Trans - ketolase . Fragment E enthält das Gen der DOXS. Fragment D 5 enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti- Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination. Fragment F enthält das Gen der GGPPOR inklusive der intrin- sischen Plastidentransitsequenz .The 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) were isolated from the plasmid pBinARHyg-GGPPOR for PCR transcription termination. An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator. The sequence of the oligonucleotide which is attached to the promoter (italics) is 5 '-ATTCTAGACÄTG- GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATTCTAGAGGACAA-TCAGGAGAATT 3 '. The fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an Xbal fragment into the correspondingly cut vector, which already contained the sequence of the DOXS as described above. The construct pBinAR-DOXS-GGPPOR (Figure 15) was created, the fragments of which have the following meaning: Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus). Fragment B contains the transit peptide of the plastid transketolase. Fragment E contains the gene of the DOXS. Fragment D 5 contains the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
10 Beispiel 1710 Example 17
Herstellung von Konstrukten zur Pflanzentransformation mit DOXS-, GGPPOR- und HPPD-DNA-SequenzenProduction of constructs for plant transformation with DOXS, GGPPOR and HPPD DNA sequences
15 Zur Herstellung von Pflanzen, welche transgen für die DOXS, die GGPPOR und die HPPD sind, wurde ein binärer Vektor angefertigt, der alle drei Gensequenzen enthält (Abbildung 16) . Das GGPPOR-Gen war mit der intrinsischen Plastidenlokalisationssequenz versehen (wie in Beispiel 15 beschrieben) . Der verwendete pBinAR-Hyg Vek-15 For the production of plants that are transgenic for the DOXS, the GGPPOR and the HPPD, a binary vector was prepared that contains all three gene sequences (Figure 16). The GGPPOR gene was tagged with the intrinsic plastid localization sequence (as described in Example 15). The pBinAR-Hyg Vek-
20 tor vermittelt in Pflanzen Resistenz gegen das Antibiotikum Hy- gromycin und ist so geeignet, Pflanzen mit Kanamycinresistenz zu superinfizieren.20 tor mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
Zur Klonierung der HPPD in Vektoren, welche zusätzlich noch eine 25 andere cDNA enthalten, wurden für eine PCR Oligonukleotide abgeleitet, denen am 5 '-Ende und am 3 ' -Ende eine BamHI Restriktions - Schnittstelle angefügt worden war. Das Oligonukleotid am 5 '-Ende umfaßt die Sequenz 5 ' -GGATCCTCCAGCGGACAAGCCAAC-3 ' (Nukleotide 37 bis 55 vom ATG in 5' -Richtung entfernt; Kursiv geschrieben), das 30 Oligonukleotid am 3 ' -Ende umfaßt die Sequenz 5'-ATGGATC-To clone the HPPD into vectors which additionally contain another 25 cDNA, oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end. The oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; written in italics), the 30 oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC -
CCGCGCCGCCTACAGGTTG-3 ' (endend mit Basenpaar 1140 der kodierenden Sequenz, beginnend 8 Basenpaare 3' des TAG Stopp-Codons; Kursiv geschrieben) . Die PCR-Reaktion wurde durchgeführt mit Tli- Polymerase von Promega GmbH, Mannheim nach Herstellerangaben. Als 35 Template wurden 10 ng des Plasmids pBinAR-HPPD eingesetzt. Das PCR-Programm lautete:CCGCGCCGCCTACAGGTTG-3 '(ending with base pair 1140 of the coding sequence, starting 8 base pairs 3' of the TAG stop codon; written in italics). The PCR reaction was carried out using Tli polymerase from Promega GmbH, Mannheim, according to the manufacturer's instructions. 10 ng of the plasmid pBinAR-HPPD were used as the 35 template. The PCR program was:
5 Zyklen: 94°C 4 sec, 68°C 30 sec, 72°C 2 min5 cycles: 94 ° C 4 sec, 68 ° C 30 sec, 72 ° C 2 min
5 Zyklen: 94°C 4 sec, 64°C 30 sec, 72°C 2 min5 cycles: 94 ° C 4 sec, 64 ° C 30 sec, 72 ° C 2 min
40 25 Zyklen: 94°C 4 sec, 60°C 30 sec, 72°C 2 min40 25 cycles: 94 ° C 4 sec, 60 ° C 30 sec, 72 ° C 2 min
Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz 45 wurde durch Sequenzierung überprüft. Aus dem Vektor PCR-Script wurde es als BamHI-Fragment ausgeschnitten und in einen entsprechend geschnittenen pBinAR-Vektor ligiert, der zusätzlich das Transitpeptid der Transketolase enthält, zur Einführung des Gen- produkts in den Piastiden. Es entstand das Plasmid pBinAR-TP- p-HPPD.The fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of sequence 45 was checked by sequencing. It was cut out as a BamHI fragment from the vector PCR script and ligated into a correspondingly cut pBinAR vector which additionally contains the Transketolase transit peptide contains, for the introduction of the gene product in the plastids. The plasmid pBinAR-TP-p-HPPD was formed.
Zur Klonierung wurde aus dem Plasmid pBinAR-TP-HPPD der 35S-Pro- motor, das Transketolase-Transitpeptid, das p-HPPD-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids PTIACH5 (Gielen et al . 1984) zur Transkriptionstermination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und den Terminator wurde jeweils eine Hindlll-Schnittstelle angefügt. Die Sequenz des Oligonukleotids, welches sich an den 5 '-Bereich des Promotors anlagert (kursiv geschrieben) lautet 5'-ATAAGCTT- CATGGAGTCAAA-GATTCAAATAGA-3 ' , die des Oligonukleotids, welches sich an die Terminationssequenz (kursiv geschrieben) anlagert lautet 5' -ATAAGCTTGGAC-AATCAGTAAATTGAACGGAG-3 ' . Das erhaltene Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus diesem PCR-Script-Vektor wurde es als Hindlll-Fragment in den entsprechend geschnittenen Vektor pBinl9 (Bevan, 1984, Nucleic Acids Res. 12, 8711-8721) übertragen.For cloning, the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the p-HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid PTIACH5 (Gielen et al. 1984 ) for transcription termination by means of PCR. A HindIII interface was added to each of the oligonucleotides for the promoter and the terminator. The sequence of the oligonucleotide which is attached to the 5 'region of the promoter (italics) is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 ' -ATAAGCTTGGAC-AATCAGTAAATTGAACGGAG-3 '. The fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. From this PCR script vector it was transferred as a HindIII fragment into the correspondingly cut vector pBin19 (Bevan, 1984, Nucleic Acids Res. 12, 8711-8721).
Aus dem Plasmid pBinAR-TP-DOXS wurde der 35S-Promotor, das Trans - ketolase-Transitpeptid, das DOXS-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al., 1984) zur Transkriptionstermination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und die Terminatorsequenz wurde jeweils eine EcoRI-Schnittstelle angefügt. Die Sequenz des Oligo- nukleotids, welches sich an den Promotor (kursiv geschrieben) anlagert lautet 5'-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3' , die des Oligonukleotids, welches sich an die Terminatorsequenz (kursiv geschrieben) anlagert lautet 5' -ATGAATTCGGACAATCÄGTAAATTGAACGGA- G-3'. Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR- Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus dem PCR- Script Vektor wurde es als EcoRI-Fragment in den entsprechend geschnittenen Vektor übertragen, welcher bereits wie oben beschrie- ben die Sequenz der HPPD enthielt.The plasmid pBinAR-TP-DOXS became the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR. An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence. The sequence of the oligonucleotide, which is attached to the promoter (italics) is 5'-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3 ', that of the oligonucleotide, which is attached to the terminator sequence (italics) is 5' -ATGAATTCGGACAATCÄGA- GTAAATTGAAC . The fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector, which already contained the sequence of the HPPD as described above.
Aus dem Plasmid pBinARHyg-GGPPOR wurde der 35S-Promotor, das GGPPOR-Gen und das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptions - termination mittels PCR isoliert. Den Oligonukleotiden für den Promotor und den Terminator wurde jeweils eine Xbal-Schnittstelle angefügt. Die Sequenz des Oligonukleotids, welches sich an den Promotor (kursiv geschrieben) anlagert lautet 5 ' -ATTCTAGACATG- GAGTCAAA-GATTCAAATAGA-3 ' , die des Oligonukleotids, welches sich an die Terminatorsequenz (kursiv geschrieben) anlagert lautet 5'-ATTCTAGAGGACAA-TCAGTAAATTGAACGGAG-3' . Das Fragment wurde mittels Gene-Clean-Kit (Dianova GmbH, Hilden) gereinigt und nach Herstellerangaben in den Vektor PCR-Script von Stratagene GmbH, Heidelberg kloniert. Die Richtigkeit der Sequenz wurde durch Sequenzierung überprüft. Aus dem PCR-Script Vektor wurde es als Xbal-Fragment in den entsprechend geschnittenen Vektor übertra- gen, welcher bereits wie oben beschrieben die Sequenzen der HPPD und der DOXS enthielt. Es entstand das Konstrukt pBinAR-DOXS- GGPPOR-HPPD (Abbildung 16) , dessen Fragmente folgende Bedeutung haben:The 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) were isolated from the plasmid pBinARHyg-GGPPOR for transcription termination by means of PCR. An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator. The sequence of the oligonucleotide, which is located at the The promoter (written in italics) is 5 '-ATTCTAGACATG-GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5'-ATTCTAGAGGACAA-TCAGTAAATTGAACGGAG-3 '. The fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an Xbal fragment into the correspondingly cut vector which already contained the sequences of the HPPD and the DOXS as described above. The construct pBinAR-DOXS-GGPPOR-HPPD (Figure 16) was created, the fragments of which have the following meaning:
Fragment A (529 bp) beinhaltet den 35S-Promotor des Cauliflower- Mosaik-Virus (Nukleotide 6909 bis 7437 des Cauliflower-Mosaik-Vi - rus) . Fragment B enthält das Transitpeptid der plastidären Trans - ketolase. Fragment C enthält das Gen der HPPD. Fragment D enthält das Polyadenylierungssignal des Gens 3 der T-DNA des Ti-Plasmids pTIACH5 (Gielen et al . , 1984) zur Transkriptionstermination.Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus). Fragment B contains the transit peptide of the plastid transketolase. Fragment C contains the gene of the HPPD. Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
Fragment E enthält das Gen der DOXS. Fragment F enthält das Gen der GGPPOR inklusive der intrinsischen Plastidentransitsequenz .Fragment E contains the gene of the DOXS. Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
Beispiel 18Example 18
Steigerung der Tocopherolbiosynthese in RapsIncrease in tocopherol biosynthesis in oilseed rape
Die cDNA der DOXS (SEQ-ID No. 3) und der GGPPOR (SEQ-ID No. 7) wurde mit einem CaMV35S-Promotor versehen und in Raps unter Verwendung des 35S-Promotors überexprimiert. Parallel dazu wurde der samenspezifische Promotor des Phaseolingenes verwendet, um den Tocopherolgehalt spezifisch im Rapssamen zu erhöhen. Mit den entsprechenden Konstrukten transformierte Rapspflanzen wurden im Gewächshaus angezogen. Anschließend wurde der α-Tocopherolgehalt der Gesamtpflanze bzw. der Samen der Pflanze bestimmt. In allen Fällen war die α-Tocopherolkonzentration im Vergleich zur nicht transfomierten Pflanze erhöht.The cDNA of DOXS (SEQ-ID No. 3) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter. In parallel, the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed. Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The α-tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the α-tocopherol concentration was increased compared to the non-transformed plant.
Beispiel 19Example 19
Steigerung der Tocopherolbiosynthese in RapsIncrease in tocopherol biosynthesis in oilseed rape
Die cDNA der DOXS (SEQ-ID No. 3), der HPPD (SEQ-ID No. 5) und der GGPPOR (SEQ-ID No . 7) wurde mit einem CaMV35S-Promotor versehen und in Raps unter Verwendung des 35S-Promotors überexprimiert. Parallel dazu wurde der samenspezifische Promotor des Phaseolingenes verwendet, um den Tocopherolgehalt spezifisch im Rapssamen zu erhöhen. Mit den entsprechenden Konstrukten transformierte Rapspflanzen wurden im Gewächshaus angezogen. Anschließend wurde der α-Tocopherolgehalt der Gesamtpflanze bzw. der Samen der Pflanze bestimmt. In allen Fällen war die α-Tocopherolkonzentra- tion im Vergleich zur nicht transfomierten Pflanze erhöht. The cDNA of DOXS (SEQ-ID No. 3), HPPD (SEQ-ID No. 5) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and in rapeseed using the 35S promoter overexpressed. In parallel, the seed-specific promoter of the phaseolin gene was used to specifically determine the tocopherol content in the rapeseed to increase. Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The α-tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the α-tocopherol concentration was increased compared to the non-transformed plant.

Claims

Patentansprüche claims
1. Verwendung von DNA-Sequenzen codierend für eine 1-Deoxy-D-Xy- lulose- 5 -Phosphat Synthase (DOXS) zur Herstellung von1. Use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) for the production of
Pflanzen mit erhöhtem Tocopherol-, Vitamin K- , Chlorophyll- und/oder Carotinoid-Gehalt.Plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
2. Verwendung einer DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 oder einer mit dieser hybridisierenden DNA- Sequenz kodierend für eine 1-Deoxy-D-Xylulose- 5-Phosphat Synthase (DOXS) zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden.2. Use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a hybridizing with this DNA sequence coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) for the production of plants with an increased content of tocopherols, vitamin K, chlorophylls and / or carotenoids.
3. Verwendung von DNA-Sequenzen codierend für eine 1-Deoxy-D-Xy- lulose-5-Phosphat Synthase (DOXS) und codierend für eine p-Hydroxyphenylpyruvat Dioxygenase (HPPD) zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt.3. Use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) and coding for a p-hydroxyphenylpyruvate dioxygenase (HPPD) for the production of plants with increased tocopherol, vitamin K , Chlorophyll and / or carotenoid content.
4. Verwendung einer DNA-Sequenz SEQ ID No. 1 oder SEQ-ID No. 3 und einer DNA-Sequenz SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequenzen kodierend für eine 1-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) und eine p-Hydroxyphenylpyru- vat Dioxygenase zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden.4. Use of a DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No. 5 or hybridizing with these DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) and a p-hydroxyphenylpyruvate dioxygenase for the production of plants with an increased content of tocopherols, vitamin K, chlorophylls and / or carotenoids.
5. Verwendung von DNA-Sequenzen codierend für eine 1-Deoxy-D-Xy- lulose-5-Phosphat Synthase (DOXS) und codierend für eine Geranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt.5. Use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) and coding for a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for the production of plants with increased tocopherol, vitamin K , Chlorophyll and / or carotenoid content.
6. Verwendung einer DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und einer DNA-Sequenz SEQ ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen kodierend für eine 1-Deoxy-D-Xylu- lose-5-Phosphat Synthase (DOXS) und eine Geranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) zur Herstellung von Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden.6. Use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ ID No. 7 or with these hybridizing DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) and a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for the production of plants with an increased tocopherol content, vitamin K, Chlorophylls and / or carotenoids.
7. Verwendung von DNA-Sequenzen codierend für eine 1-Deoxy-D-Xy- lulose-5-Phosphat Synthase (DOXS), codierend für eine Hydro- xyphenylpyruvat Dioxygenase (HPPD) und codierend für eine Geranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) zur Her- Stellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-,7. Use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS), coding for a hydroxyphenylpyruvate dioxygenase (HPPD) and coding for a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for Her- Position of plants with increased tocopherol, vitamin K,
Chlorophyll- und/oder Carotinoid-Gehalt.Chlorophyll and / or carotenoid content.
8. Verwendung einer DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3, 5 einer DNA-Sequenz SEQ-ID No. 5 und einer DNA-Sequenz SEQ-ID8. Use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3, 5 of a DNA sequence SEQ-ID No. 5 and a DNA sequence SEQ-ID
No. 7 oder mit diesen hybridisierende DNA-Sequenzen kodierend für eine l-Deoxy-D-Xylulose-5-Phosphat Synthase (DOXS) , eine Hydroxyphenylpyruvat Dioxygenase (HPPD) und eine Geranylgeranyl-Pyrophosphat Oxidoreduktase (GGPPOR) zur Herstellung von 10 Pflanzen mit erhöhtem Gehalt an Tocopherolen, Vitamin K, Chlorophyllen und/oder Carotinoiden.No. 7 or with these hybridizing DNA sequences coding for an l-deoxy-D-xylulose-5-phosphate synthase (DOXS), a hydroxyphenylpyruvate dioxygenase (HPPD) and a geranylgeranyl pyrophosphate oxidoreductase (GGPPOR) for the production of 10 plants with increased content on tocopherols, vitamin K, chlorophylls and / or carotenoids.
9. Verfahren zur Herstellung von Pflanzen mit erhöhte Tocopherol-, Vitamin K- , Chlorophyll- und/oder Carotinoid-Gehalt,9. Process for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content,
15 dadurch gekennzeichnet, daß eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3 oder eine mit dieser hybridisierende DNA- Sequenz in Pflanzen exprimiert wird.15 characterized in that a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this is expressed in plants.
10. Verfahren zur Herstellung von Pflanzen mit erhöhtem Toco-10. Process for the production of plants with increased toco
20 pherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt, dadurch gekennzeichnet, daß eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 und eine DNA-Sequenz SEQ-ID No. 5 oder mit diesen hybridisierende DNA-Sequenzen in Pflanzen exprimiert werden.20 pherol, vitamin K, chlorophyll and / or carotenoid content, characterized in that a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No. 5 or with these hybridizing DNA sequences are expressed in plants.
2525
11. Verfahren zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt, dadurch gekennzeichnet, daß eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3 und eine DNA-Sequenz SEQ-ID No. 7 oder mit11. A process for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content, characterized in that a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No. 7 or with
30 diesen hybridisierende DNA-Sequenzen in Pflanzen exprimiert werden.30 these hybridizing DNA sequences are expressed in plants.
12. Verfahren zur Herstellung von Pflanzen mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll- und/oder Carotinoid-Gehalt,12. Process for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content,
35 dadurch gekennzeichnet, daß DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3, SEQ-ID No. 5 und SEQ-ID No. 7 oder mit diesen hybridisierende DNA-Sequenzen in Pflanzen exprimiert werden.35 characterized in that DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or with these hybridizing DNA sequences are expressed in plants.
13. Verfahren zur Transformation einer Pflanze dadurch geken - 40 zeichnet, daß man eine Expressionskassette enthaltend einen13. A process for transforming a plant is characterized by drawing an expression cassette containing one
Promotor und eine DNA-Sequenz SEQ-ID No. 1 oder SEQ-ID No. 3 in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzenzellen einbringt.Promoter and a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 in a plant cell, in callus tissue, an entire plant or protoplasts of plant cells.
45 14. Verfahren zur Transformation einer Pflanze dadurch gekennzeichnet, daß man eine Expressionskassette enthaltend einen Promotor und DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 5 in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzenzellen einbringt.45 14. A method for transforming a plant, characterized in that an expression cassette containing a promoter and DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ ID No. 5 in a plant cell, in callus tissue, an entire plant or protoplasts of plant cells.
15. Verfahren zur Transformation einer Pflanze dadurch gekenn- 5 zeichnet, daß man eine Expressionskassette enthaltend einen15. A method for transforming a plant is characterized in that one contains an expression cassette
Promotor und DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3 und SEQ-ID No. 7- in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzenzellen einbringt.Promoter and DNA Sequences SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7- in a plant cell, in callus tissue, an entire plant or protoplasts of plant cells.
10 16. Verfahren zur Transformation einer Pflanze dadurch gekennzeichnet, daß man eine Expressionskassette enthaltend einen Promotor und DNA-Sequenzen SEQ-ID No. 1 oder SEQ-ID No. 3, SEQ-ID No. 5 und SEQ-ID No. 7 in eine Pflanzenzelle, in Kallusgewebe, eine ganze Pflanze oder Protoplasten von Pflanzen-16. A method for transforming a plant, characterized in that an expression cassette containing a promoter and DNA sequences SEQ ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 in a plant cell, in callus tissue, an entire plant or protoplasts of plant
15 zellen einbringt.15 cells.
17. Verfahren zur Transformation von Pflanzen gemäß Anspruch 13-16, dadurch gekennzeichnet, daß die Transformation mit Hilfe des Stammes Agrobacterium tumefaciens, der Elektro-17. A method for transforming plants according to claim 13-16, characterized in that the transformation with the help of the strain Agrobacterium tumefaciens, the electro
20 poration oder der particle bombardment Methode erfolgt.20 poration or the particle bombardment method.
18. Pflanze mit erhöhtem Tocopherol-, Vitamin K-, Chlorophyll und/oder Carotinoid-Gehalt enthaltend eine Expressionskassette gemäß Anspruch 13-16.18. Plant with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content containing an expression cassette according to claim 13-16.
2525
19. Pflanze nach Anspruch, ausgewählt aus der Gruppe Soja, Canola, Gerste, Hafer, Weizen, Raps, Mais oder Sonnenblume.19. Plant according to claim, selected from the group of soybeans, canola, barley, oats, wheat, rapeseed, maize or sunflower.
20. Verwendung der SEQ-ID No. 1 oder SEQ-ID No. 3 zur Herstellung 30 eines Testsystems zur Identifizierung von Inhibitoren der20. Use of SEQ-ID No. 1 or SEQ-ID No. 3 for the production 30 of a test system for the identification of inhibitors of the
DOXS.DOXS.
21. Testsystem basierend auf der Expression einer Expressionskassette gemäß Anspruch 13 zur Identi izierung von21. Test system based on the expression of an expression cassette according to claim 13 for the identification of
35 Inhibitoren der DOXS.35 DOXS inhibitors.
22. Verwendung einer Pflanze enthaltend eine DNA- Sequenz SEQ-ID No. 1 oder SEQ-ID No . 3 oder eine mit dieser hybridisierende DNA- Sequenz zur Herstellung pflanzlicher und bakterieller22. Use of a plant containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a hybridizing with this DNA sequence for the production of plant and bacterial
40 DOXS .40 DOXS.
45 45
PCT/EP1999/005467 1998-08-05 1999-07-30 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants WO2000008169A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU54157/99A AU757440B2 (en) 1998-08-05 1999-07-30 DNA sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants
JP2000563793A JP2002525034A (en) 1998-08-05 1999-07-30 DNA sequence encoding 1-deoxy-D-xylulose-5-phosphate synthase and its overproduction in plants
CA002339519A CA2339519A1 (en) 1998-08-05 1999-07-30 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants
EP99940083A EP1102852A1 (en) 1998-08-05 1999-07-30 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE1998135219 DE19835219A1 (en) 1998-08-05 1998-08-05 Use of 1-deoxy-D-xylulose-5-phosphate synthase DNA to produce plants with increased tocopherol, vitamin K, chlorophyll and/or carotenoid content
DE1998145224 DE19845224A1 (en) 1998-10-01 1998-10-01 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
DE1998145216 DE19845216A1 (en) 1998-10-01 1998-10-01 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
DE19845224.1 1998-10-01
DE1998145231 DE19845231A1 (en) 1998-10-01 1998-10-01 Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
DE19845231.4 1998-10-01
DE19835219.0 1998-10-01
DE19845216.0 1998-10-01

Publications (2)

Publication Number Publication Date
WO2000008169A1 true WO2000008169A1 (en) 2000-02-17
WO2000008169A8 WO2000008169A8 (en) 2000-05-04

Family

ID=27438844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/005467 WO2000008169A1 (en) 1998-08-05 1999-07-30 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants

Country Status (5)

Country Link
EP (1) EP1102852A1 (en)
JP (1) JP2002525034A (en)
AU (1) AU757440B2 (en)
CA (1) CA2339519A1 (en)
WO (1) WO2000008169A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044912A1 (en) * 1999-01-28 2000-08-03 Royal Holloway And Bedford New College Manipulating isoprenoid expression
WO2000044911A1 (en) * 1999-01-29 2000-08-03 Basf Aktiengesellschaft Overexpression of a dna sequence coding for a transketolase in plants
WO2001012827A2 (en) * 1999-08-11 2001-02-22 Sungene Gmbh & Co. Kgaa Method for production of transgenic plants with increased tocopherol content
WO2001073031A2 (en) * 2000-03-28 2001-10-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6326164B1 (en) * 2000-07-27 2001-12-04 Paradigm Genetics, Inc. Methods for determining deoxyxylulose 5-phosphate synthase activity
WO2002000901A1 (en) * 2000-06-29 2002-01-03 Sungene Gmbh & Co. Kgaa Changing the fine chemical content in organisms by genetically modifying the shikimate pathway
WO2002012478A2 (en) * 2000-08-07 2002-02-14 Monsanto Technology, Llc Methyl-d-erythritol phosphate pathway genes
WO2002072848A2 (en) * 2001-03-09 2002-09-19 Sungene Gmbh & Co. Kgaa Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
FR2844142A1 (en) * 2002-09-11 2004-03-12 Bayer Cropscience Sa Transformed plants or cells, useful for prenylquinone production and resistant to specific herbicides, overexpress prephenate dehydrogenase and p-hydroxyphenyl- pyruvate dioxygenase
WO2004058934A2 (en) * 2002-12-23 2004-07-15 Sungene Gmbh & Co. Kgaa Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content
EP1072683A4 (en) * 1998-04-14 2004-10-06 Kyowa Hakko Kogyo Kk Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity
US6872815B1 (en) 2000-10-14 2005-03-29 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
US7067647B2 (en) 1999-04-15 2006-06-27 Calgene Llc Nucleic acid sequences to proteins involved in isoprenoid synthesis
US7112717B2 (en) 2002-03-19 2006-09-26 Monsanto Technology Llc Homogentisate prenyl transferase gene (HPT2) from arabidopsis and uses thereof
US7161061B2 (en) 2001-05-09 2007-01-09 Monsanto Technology Llc Metabolite transporters
US7230165B2 (en) 2002-08-05 2007-06-12 Monsanto Technology Llc Tocopherol biosynthesis related genes and uses thereof
US7238855B2 (en) 2001-05-09 2007-07-03 Monsanto Technology Llc TyrA genes and uses thereof
US7244877B2 (en) 2001-08-17 2007-07-17 Monsanto Technology Llc Methyltransferase from cotton and uses thereof
US7262339B2 (en) 2001-10-25 2007-08-28 Monsanto Technology Llc Tocopherol methyltransferase tMT2 and uses thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007244240A (en) * 2006-03-14 2007-09-27 Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai Method for producing green callus cell

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0723017A2 (en) * 1995-01-23 1996-07-24 Basf Aktiengesellschaft Transketolase
WO1997027285A1 (en) * 1996-01-29 1997-07-31 Arizona Board Of Regents, On Behalf Of University Of Arizona Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase
WO1998006862A1 (en) * 1996-08-09 1998-02-19 Calgene Llc Methods for producing carotenoid compounds and speciality oils in plant seeds
WO1999011757A1 (en) * 1997-09-02 1999-03-11 Washington State University Research Foundation NUCLEIC AND AMINO ACID SEQUENCES FOR A NOVEL TRANSKETOLASE FROM $i (MENTHA PIPERITA)
DE19752700A1 (en) * 1997-11-28 1999-06-02 Hoechst Schering Agrevo Gmbh 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators
WO1999052938A2 (en) * 1998-04-14 1999-10-21 Jomaa Hassan Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0723017A2 (en) * 1995-01-23 1996-07-24 Basf Aktiengesellschaft Transketolase
WO1997027285A1 (en) * 1996-01-29 1997-07-31 Arizona Board Of Regents, On Behalf Of University Of Arizona Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase
WO1998006862A1 (en) * 1996-08-09 1998-02-19 Calgene Llc Methods for producing carotenoid compounds and speciality oils in plant seeds
WO1999011757A1 (en) * 1997-09-02 1999-03-11 Washington State University Research Foundation NUCLEIC AND AMINO ACID SEQUENCES FOR A NOVEL TRANSKETOLASE FROM $i (MENTHA PIPERITA)
DE19752700A1 (en) * 1997-11-28 1999-06-02 Hoechst Schering Agrevo Gmbh 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators
WO1999052938A2 (en) * 1998-04-14 1999-10-21 Jomaa Hassan Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KELLER ET AL: "metabolic compartmentation of plastid prenyllipid biosynthesis - evidence for the involvement of a multifunctional geranylgeranyl reductase", EUROPEAN JOURNAL OF BIOCHEMISTRY,DE,BERLIN, vol. 251, no. 1/02, pages 413-417-417, XP002100518, ISSN: 0014-2956 *
LANGE B M ET AL: "A family of transketolases that directs isoprenoid biosynthesis via a mevalonate-independent pathway.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1998 MAR 3) 95 (5) 2100-4., XP002116672 *
LOIS L M ET AL: "Cloning and characterization of a gene from Escherichia coli encoding a transketolase-like enzyme that catalyzes the synthesis of D-1-deoxyxylulose 5-phosphate, a common precursor for isoprenoid, thiamin and pyridoxol biosynthesis.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1998 MAR 3) 95 (5) 2105-10., XP002116673 *
MANDEL A. ET AL.: "CLA1, a novel gene required for chloroplast development, is highly conserved in evolution", PLANT JOURNAL, vol. 9, no. 5, 1996, pages 649 - 658, XP002122907 *
SPRENGER G A ET AL: "Identification of a thiamin-dependent synthase in Escherichia coli required for the formation of the 1-deoxy-D- xylulose 5-phosphate precursor to isoprenoids, thiamin, and pyridoxol.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (1997 NOV 25) 94 (24) 12857-62., XP002116674 *

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1072683A4 (en) * 1998-04-14 2004-10-06 Kyowa Hakko Kogyo Kk Process for producing isoprenoid compounds by using microorganisms and method for detecting compounds having antibacterial or herbicidal activity
US7132268B2 (en) 1998-04-14 2006-11-07 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7531333B2 (en) 1998-04-14 2009-05-12 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7364885B2 (en) 1998-04-14 2008-04-29 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
US7208298B2 (en) 1998-04-14 2007-04-24 Kyowa Hakko Kogyo Co., Ltd. Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity
WO2000044912A1 (en) * 1999-01-28 2000-08-03 Royal Holloway And Bedford New College Manipulating isoprenoid expression
WO2000044911A1 (en) * 1999-01-29 2000-08-03 Basf Aktiengesellschaft Overexpression of a dna sequence coding for a transketolase in plants
US7067647B2 (en) 1999-04-15 2006-06-27 Calgene Llc Nucleic acid sequences to proteins involved in isoprenoid synthesis
US7335815B2 (en) 1999-04-15 2008-02-26 Calgene Llc Nucleic acid sequences to proteins involved in isoprenoid synthesis
US7265207B2 (en) 1999-04-15 2007-09-04 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
US7141718B2 (en) 1999-04-15 2006-11-28 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
WO2001012827A3 (en) * 1999-08-11 2001-08-23 Sungene Gmbh & Co Kgaa Method for production of transgenic plants with increased tocopherol content
WO2001012827A2 (en) * 1999-08-11 2001-02-22 Sungene Gmbh & Co. Kgaa Method for production of transgenic plants with increased tocopherol content
WO2001073031A3 (en) * 2000-03-28 2003-01-23 Corixa Corp Compositions and methods for the therapy and diagnosis of ovarian cancer
WO2001073031A2 (en) * 2000-03-28 2001-10-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
US7332649B2 (en) 2000-06-29 2008-02-19 Sungene Gmbh & Co. Kgaa Changing the fine chemical content in organisms by genetically modifying the shikimate pathway
WO2002000901A1 (en) * 2000-06-29 2002-01-03 Sungene Gmbh & Co. Kgaa Changing the fine chemical content in organisms by genetically modifying the shikimate pathway
US6326164B1 (en) * 2000-07-27 2001-12-04 Paradigm Genetics, Inc. Methods for determining deoxyxylulose 5-phosphate synthase activity
WO2002012478A3 (en) * 2000-08-07 2003-07-03 Monsanto Technology Llc Methyl-d-erythritol phosphate pathway genes
WO2002012478A2 (en) * 2000-08-07 2002-02-14 Monsanto Technology, Llc Methyl-d-erythritol phosphate pathway genes
US6841717B2 (en) 2000-08-07 2005-01-11 Monsanto Technology, L.L.C. Methyl-D-erythritol phosphate pathway genes
US7405343B2 (en) 2000-08-07 2008-07-29 Monsanto Technology Llc Methyl-D-erythritol phosphate pathway genes
US8362324B2 (en) 2000-10-14 2013-01-29 Monsanto Technology Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
US6872815B1 (en) 2000-10-14 2005-03-29 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
US7420101B2 (en) 2000-10-14 2008-09-02 Calgene Llc Nucleic acid sequences to proteins involved in tocopherol synthesis
WO2002072848A3 (en) * 2001-03-09 2003-10-30 Sungene Gmbh & Co Kgaa Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
WO2002072848A2 (en) * 2001-03-09 2002-09-19 Sungene Gmbh & Co. Kgaa Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
US7348167B2 (en) 2001-03-09 2008-03-25 Sungene Gmbh & Co. Kgaa Increase in the vitamin E content in organisms due to an increase in the tyrosine aminotransferase activity
US7161061B2 (en) 2001-05-09 2007-01-09 Monsanto Technology Llc Metabolite transporters
US7238855B2 (en) 2001-05-09 2007-07-03 Monsanto Technology Llc TyrA genes and uses thereof
US7244877B2 (en) 2001-08-17 2007-07-17 Monsanto Technology Llc Methyltransferase from cotton and uses thereof
US7553952B2 (en) 2001-08-17 2009-06-30 Monsanto Technology Llc Gamma tocopherol methyltransferase coding sequence identified in Cuphea and uses thereof
US7595382B2 (en) 2001-08-17 2009-09-29 Monsanto Technology Llc Gamma tocopherol methyltransferase coding sequences from Brassica and uses thereof
US7605244B2 (en) 2001-08-17 2009-10-20 Monsanto Technology Llc Gamma tocopherol methyltransferase coding sequence from Brassica and uses thereof
US7262339B2 (en) 2001-10-25 2007-08-28 Monsanto Technology Llc Tocopherol methyltransferase tMT2 and uses thereof
US7112717B2 (en) 2002-03-19 2006-09-26 Monsanto Technology Llc Homogentisate prenyl transferase gene (HPT2) from arabidopsis and uses thereof
US7230165B2 (en) 2002-08-05 2007-06-12 Monsanto Technology Llc Tocopherol biosynthesis related genes and uses thereof
FR2844142A1 (en) * 2002-09-11 2004-03-12 Bayer Cropscience Sa Transformed plants or cells, useful for prenylquinone production and resistant to specific herbicides, overexpress prephenate dehydrogenase and p-hydroxyphenyl- pyruvate dioxygenase
WO2004024928A2 (en) * 2002-09-11 2004-03-25 Bayer Cropscience S.A. Transformed plants with enhanced prenylquinone biosynthesis
WO2004024928A3 (en) * 2002-09-11 2004-04-22 Bayer Cropscience Sa Transformed plants with enhanced prenylquinone biosynthesis
US10138490B2 (en) 2002-09-11 2018-11-27 Michel Matringe Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase
WO2004058934A2 (en) * 2002-12-23 2004-07-15 Sungene Gmbh & Co. Kgaa Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content
WO2004058934A3 (en) * 2002-12-23 2004-09-02 Sungene Gmbh & Co Kgaa Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content

Also Published As

Publication number Publication date
WO2000008169A8 (en) 2000-05-04
CA2339519A1 (en) 2000-02-17
AU757440B2 (en) 2003-02-20
AU5415799A (en) 2000-02-28
EP1102852A1 (en) 2001-05-30
JP2002525034A (en) 2002-08-13

Similar Documents

Publication Publication Date Title
EP1102852A1 (en) Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants
WO1999004021A1 (en) Dna sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants
DE60129011T2 (en) NUCLEIC ACID SEQUENCES FOR PROTEINS INVOLVED IN TOCOPHEROL BIOSYNTHESIS
EP1294913B1 (en) Changing the fine chemical content in organisms by genetically modifying the shikimate pathway
EP1299413A2 (en) Homogentisate phytyl transferase
EP1194577A1 (en) Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants
WO2000065036A2 (en) Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants
KR20010105373A (en) Method for Improving the Agronomic and Nutritional Value of Plants
DE19752647C1 (en) Reduction of the chlorophyll content in oil plant seeds
DE19835219A1 (en) Use of 1-deoxy-D-xylulose-5-phosphate synthase DNA to produce plants with increased tocopherol, vitamin K, chlorophyll and/or carotenoid content
DE10046462A1 (en) Improved procedures for vitamin E biosynthesis
WO2001012827A2 (en) Method for production of transgenic plants with increased tocopherol content
WO2000044911A1 (en) Overexpression of a dna sequence coding for a transketolase in plants
DE10111676A1 (en) Increasing vitamin E content in organisms by increasing tyrosine aminotransferase activity
DE19845231A1 (en) Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
DE19845216A1 (en) Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
DE19845224A1 (en) Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content
Abbasi Functional analysis of tocopherol biosynthesis in plant
WO1999022011A1 (en) Reduction of chlorophyll content in oil plant seeds
EP1576164A2 (en) Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content
DE10064454A1 (en) Preparing fine chemicals, particularly Vitamins E and K, useful as antioxidants e.g. in foods or medicine, by growing organisms with altered shikimate biosynthesis pathway
EP1198578A2 (en) PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF
DE10030647A1 (en) Preparing fine chemicals, particularly Vitamins E and K, useful as antioxidants e.g. in foods or medicine, by growing organisms with altered shikimate biosynthesis pathway
DE19632121A1 (en) Transgenic plant cells

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AU BG BR BY CA CN CZ GE HR HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AL AU BG BR BY CA CN CZ GE HR HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
WWE Wipo information: entry into national phase

Ref document number: 1999940083

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2339519

Country of ref document: CA

Ref country code: CA

Ref document number: 2339519

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 54157/99

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1999940083

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09762045

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 54157/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1999940083

Country of ref document: EP